Omega amplification

ABSTRACT

The present disclosure provides compositions, methods and kits for Omega amplification technologies. In addition, the present disclosure provides compositions, methods and kits for universal FQ probe and for G-quadruplex detection methods for use in isothermal amplification technologies.

FIELD

The present disclosure relates generally to compositions and methodsrelated to nucleic acid amplification technologies (NAATs). Inparticular, it relates to improvements in detection of nucleic acidsamplified using NAATs with a preferred emphasis on foldback primermediated isothermal amplification technologies.

SUBMISSION OF SEQUENCE LISTING AS ASCII TEXT FILE

The content of the following submission on ASCII text file isincorporated herein by reference in its entirety: a computer readableform (CRF) of the Sequence Listing (file name: 737962000140SEQLIST.txt,date recorded: May 24, 2017, size: 20 KB).

BACKGROUND

A technique known as loop mediated isothermal amplification (LAMP) hasbecome the focus of significant research and development in thediagnostics and testing industry due to advantages that LAMP has overprior technologies, such as PCR. LAMP is a robust technique that can bepracticed in a single reaction tube with minimal processing of thenucleic acid. Further, LAMP is an isothermal amplification technologyand therefore does not require expensive thermocyclers used for PCR.LAMP has been adapted for a number of applications, such as SNPdetection. An exemplary LAMP-based SNP detection method is disclosed inU.S. Pat. No. 7,175,985, where even a single mismatch at the 5′ end ofone of the looping primers was sufficient to inhibit amplification (see,e.g., Example 1 of U.S. Pat. No. 7,175,985). This highlights the view inthe art of the importance of the ability of the foldback primers to forma new, free 3′ hydroxyl (OH) from which complementary strand synthesiscan occur.

Since the development of LAMP, a number of related techniques andimprovements have been developed. SMAP is similar to LAMP except that itis asymmetric. SMAP uses a single looping primer and a “folding” primerthat folds back on itself rather than onto the template. SMAP can becombined with MutS for detection of nucleic acid polymorphisms insamples (see, e.g., WO2005/063977). GEAR is a variation on LAMPamplification where the two foldback primers fold back on downstreamcomplementary sequences so that only three internal regions are needed.GEAR can also be included with loop acceleration primers so thatflanking “kicker” acceleration primers are not needed. All of theseNAATs are related because at least one of the primers (and typicallytwo) has an additional region at its 5′ terminus that folds back ontothe replicated nucleic acid (template sequence). When the complementarystrand is generated, this becomes a free 3′ end in the complementarystrand that folds back and allows further amplification to occur. Thisability of the foldback primers to generate a new, free 3′ OH from whichfurther strand synthesis can occur is viewed as an important feature inthese amplification reactions.

These foldback amplification technologies are more complicated than PCR,as each amplicon typically requires four primers (or six primers) withsix (or even eight) regions of homology. This complicates multiplexingof these technologies due to the requirement for multiple primers foreach reaction. Further, the use of strand displacing polymerasesprohibits the use of hydrolysis probes (e.g., TAQMAN™), which rely uponthe 5′ to 3′ exonuclease activity of the amplification polymerase. Theconcatenated products of foldback amplification technologies confounddifferentiation of multiple amplification targets on a gel. In onemultiplexed assay, amplicons were selected with restriction sites thatallow resolution of the concatenated products into products that canreadily be separated and identified on a gel (H. Iseki et al. (2007)).However, this assay required additional processing steps. In anothermultiplex assay, duplexed probes were used which have a quencher in onestrand and a fluorescent probe in the second strand. Duringamplification, the strands are displaced, allowing the fluorescent probeto fluoresce (Biosensors and Bioelectronics 30 (2011) 255-260). Thisprocess complicates manufacturing, as at least one of the probesrequires a double stranded portion and specific fluorescent probes needto be designed for each detection reaction.

Thus, there is a need for additional technologies that improve detectionof nucleic acids amplified using NAATs generally, and particularly fortechnologies that improve detection of fold back amplificationtechnologies without requiring additional primers, regions of homology,or more complicated probes which necessitate synthesis of two strands.

SUMMARY

The disclosed invention provides methods of monitoring isothermalamplification of a target DNA in real time through monitoringinteraction between specific detection probe and universal detectionprobes or chemicals. The current inventions enable to detect multipletargets isothermal amplification in real time. The methods generallycomprise providing a reaction mixture comprising a target nucleic acid,and a specific detection probe, and the universal detection probes. Thesignal generated through interaction between the specific detectionprobe and universal detection probe monitors the isothermalamplification of a target nucleic acid in real time. The specificdetection probe comprises a specific probe sequence, which can be anarbitrary sequence, that is linked to the 5′ of a target specific primeror probe. The specific probe sequence may also hybridize with a providedsecond oligonucleotide that is complementary to the specific probesequences. The provided second oligonucleotide may be linked with thespecific probe sequence through a linker covalently. The linker may ormay not block polymerase extension. The universal detection probe (auniversal fluorescent quencher (FQ) probe) comprises two oligonucleotidestrands, wherein a first oligonucleotide strand comprises a quencherprobe positioned at a 3′ end and wherein a second oligonucleotide strandof the universal FQ probe comprises a fluorophore conjugated at a 5′ endand is complementary to the first oligonucleotide stand at its 5′portion. Alternatively, the first oligonucleotide strand comprises afluorophore probe positioned at a 3′ end and wherein a secondoligonucleotide strand of the universal FQ probe comprises a quencherconjugated at a 5′ end and is complementary to the first oligonucleotidestand at its 5′ portion. In some embodiments, the 3′ portion of thesecond oligonucleotide stand contains a full sequence or part of thespecific probe sequence or the specific probe complementary sequence. Insome embodiments, a ratio of the amount of the second oligonucleotidestrand to the amount of the first oligonucleotide strand that is addedto the reaction mixture may be less than 1:1. A DNA polymerase may alsobe added to the reaction mixture. Fluorescence emitted by the reactionmixture including the specific probe and the FQ probe and the target DNAcan be measured. In some embodiment, the universal detection probe maybe single strand oligonucleotides, wherein the quencher and fluorophoremay be labeled at 3′ or 5′ end or at middle of the oligonucleotides. Inanother embodiment, the universal detection probes comprises more thanone set of oligonucleotides, wherein the specific detection probetriggers the sequential interaction amount the sets of oligonucleotidesto generate detection signal. In another embodiment, the specific probesequence may be used as a template to interact with the universaldetection probes.

In the presence of strand displacing DNA polymerase, once the specificprobe containing template-specific primer is involved in theamplification reaction, the complementary sequence of the specific probesequence is generated. When a second oligo complementary to the specificprobe sequence is already hybridized to the specific probe sequence, thesecond oligo will be displaced away from the specific probe. Thesynthesized or displaced sequence complementary to the specific probesequence will interact with the universal FQ probe, generatingdetectable fluorescent signal. In another embodiment, the generatedcomplementary sequence of the specific probe sequence duringamplification will interact with universal detection probe to generatedetection signal. Alternatively, the synthesized or displaced sequencecomplementary to the specific probe sequence contains certain structuralfeatures, such as G-quadruplex or other aptamer binding capabilities.Detection of the formation of such nucleic acids' structural featurescan reflect the proceedings of the target amplification reactions.

The interaction between the complementary sequence of the specific probesequence and the universal FQ probe can be DNA polymerase independent,such as in the case of molecular beacon and Yin-yang probes. In thiscase, the hybridization of the complementary sequence of the specificprobe sequence to the universal FQ probe causes separation or structuralchange between the fluorescent and quench moieties in the FQ probe,giving the fluorescent signal. The interaction between the complementarysequence of the specific probe sequence and the universal FQ probe canalternatively be DNA polymerase dependent. In this case, the newlysynthesized/displaced complementary sequence of the specific probesequence serves as a primer on the universal FQ probe and extends on theFQ probe as template, displacing the quench moiety away from thefluorescent moiety of the FQ probe and giving the fluorescent signal. Inanother case, the newly synthesized/displaced complementary sequence ofthe specific probe sequence serves as a template for the universal FQprobe and extends on the specific probe sequence to generate thefluorescent signal changes.

The interaction between the complementary sequence of the specific probesequence or displaced sequence and the universal probe can be utilizedto further amplify the signal. The newly synthesized complementarysequence of the specific probe sequence or displaced sequence can besubjected to other signal amplification reactions such as rolling cycleamplification (RCA), exponential amplification reaction (EXPAR), and FQinvader sequence amplification.

Another aspect of the present disclosure is the attachment of specificprobe sequences to target-specific primers, such as FIP or BIP inloop-mediated isothermal amplification (LAMP) and related amplificationtechnologies such as SMAP and GEAR technologies. In some embodiments,both the specific probe sequence labeled target-specific primer and thenon-labeled target specific primer are included in the reaction mixture.The ratio of the amount of the specific probe sequence labeledtarget-specific primer and the amount of the non-labeled target specificprimer may be adjusted depending on the amplification and detectionapplications needs.

LAMP (or SMAP and GEAR) technologies require that the 5′ regions,especially the 5′ terminal nucleotide, of the foldback primers (FIP andBIP) anneal by forming base pairs to the synthesized sequences when theprimer is extended on the target template. When the complementary strandof such strand is synthesized, the 3′ region can form base pairs with aregion in the same strand, and the 3′ terminal nucleotide can be usedeffectively as a primer to carry out amplification as specified by LAMP.Introduction of artificial sequences at the 5′ region of FIP or BIPtherefore will result in a 3′ terminal region having a complementaryartificial sequence extruding out and which does not anneal to theupstream sequences. This should prevent the newly synthesized 3′terminus from being used as a primer for strand extension.

Surprisingly, the introduction of extra artificial sequences to the 5′regions of FIP and BIP has only a minimum effect on amplificationefficiency. The 5′ region of the artificial sequence attached to thefoldback primers is a distinguished feature as compared to LAMP, SMAP orGEAR technology. We termed this new technology the OMEGA amplificationtechnology. The extruding sequence that is unique to OMEGA amplificationtechnology allows introduction of additional sequences that can be usedfor detection (especially for multiplex reaction), further accelerationof the amplification reaction, and other uses.

Another aspect of the present disclosure is to improve foldback primeramplification (LAMP, GEAR, SMAP, OMEGA) speed and sensitivity. In oneembodiment, more than one sets of kicker primer (forward kicker primerand reverse kicker primer) are used in the amplification reaction. Inanother embodiment, the kicker primer has additional sequence at 5′ endand behavior as a foldback primer that can hybridize to the downstreamof the same strand DNA molecule when the kick primer is extended duringthe amplification by DNA polymerase. In another embodiment, theadditional sequence at 5′ end of kick primer can be any artificialsequences that can accelerate or inhibit the amplification reaction. Inanother aspect, loop accelerate primer has additional sequence at 5′ endthat can hybridize to the downstream of the same strand DNA moleculewhen the loop accelerate primer is extended after foldback primeramplification initiated by DNA polymerase. In another aspect, thecomplementary of the loop accelerate primer can be used as primer toinitiate additional reaction and amplification. In another aspect, theadditional sequence at 5′ end of the loop primer can be any artificialsequence that can accelerate or inhibit the amplification reaction. Inanother aspect, additional sequences can be added to the stem primers.The additional sequence can hybridize to the downstream sequences or anyartificial sequences as long as they can help to speed up theamplification reactions. In another aspect, additional primer that isthe same to folding sequence of FIB or BIP or the same as extrudingsequence can be added into the reactions. In another aspect, theamplification reaction mixture can include both modified and unmodifiedprimers mentioned previously. The ratios can be used to adjust theamplification reaction speed or sensitivity. For instance, the loopprimers in the reaction mixture can include both with extra sequence at5′ end or without additional sequence at 5′ end. The ratio of withadditional sequence and without additional sequence can be adjusteddepending on amplification and detection applications.

DESCRIPTION OF THE DRAWINGS

The patent or application file contains at least one drawing executed incolor. Copies of this patent or patent application publication withcolor drawing(s) will be provided by the Office upon request and paymentof the necessary fee. The following drawings form part of the presentspecification and are included to further demonstrate certain aspects ofthe present disclosure. The disclosure may be better understood byreference to one or more of these drawings in combination with thedetailed description of specific embodiments presented herein.

FIG. 1A and FIG. 1B show an exemplary implementation of omegaamplification based upon a primer set of one extruding primer and onefoldback primer.

FIG. 2A and FIG. 2B show an exemplary implementation of omegaamplification based upon a primer set of one extruding primer and onehairpin primer.

FIG. 3 shows an exemplary implementation of a detection method in omegaamplification using a universal fluorescent FQ probe and a loop primeras a specific detection probe. During omega amplification reaction, thecomplement of the loop primer will be replaced and then hybridize withthe universal FQ probe to be extended to kick of the quencher togenerate fluorescent signal.

FIG. 4 shows an exemplary implementation of a detection method in omegaamplification using a universal fluorescent FQ probe and a loop primeras a specific detection probe. During the amplification reaction, thenewly synthesized complement of the loop primer will hybridize with theuniversal FQ probe to be extended to kick of the quencher to generatefluorescent signal.

FIG. 5 shows an exemplary implementation of a detection method in omegaamplification using loop primer as a detection probe. The complement ofthe loop primer contains G-quadruplex sequence. During the omegaamplification reaction, the complement of the loop primer will bereplaced to form a G-quadruplex structure which can interact with allkinds of ligands to generate detection signal.

FIG. 6 shows an exemplary implementation of a detection method in omegaamplification using loop primer as universal FQ probe.

FIG. 7 shows an exemplary implementation of a detection method in omegaamplification using a universal FQ probe and a loop primer LB as aspecific detection probe. The complement of loop primer is a FQ invaderlinked at 5′ end of loop primer with C3 linker. During omegaamplification reaction, the replaced FQ invader will hybridize with theuniversal FQ probe to kick off spine cover to generate fluorescentsignal. Once the spine cover is off, the invader kicker can hybridizewith spine to be extended by a polymerase to displace the FQ invader.The displaced FQ invader can hybridize with another universal FQ probeto cycle fluorescent signal amplification.

FIG. 8 shows an exemplary primer design for HPV18 amplification anddetection (SEQ ID NO: 86).

FIG. 9 shows a comparison of real time amplification with Omega primerscontaining extruding sequences on the first (FIP), second (BIP), or onboth primers as compared to LAMP primers not containing extrudingsequences.

FIG. 10 shows a gel image of PCR amplification products produced usingOmega primers containing extruding sequences as compared to LAMP primersnot containing extruding sequences. Lane 1: Omega FIP with extrudingsequences, 10 NT long. Lane 2: Omega BIP with extruding sequences, 10 NTlong. Lane 3: Omega FIP and BIP both contain extruding sequences, 10 NTlong. Lane 4: LAMP amplification as a control.

FIG. 11 shows a gel image of Omega amplification products and LAMPamplification products cut by restriction enzymes. Lane 1: Omegaamplification product by a 10 nt extruding FIP primer was cut by therestriction enzyme EcoRI whose recognition site was located in the E2position (joint sequence inserted between extruding sequence andfold-back sequence of FIP). Lane 2: Omega amplification product by a 22nt extruding BIP primer was cut by the restriction enzyme EcoRI whoserecognition site was located in the E2 position (between extrudingsequence and fold-back sequence of BIP). Lane 3: Standard LAMPamplification product was cut by the restriction enzyme EcoRI whoserecognition site was located in the E1 position (joint sequence insertedbetween F1c and F2 of FIP). Lane 4: Replicate of lane 3. For comparison,lanes 5-8 show the amplification products from lanes 1-4 withoutrestriction enzyme digestion.

FIG. 12 shows an exemplary implementation of omega amplification byeither a forward extruding primer having hairpin structure at 5′terminus or a reverse extruding primer having hairpin structure at 5′terminus, or both.

FIG. 13 shows an exemplary implementation of omega amplification byeither a forward extruding primer having hairpin structure at middle ora reverse extruding primer having hairpin structure at middle, or both.

FIG. 14 shows an exemplary implementation of a signal detection methodin foldback primer amplification using one type of universal detectionprobes system. The universal detection probe having spine sequence (thesecond strand of FQ probe) is labeled with fluorescence at the 3′ endand correspondingly the spine cover (the first strand of FQ probelabeled with quencher at 5′ end) hybridized with spine sequence islabeled with quencher at its 5′ end. Reverse complementary of thespecific detection probe of the loop primer in LAMP amplification isreplaced and becomes single stranded from the reaction, and then servesas a trigger (FQ invader) to replace spine cover to generate detectionfluorescent signal. After displacing the spine cover by the trigger, thetrigger in turn gets displaced by FQ invader kicker primer extension andcan therefore be used in the next round of signal generation.

FIG. 15 shows an exemplary implementation of an exponential signaldetection method in foldback primer amplification using one type ofuniversal detection probes system describe in FIG. 14. The spine islabeled with fluorescence or quencher at the 3′ end and correspondinglythe spine cover hybridized with spine is labeled with quencher orfluorescence at its 5′ end. The spine contains a copy of a triggersequence (inactivated trigger) at its 5′ end and keeps it inactive byhybridizing it with its reverse complementary sequence. Specific probeor reverse complementary of specific probe becomes single stranded fromthe reaction, serves as the trigger, and displaces the spine cover withthe universal primer (FQ invader kicker) to separate fluorescent dyefrom quencher to generate signal. The trigger from the reaction and theinactive trigger gets displaced by universal primer extension and bothcan therefore be used in the next round of signal generation.

FIG. 16 shows an exemplary implementation of an exponential signaldetection method in foldback primer amplification using one type ofuniversal detection probes systems containing two spine covers. Thespine is labeled with fluorescence or quencher at the 3′ end andcorrespondingly the 1st spine cover hybridized with spine is labeledwith quencher or fluorescence at its 5′ end. A single-stranded specificprobe or reverse complementary of specific probe generated from thereaction serves as the invader trigger and displaces the 2nd spine coverwith the help from the invader kicker 2. Extension of invader kicker 2leads to not only displacement of the trigger, but also separation ofthe 1st spine cover from the spine with the help from the invader kicker1, which in turn leads to separation of fluorescent dye from quencher togenerate signal. The trigger from the reaction and the extended productof invader kicker 2 can therefore be used in the next round of signalgeneration.

FIG. 17 shows an exemplary implementation of a G-quadruplex motifmediated exponential signal detection method in foldback primeramplification using one type of universal detection probe systems. Spineis labeled with fluorescence or quencher at the 3′ end andcorrespondingly the spine cover hybridized with spine is labeled withquencher or fluorescence at its 5′ end. A single-stranded specific probeor reverse complementary of specific probe generated from the reactionserves as the invader trigger and displaces the spine cover with thehelp from the invader kicker to generate fluorescence. The invaderkicker contains a partial G-quadruplex forming sequence and theextension of invader kicker along the spine completes the fullG-quadruplex sequence and leads G-quadruplex formation, which in turnallows another invader kicker to hybridize with the spine and todisplace the G-quadruplex-contained elongated product. The trigger fromthe reaction and the G-quadruplex-contained extended product of invaderkicker can therefore be used in the next round of signal generation.

FIG. 18 shows an exemplary implementation of a signal detection methodin foldback primer amplification using one type of universal detectionprobe system featuring signal generation from the invader kicker. Wheninvader trigger is not active in the system, invader kicker forms amolecular beacon structure. Fluorescence labeled at its 5′ end isquenched either by liquid quencher or by a quenching dye internallylabeled near its 3′ end. When the invader trigger becomes available, itdisplaces the cover with the invader kicker. During this process,invader kicker becomes linear and gets extended, leaving the 5′ portionsingle stranded, which leads to increase of fluorescent signal. Theinvader trigger gets displaced by invader kicker extension and cantherefore be used in the next round of signal generation.

FIG. 19 shows an exemplary implementation of a signal detection methodin foldback primer amplification using one type of universal detectionprobe system featuring a probe containing both spine and cover.Fluorescent dye is labeled at 3′ end functioning with intercalatingquencher dye, or self quencher primer (nucleic acid research 2002, vol30, No 9, e37), both of which allows lower fluorescent signal wherebycover portion and spine portion are hybridized with each other to form ahairpin-loop structure. Presence of invader trigger leads to extensionof universal primer along the spine all the way to the 5′ end of thespine-cover probe and displacement of the cover portion. Single strandtagged with fluorescent dye showed increased fluorescent signal byintercalating quencher dye or self quencher primer (nucleic acidresearch 2002, vol 30, No 9, e37).

FIG. 20 shows an exemplary implementation of a signal detection methodin foldback primer amplification using one type of universal detectionprobe system featuring a spine that is capable of self-priming when itis not hybridized with a spine cover. Presence of invader trigger leadsto displacement of the cover and self-priming of the spine. Extension ofthe spine along itself leads to generation of signal as well asrecycling of invader trigger for the next round.

FIG. 21 shows an exemplary implementation of a signal detection methodin foldback primer amplification using one type of universal detectionprobe system featuring a spine that is capable of self-priming afterextension along the invader trigger. When the invader trigger is presentin the system, it serves as a template for the spine. Extension of thespine along the invader trigger generates the sequence that can befolded back onto its reverse complementary sequence located on thespine. Therefore, FQ fluorescent/quencher probe is displaced and signalis generated upon this self-folding and extension.

FIG. 22 shows an exemplary implementation of a signal detection methodin foldback primer amplification using one type of universal detectionprobe system featuring an alternative design of a spine that is capableof self-priming after extension along the invader trigger. The spinecontains a stem-loop structure within the invader trigger bindingregion. When the invader trigger is present in the system, it serves asa template for the spine. Extension of the spine along the invadertrigger generates the sequence that can be folded back onto its reversecomplementary sequence located in the loop region. Therefore, FQfluorescent/quencher probe is displaced and signal is generated uponthis self-folding and extension.

FIG. 23A shows an exemplary experiment result using universal detectionprobes in a real-time isothermal reaction based on the format as shownin FIG. 14. 0 nM (green), 0.8 nM (black), 8 nM (red), 80 nM (light blue)and 800 nM (dark blue) invader trigger was detected in a 25 ul reactioncontaining 0.1 μM spine sequence, 0.1 μM spine cover, 0.8 μM universalprimer. The reaction was carried out at 60° C. for 48 minutes with FAMfluorescence measured at 60 second interval in an ABI StepOne Real-timePCR Instrument™.

FIG. 23B shows comparison result of a LAMP reaction using universaldetection probe as shown in FIG. 9 as compared to a LAMP reaction usingspecific FQ probe

DEFINITIONS

As used herein, the terms “complementary” or “complementarity” are usedin reference to polynucleotides (e.g., a sequence of nucleotides such asan oligonucleotide or a target nucleic acid) related by the base-pairingrules. For example, the sequence “A-G-T” is complementary to thesequence “T-C-A.” Complementarity may be “partial,” in which only someof the nucleic acids' bases are matched according to the base pairingrules. Or, there may be “complete” or “total” complementarity betweenthe nucleic acids. The degree of complementarity between nucleic acidstrands has significant effects on the efficiency and strength ofhybridization between nucleic acid strands. This is of particularimportance in amplification reactions, as well as detection methodswhich depend upon binding between nucleic acids.

As used herein, the term “hybridization” is used in reference to thepairing of complementary nucleic acids. Hybridization and the strengthof hybridization (the strength of the association between the nucleicacids) is impacted by such factors as the degree of complementarybetween the nucleic acids, stringency of the conditions involved, theT_(m) of the formed hybrid, and the G:C ratio within the nucleic acids.

As used herein, the term “T_(m)” is used in reference to the “meltingtemperature.” The melting temperature is the temperature at which apopulation of double-stranded nucleic acid molecules becomes halfdissociated into single strands. The equation for calculating the T_(m)of nucleic acids is well known in the art. As indicated by standardreferences, a simple estimate of the T_(m) value may be calculated bythe equation: T_(m)=81.5+0.41(% G+C), when a nucleic acid is in aqueoussolution at 1 M NaCl (see e.g., Anderson and Young, Quantitative FilterHybridization, in Nucleic Acid Hybridization (1985)). Other referencesinclude more sophisticated computations which take structural as well assequence characteristics into account for the calculation of T_(m).

As used herein the term “stringency” is used in reference to theconditions of temperature, ionic strength, and the presence of othercompounds, under which nucleic acid hybridizations are conducted. With“high stringency” conditions, nucleic acid base pairing will occur onlybetween nucleic acid fragments that have a high frequency ofcomplementary base sequences. Thus, conditions of “weak” or “low”stringency are often required when it is desired that nucleic acidswhich are not completely complementary to one another be hybridized orannealed together.

The term “oligonucleotide” encompasses a singular “oligonucleotide” aswell as plural “oligonucleotides as used herein is defined as a moleculecomprised of two or more deoxyribonucleotides or ribonucleotides,preferably at least 5 nucleotides, more preferably at least about 10-15nucleotides and more preferably at least about 15 to 30 nucleotides. Theexact size will depend on many factors, which in turn depends on theultimate function or use of the oligonucleotide. The oligonucleotide maybe generated in any manner, including chemical synthesis, DNAreplication, reverse transcription, or a combination thereof. Becausemononucleotides are reacted to make oligonucleotides in a manner suchthat the 5′ phosphate of one mononucleotide pentose ring is attached tothe 3′ oxygen of its neighbor in one direction via a phosphodiesterlinkage, an end of an oligonucleotide is referred to as the “5′ end” ifits 5′ phosphate is not linked to the 3′ oxygen of a mononucleotidepentose ring and as the “3′ end” if its 3′ oxygen is not linked to a 5′phosphate of a subsequent mononucleotide pentose ring. As used herein, anucleic acid sequence, even if internal to a larger oligonucleotide,also may be said to have 5′ and 3′ ends. A first region along a nucleicacid strand is said to be upstream of another region if the 3′ end ofthe first region is before the 5′ end of the second region when movingalong a strand of nucleic acid in a 5′ to 3′ direction. When twodifferent, non-overlapping oligonucleotides anneal to different regionsof the same linear complementary nucleic acid sequence, and the 3′ endof one oligonucleotide points towards the 5′ end of the other, theformer may be called the “upstream” oligonucleotide and the latter the“downstream” oligonucleotide. The term “oligonucleotide” may be DNAand/or RNA and/or analogs thereof and/or DNA RNA chimeric/or singlestranded or double stranded/or partial double strand and partial singlestrand. The term oligonucleotide does not denote any particular functionto the reagent, rather, it is used generically to cover all suchreagents described herein. An oligonucleotide may serve variousdifferent functions, e.g., it may function as a primer if it is capableof hybridizing to a complementary strand and can further be extended inthe presence of a nucleic acid polymerase, it may provide a promoter ifit contains a sequence recognized by an RNA polymerase and allows fortranscription, it may contain detection reagents for signalgeneration/amplification, and it may function to prevent hybridizationor impede primer extension if appropriately situated and/or modified.Specific oligonucleotides of the present invention are described in moredetail below. As used herein, an oligonucleotide can be virtually anylength, limited only by its specific function in the amplificationreaction or in detecting an amplification product of the amplificationreaction. As intended by this disclosure, an oligonucleotide does notconsist solely of wild-type chromosomal DNA or the in vivo transcriptionproducts thereof. Oligonucleotides may be modified in any way, as longas a given modification is compatible with the desired function of agiven oligonucleotide as can be easily determined. Modifications includebase modifications, sugar modifications or backbone modifications. Basemodifications include, but are not limited to the use of the followingbases in addition to adenine, cytidine, guanosine, thymine and uracil:C-5 propyne, 2-amino adenine, 5-methyl cytidine, inosine, and dP and dKbases. The sugar groups of the nucleoside subunits may be ribose,deoxyribose and analogs thereof, including, for example, ribonucleosideshaving a 2′-O-methyl (2′-O-ME) substitution to the ribofuranosyl moiety.See “Method for Amplifying Target Nucleic Acids Using Modified Primers,”(Becker, Majlessi, & Brentano, 2000, U.S. Pat. No. 6,130,038). Othersugar modifications include, but are not limited to 2′-amino, 2′-fluoro,(L)-alpha-threofuranosyl, and pentopuranosyl modifications. Thenucleoside subunits may be joined by linkages such as phosphodiesterlinkages, modified linkages or by non-nucleotide moieties which do notprevent hybridization of the oligonucleotide to its complementary targetnucleic acid sequence. Modified linkages include those linkages in whicha standard phosphodiester linkage is replaced with a different linkage,such as a phosphorothioate linkage or a methylphosphonate linkage. Thenucleobase subunits may be joined, for example, by replacing the naturaldeoxyribose phosphate backbone of DNA with a pseudo peptide backbone,such as a 2-aminoethylglycine backbone which couples the nucleobasesubunits by means of a carboxymethyl linker to the central secondaryamine. (DNA analogs having a pseudo peptide backbone are commonlyreferred to as “peptide nucleic acids” or “PNA” and are disclosed byNielsen et al., “Peptide Nucleic Acids,” (Nielsen, Buchardt, Egholm, &Berg, 1996, U.S. Pat. No. 5,539,082). Other linkage modificationsinclude, but are not limited to, morpholino bonds. Non-limiting examplesof oligonucleotides or oligomers contemplated by the present inventioninclude nucleic acid analogs containing bicyclic and tricyclicnucleoside and nucleotide analogs (LNAs), See Imanishi et al.,“Bicyclonucleoside and Oligonucleotide Analogues,” (Imanishi & Obika,2001, U.S. Pat. No. 6,268,490); and Wengel et al., “OligonucleotideAnalogues,” (Wengel & Nielsen, 2003, U.S. Pat. No. 6,670,461), Anynucleic acid analog is contemplated by the present invention providedthe modified oligonucleotide can perform its intended function, e.g.,hybridize to a target nucleic acid under stringent hybridizationconditions or amplification conditions, or interact with a DNA or RNApolymerase, thereby initiating extension or transcription. In the caseof detection probes, the modified oligonucleotides must also be capableof preferentially hybridizing to the target nucleic acid under stringenthybridization conditions. The 3′-terminus of an oligonucleotide (orother nucleic acid) can be blocked in a variety of ways using a blockingmoiety, as described below. A “blocked” oligonucleotide is notefficiently extended by the addition of nucleotides to its 3′-terminus,by a DNA- or RNA-dependent DNA polymerase, to produce a complementarystrand of DNA. As such, a “blocked” oligonucleotide cannot be a“primer.”

The term “primer” refers to an oligonucleotide which is capable ofacting as a point of initiation of synthesis when placed underconditions in which primer extension is initiated. An oligonucleotide“primer” may occur naturally, as in a purified restriction digest or maybe produced synthetically. A primer is selected to be “substantially”complementary to a strand of specific sequence of the template. A primermust be sufficiently complementary to hybridize with a template strandfor primer elongation to occur. A primer sequence need not reflect theexact sequence of the template. For example, a non-complementarynucleotide fragment may be attached to the 5′ end of the primer, withthe remainder of the primer sequence being substantially complementaryto the strand. Non-complementary bases or longer sequences can beinterspersed into the primer, provided that the primer sequence hassufficient complementarity with the sequence of the template tohybridize and thereby form a template primer complex for synthesis ofthe extension product of the primer.

“Hybridization” methods involve the annealing of a complementarysequence to the target nucleic acid (the sequence to be detected; thedetection of this sequence may be by either direct or indirect means).The ability of two polymers of nucleic acid containing complementarysequences to find each other and anneal through base pairing interactionis a well-recognized phenomenon. The initial observations of the“hybridization” process by Marmur and Lane, Proc. Natl. Acad. Sci. USA46:453 (1960) and Doty et al., Proc. Natl. Acad. Sci. USA 46:461 (1960)have been followed by the refinement of this process into an essentialtool of modern biology. With regard to complementarity, it is importantfor some diagnostic applications to determine whether the hybridizationrepresents complete or partial complementarity. For example, where it isdesired to detect simply the presence or absence of pathogen DNA (suchas from a virus, bacterium, fungi, mycoplasma, protozoan) it is onlyimportant that the hybridization method ensures hybridization when therelevant sequence is present; conditions can be selected where bothpartially complementary probes and completely complementary probes willhybridize. Other diagnostic applications, however, may require that thehybridization method distinguish between partial and completecomplementarity. It may be of interest to detect genetic polymorphisms.For example, human hemoglobin is composed, in part, of four polypeptidechains. Two of these chains are identical chains of 141 amino acids(alpha chains) and two of these chains are identical chains of 146 aminoacids (beta chains). The gene encoding the beta chain is known toexhibit polymorphism. The normal allele encodes a beta chain havingglutamic acid at the sixth position. The mutant allele encodes a betachain having valine at the sixth position. This difference in aminoacids has a profound (most profound when the individual is homozygousfor the mutant allele) physiological impact known clinically as sicklecell anemia. It is well known that the genetic basis of the amino acidchange involves a single base difference between the normal allele DNAsequence and the mutant allele DNA sequence. The complement of a nucleicacid sequence as used herein refers to an oligonucleotide which, whenaligned with the nucleic acid sequence such that the 5′ end of onesequence is paired with the 3′ end of the other, is in “antiparallelassociation.” Certain bases not commonly found in natural nucleic acidsmay be included in the nucleic acids of the present invention andinclude, for example, inosine and 7-deazaguanine. Complementarity neednot be perfect; stable duplexes may contain mismatched base pairs orunmatched bases. Those skilled in the art of nucleic acid technology candetermine duplex stability empirically considering a number of variablesincluding, for example, the length of the oligonucleotide, basecomposition and sequence of the oligonucleotide, ionic strength andincidence of mismatched base pairs. Stability of a nucleic acid duplexis measured by the melting temperature, or “T_(m).”

The term “label” as used herein refers to any atom or molecule which canbe used to provide a detectable (preferably quantifiable) signal, andwhich can be attached to a nucleic acid or protein. Labels may providesignals detectable by fluorescence, radioactivity, colorimetry,gravimetry, X-ray diffraction or absorption, magnetism, enzymaticactivity, and the like. A label may be a charged moiety (positive ornegative charge) or alternatively, may be charge neutral.

The term “foldback primer” as used herein, refers to a primer containinga region that can hybridize to the downstream of the same strand DNAmolecule when this primer is extended during the amplification by DNApolymerase. Exemplary foldback primers include, without limitation, theFIP and BIP primers in LAMP and GEAR amplification, the turn-back primerin SMAP amplification and extruding primers in Omega amplification.

The term “foldback primer amplification” as used herein, describes asany isothermal amplification that uses one or more than one primers thathave a region which can hybridize to the downstream of the same strandDNA molecule when this primer is extended during the amplification byDNA polymerase. Exemplary foldback primer amplification include, withoutlimitation, LAMP, SMAP, GEAR, and OMEGA. In one embodiment, a foldbackprimer may be used in the NEAR reaction. In such case, NEARamplification is also counted as foldback primer amplification.

The term “hairpin” as used herein, describes a structure formed by apolynucleotide whose 5′ and 3′ regions form a substantial double-helix.A hairpin primer is a primer containing a hairpin structure as part orwhole of the primer and this hairpin structure can exist at 5′ region orinternal region of the primer. The 5′ region of hairpin sequences willnot hybridize to the same strand downstream sequences after 3′ endpolymerase extension.

The term “extruding primer or extruding probe” as used herein, refers toan oligonucleotide that is used as a primer or a probe containing threeregions. The first region at 3′ end hybridizes with target DNA forpolymerase extension. The second region, in the middle of the extrudingprimer or probe, can hybridize to the downstream of the same strand DNAmolecule when this primer is extended during the amplification by DNApolymerase. The third region at 5′ end, called an extruding sequence,does not hybridize to the downstream of the same strand DNA moleculewhen this primer or probe is extended during the amplification by DNApolymerase. The third region may have any kind of folding structure ormay be single stranded or double stranded or may contain any modifiednucleotides. Any primer in foldback primer amplification with extrasequences added at its 5′ end that does not hybridize to the downstreamof the same strand DNA molecule when this primer is extended during theamplification by DNA polymerase will be counted as an extruding primeror extruding probe. Additional artificial sequences or any unnaturalnucleotides can be included between first region and second region.

The term “extruding sequence” as used herein, refers to anoligonucleotide sequence located at the 5′ end of an extruding primer orextruding probe that does not hybridize to the downstream of the samestrand DNA molecule when this primer is extended during theamplification by DNA polymerase. The extruding sequence may includenatural or unnatural nucleotides or modified nucleotides such asInosine. The extruding sequences may be chimeric sequences. Extrudingsequence may include nicking site, promoter sequences or any otherfunctional sequences or nucleotides that may be used to facilitatetarget amplification and detection.

The term “substantially single-stranded” when used in reference to anucleic acid region means that the nucleic acid region exists primarilyas a single strand in contrast to a double-stranded region which existsas two strands of nucleic acid which are held together by inter-strandbase pairing interactions.

The term “thermostable” when used in reference to an enzyme, such as aDNA polymerase, indicates that the enzyme is functional or active (e.g.,can perform catalysis) at an elevated temperature, e.g., at about 55° C.or higher.

The term “target nucleic acid” refers to a nucleic acid molecule whichcontains a sequence which has at least partial complementarity with atleast a probe oligonucleotide and may also have at least partialcomplementarity with an invader oligonucleotide. The target nucleic acidmay comprise single- or double-stranded DNA or RNA.

The term “amplicon nucleic acids” as used herein refers to any and allof the copies of the template nucleic acid strand or complement ofgenerated by the amplification reactions from target nucleic acids.

The term “specific probe sequence” or “specific detection sequence”refers to either an oligonucleotide or its complementary sequence or anoligonucleotide paired with its complementary sequence oligonucleotidewhich links to 5′ end a primer or a probe and interacts with a universaldetection probe or a chemical or an oligonucleotide or its complementarysequence which itself can be detected because of sequence or structuresfeatures existed in this specific detection sequence. The specificdetection sequence may have internal modification with a moiety to stoppolymerase extension. The specific detection sequence may includeunnatural nucleotides.

The term “a specific detection probe or a detection probe” refers to aprobe or a primer includes a specific detection sequence that can beused to monitor amplification reaction through monitoring signal changefrom a specific detection probe or a detection probe or interactionbetween specific detection sequence and universal detection probe. Inanother embodiment, the specific detection probe includes a specificdetection sequence that may have special structure features whichinteracts with special chemicals or ligands to monitor amplificationreaction. Example of the special structure feature is G-quadruplexstructures or aptamer structures such as ATP aptamer. In Omegaamplification, monitoring amplification can monitor a detection probesignal change directly without monitoring interaction between adetection probe and a universal detection probe. For instance, adetection probe is a primer with a universal FQ probe attached at 5′ endof primers. In this case, two oligonucleotide strands, wherein a firstoligonucleotide strand comprises a quencher probe positioned at a 3′ endand a second oligonucleotide strand of the universal FQ probe comprisesa fluorophore positioned at a 5′ end and is complementary to the firstoligonucleotide stand at its 5′ portion. The 3′ region of the secondoligonucleotide strand of the universal FQ probe will hybridize totemplate as a primer to be extended by a strand displacement polymerase.

The term “universal FQ probe” as used herein refers to twooligonucleotide strands, wherein the first FQ oligonucleotide strandcomprises a quencher moiety and the second FQ oligonucleotide strandcomprises a fluorophore, or the first FQ oligonucleotide strandcomprises a fluorophore and the second FQ oligonucleotide strandcomprises a quencher moiety. The first and second oligonucleotidestrands are complementary and when annealed the quencher moiety quenchesthe fluorescence of the fluorophore. The first and second strands areconfigured so that the first strand can be displaced from the secondstrand or vice versa allowing the fluorophore to fluoresce. In certainembodiments, one strand anneals to a 3′ portion of the other strandallowing an FQ primer to anneal and displace the one strand annealed tothe 3′ portion of the other strand. In certain embodiments, the firstand second oligonucleotide strands of the universal FQ probe are part ofa single oligonucleotide strand folded back on itself. Either strand mayinclude secondary structure or aptamer sequences to facilitate itsreplacement by FQ invader. The second oligonucleotides may includesecondary structure or modified nucleotides to facilitate replacement ofthe FQ invader kicker once it is extended using the secondoligonucleotides as template.

The term “universal detection probe” as used herein refers to anoligonucleotide that will interact with specific probe sequencesdirectly or indirectly. Universal detection probes preferably will notinteract with the template nucleic acid. The universal detection probescan be single stranded or double stranded oligonucleotides. Theseoligonucleotides can include natural or un-natural nucleotides. Theuniversal detection probe can have secondary structures such as stemloop hairpin structures. The universal detection probes can include oneor more than one oligonucleotides. The specific detection probe caninitiate sequential interaction amount these universal detection probesif more than one universal detection probes included in order togenerate detectable amplification signal. The interaction betweenspecific probe sequence and universal detection probes can be polymerasedependent or independent of polymerase activity. When polymeraseinvolves the interaction between specific probe sequences and universaldetection probes, both specific probe sequences and universal detectionprobe can be used either as a primer or a template. A typical example ofa universal detection probe is the universal FQ probe that may includefour basic components—a universal primer (FQ invader kicker), a trigger(FQ invader, a part of the specific detection probe), a spine sequence(the second strand FQ probe), and a spine cover (the first strand of theFQ probe). A trigger refers to an oligonucleotides that can interactwith the spine and initiate a cascade of signal amplification anddetection reactions. The trigger is portion of the specific detectionprobe sequences or reverse complementary sequence of the portion of thespecific detection probe sequences, or it can be any sequence generatedor released during amplification. The spine is an oligonucleotidescontaining complementary sequence of the FQ invader kicker, the FQinvader, and the spine cover (the first strand of the FQ probe). A spinecover is hybridized with spine and prevents the FQ invader kicker frombeing extended when the trigger is not hybridized with spine. When thetrigger is available and hybridizes with the spine, separates the spinecover form the spine, and allows the FQ invader kicker to hybridize withthe spine and to get extended by a DNA polymerase with stranddisplacement activity. In turn, the trigger gets displaced andhybridizes with another un-reacted spine. Some formats may combine twoof the basic components in a single oligonucleotides via a stem loopstructure. Some formats of the universal detection probe may alreadyhave a trigger hybridized with its complementary sequence as part of thespine or as a separate oligonucleotides in order to exponentiallyamplify fluorescent signal. Some formats of the universal detectionprobe may carry the fluorophore and quencher on spine and spine cover,or vice versa, whereas other formats may carry fluorophore and quencherin the FQ invader kicker, or a separate universal FQ probe is providedto generate fluorescent signal. Some formats may only carry fluorophorewithout a quencher in the system, and use intercalating dye as afluorescence quencher (patent pub. NO.: US 2012/0282617 A1).

The term “FQ invader” refers to a part of specific probe sequencereleased or generated during amplification. The FQ invader interactswith the universal detection probe or universal FQ probe wherein the FQinvader anneals to the second strand of the FQ probe, displaces thefirst strand of the FQ probe from the FQ probe and in turn separates thefluorophore from the quencher, allowing the fluorophore to fluoresce.Alternatively, the FQ invader can be used as a template to interact withuniversal detection probe to generate detection signal.

The term “FQ invader kicker” refers to a specific oligonucleotide thatwill hybridize to the second strand of the FQ probe only after the FQinvader anneals to the second strand of the FQ probe. Under stranddisplacement amplification condition, FQ invader kicker is a primer touse the second stand of the FQ probe as a template to be extended toreplace FQ invader. The newly replaced FQ invader can be cycled toinitiate another round signal generation. The FQ invader kicker mayattach fluorescent dye to generate detectable amplification signal. TheFQ invader kicker may include artificial sequences at its 5′ end. The FQinvader kicker may include mismatch near its 3′ end when it hybridizesto the second strand of the FQ probe.

The term “FQ invader kicker replacement” refers to a primer or a probeor a reaction that will replace the FQ invader kicker once the FQinvader kicker is extended along the second strand of the FQ probe. TheFQ invader kicker replacement can occur based on nicking extensionreplacement reaction, aptamer reaction, strand exchange reaction, etc.

The term “sequence variation” as used herein refers to differences innucleic acid sequence between two nucleic acids. For example, awild-type structural gene and a mutant form of this wild-type structuralgene may vary in sequence by the presence of single base substitutionsand/or deletions or insertions of one or more nucleotides. These twoforms of the structural gene are said to vary in sequence from oneanother. A second mutant form of the structural gene may exist. Thissecond mutant form is said to vary in sequence from both the wild-typegene and the first mutant form of the gene.

The term “displacement” as used herein refers to the release of anoligonucleotide or part of an oligonucleotide from the base-paringinteraction with its complimentary sequences by the action of certainpolymerases with strand-displacement activity during nucleic acidsynthesis.

The term “nucleotide analog or unnatural nucleotide” as used hereinrefers to modified or non-naturally occurring nucleotides such as7-deaza purines (e.g., 7-deaza-dATP and 7-deaza-dGTP), inosine, etc.Nucleotide analogs include base analogs and comprise modified forms ofdeoxyribonucleotides as well as ribonucleotides.

The term “sample” in the present specification and claims is used in itsbroadest sense. On the one hand it is meant to include a specimen orculture (e.g., microbiological cultures). On the other hand, it is meantto include both biological and environmental samples. “Patient samples”include any sample taken from a subject and can include blood, saliva,cerebral spinal fluid, pleural fluid, milk, lymph, sputum, semen, stool,swabs, Broncho Alveolar Lavage Fluid, tissue samples, or urine. Othersuitable patient samples and methods of extracting them are well knownto those of skill in the art. A patient or subject from whom the sampleis taken may be a human or a non-human animal. When a sample is notspecifically referred to as a patient sample, the term also comprisessamples taken from other sources. Examples include swabs from surfaces,water samples (for example waste water, marine water, lake water,drinking water), food samples, cosmetic products, pharmaceuticalproducts, fermentation products, cell and microorganism cultures andother samples in which the detection of a microorganism is desirable.Biological samples may be obtained from all of the various families ofdomestic animals, as well as feral or wild animals, including, but notlimited to, such animals as ungulates, bear, fish, lagamorphs, rodents,etc.

The term “source of target nucleic acid” refers to any sample whichcontains nucleic acids (RNA or DNA). Particularly preferred sources oftarget nucleic acids are biological samples including, but not limitedto blood, saliva, cerebral spinal fluid, pleural fluid, milk, lymph,sputum, semen, stool, swabs, Broncho Alveolar Lavage Fluid, tissuesamples, or urine.

An oligonucleotide is said to be present in “excess” relative to anotheroligonucleotide (or target nucleic acid sequence) if thatoligonucleotide is present at a higher molar concentration that theother oligonucleotide (or target nucleic acid sequence). When anoligonucleotide such as a probe oligonucleotide is present in a cleavagereaction in excess relative to the concentration of the complementarytarget nucleic acid sequence, the reaction may be used to indicate theamount of the target nucleic acid present. Typically, when present inexcess, the probe oligonucleotide will be present at least a 100-foldmolar excess; typically at least 1 pmole of each probe oligonucleotidewould be used when the target nucleic acid sequence was present at about10 fmoles or less.

A sample “suspected of containing” a first and a second target nucleicacid may contain either, both or neither target nucleic acid molecule.

The term “polymerization means” refers to any agent capable offacilitating the addition of nucleoside triphosphates to anoligonucleotide. Preferred polymerization means comprise DNApolymerases.

As used herein, the term “purified” or “to purify” refers to the removalof contaminants from a sample.

The term “recombinant DNA molecule” as used herein refers to a DNAmolecule which is comprised of segments of DNA joined together by meansof molecular biological techniques.

“Nucleic acid sequence” as used herein refers to an oligonucleotide orpolynucleotide, and fragments or portions thereof, which may be single-or double-stranded, and represent the sense or antisense strand. As usedherein nucleic acids can be DNA, RNA, and chimeras thereof. Nucleicacids can be naturally produced or artificially synthesized. Nucleicacids can include or be entirely comprised of non-naturally occurringnucleotides as long as the regions that need to anneal can anneal underthe reaction conditions. By way of example, nucleic acids may have abackbone is formed partially or entirely by phosphorothioate bonds. Thenumber of nucleotides making up a nucleic acid as disclosed herein isnot limited unless expressly specified. For example, the nucleic acidsof the template molecule can be intact eukaryotic chromosomes.Similarly, “amino acid sequence” as used herein refers to peptide orprotein sequence.

“Peptide nucleic acid” (“PNA”) as used herein refers to a molecule whichcomprises an oligomer to which an amino acid residue, such as lysine,and an amino group have been added. These small molecules, alsodesignated anti-gene agents, stop transcript elongation by binding totheir complementary strand of nucleic acid [Nielsen P E et al. (1993)Anticancer Drug Des. 8:53-63].

DETAILED DESCRIPTION

The various implementations of foldback primer amplification all relyupon generation of a new, free 3′ OH for extension when the foldbackprimer is extended during the amplification by DNA polymerase from whichadditional complementary strand synthesis can occur. Certain aspects ofthe compositions, reactions, methods, and kits disclosed herein arebased upon the surprising discovery that the foldback primeramplification efficiency is not dramatically affected when one or moreof the foldback primers have one or more extra nucleotides at its 5′ endthat prevents such generation of a new, free 3′ OH for extension(despite Example 1 of U.S. Pat. No. 7,175,985 indicating that even asingle nucleotide mismatch at the 5′ terminus of a foldback primer caninhibit amplification). The inventors of the present applicationsurprisingly discovered that an extruding sequence can be added at the5′ terminus of the foldback primer where the extruding sequence does nothybridize to the downstream of the same strand DNA molecule when thisfoldback primer is extended during the foldback primer amplification byDNA polymerase. This prevents one important mode of amplification sincethe foldback primer after replication does not provide a new free 3′ OHfor replication due to the presence of the extruding sequence. However,even without this additional 3′ OH mode of extension downstream of thesame DNA strand molecular amplification, the omega amplificationreactions disclosed herein can still be nearly as fast as theamplification reaction where the foldback primer does not have theextruding sequence. In certain aspects, the omega amplification is atleast 20% as fast, at least 30% as fast, at least 40% as fast, at least50% as fast, at least 60% as fast, at least 70% as fast, at least 80% asfast, at least 90% as fast, or even at least 100% as fast as thecorresponding foldback amplification without any extruding sequences onthe foldback primers.

Omega amplification distinguishes from LAMP, SMAP and GEAR since atleast one of the foldback primers will include an extruding sequence atits 5′ terminus that will not hybridize to the downstream of the samestrand DNA molecule when this primer is extended during theamplification by DNA polymerase. Omega amplification reactions as usedherein are a subset of foldback primer amplification reactions. In someembodiments, the extruding sequence is found at one (or both ends) of anamplicon nucleic acid The extruding sequence preferably will nothybridize to the downstream of the same strand DNA molecule when thisprimer is extended during the amplification by DNA polymerase or atleast will not anneal to the template nucleic acid in proximity to theamplified portion of the template nucleic acid.

The extruding sequence is at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12,14, 16, 18, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200nucleotides. The extruding sequence can be less than 500, 450, 400, 350,300, 250, 200, 150, 100, 90, 80, 70, 60, 50, 45, 40, 35, 30, 25, or 20nucleotides. In certain aspects, the extruding sequence can be 1 to 100nucleotides, 2 to 75 nucleotides, 3 to 50 nucleotides, or 4 to 30nucleotides in length. The extruding sequence can be of any sequence aslong as the sequence will not provide a free ′3 OH to hybridize to thedownstream of the same strand DNA molecule when this primer is extendedduring the omega amplification reaction. By way of example, theextruding sequence in a forward foldback primer will not anneal to theregion immediately 3′ of the F1T region of the template second strand.In some embodiments, the extruding sequence comprises a G-quadruplex, aT7 promoter sequence, a nicking site, or an FQ sequence. In someembodiments, the extruding sequence will be Guanidine-rich (G-rich)because G-rich extruding sequences can accelerate the omegaamplification reactions. In some embodiment, the extruding sequence mayhave a hairpin structure including modified nucleotides or unnaturalnucleotides.

The extruding sequence is an arbitrary sequence since it will nothybridize to the downstream of the same strand DNA molecule when thisprimer is extended during the amplification by DNA polymerase. Theextruding sequence that is unique to OMEGA amplification technologyallows introduction of any additional sequences that can be used fordetection (especially for multiplex reaction), further acceleration ofthe amplification reaction, and other uses.

Another aspect of the present disclosure is to improve foldback primeramplification speed and sensitivity. In one embodiment, the currentinvention discovered that more than one sets of kick primers (forwardkick primer and reverse kick primer) used in the amplification reactioncan improve foldback primer amplification sensitivity. In anotherembodiment, the kick primer having extra sequence at 5′ end that canhybridize to the downstream of the same strand DNA molecule when thekick primer is extended during the amplification by DNA polymerase thatwill increase reaction speed and also improve amplification sensitivity.In another aspect, the current invention discovered that loop accelerateprimer has extra sequence at it's 5′ end that can hybridize to thedownstream of the same strand DNA molecule when the loop accelerateprimer is extended during foldback primer amplification by DNApolymerase. In another aspect, a free 3′ OH from the complementary ofthe loop accelerate primer which a complementary strand synthesizedduring the foldback primer amplification reaction can be used as primerto initiate additional reaction and amplification. In another aspect,extra sequences can be added to the stem primers (WO2010146349). Theextra sequence of the stem primers can hybridize to the downstreamsequences or any artificial sequences as long as they can help to speedup the amplification reactions. In another aspect, extra primers may beadded to the reaction mixture that are the same sequence as the regionsof the folding sequence of FIB or BIP or the same as extruding sequencescan be added into the reactions. In another aspect, for the same primersuch as a FIP as an example, the amplification reaction mixture caninclude the FIP primer both with extruding sequence FIP and withoutextruding sequence FIP primer. The ratios of with extruding sequence FIPand without extruding sequence FIP primer can be used to adjust theamplification reaction speed or sensitivity. In another aspect, the GCcontent of the folding regions of the foldback primers can be used toadjust the reaction speed and sensitivity. The GC content is between 10to 20%, 20 to 30%, 30 to 40%, 40 to 50%, 50 to 60%, 60 to 70%, 70 to80%, ideally between 30 to 40%. For NEAR amplification, one or bothprimers may be designed as extruding primers. The nicking site will belocated within extruding sequences. For TMA amplification, one or bothprimers may be designed as extruding primers. The promoter sequenceswill be located within extruding sequences.

Another aspect of present invention is to use OMEGA technology to detectmutations. The first nucleotide of 3′ end specific probe sequence primeror probe will hybridize over the mutation site and the second nucleotideof 3′ end specific probe sequence will be mismatched with the template.Once both the 3′ end first and second base are mismatched with template,polymerase will not be able to extend the specific probe sequence primeror probe and no amplification signal is detected. However when the firstnucleotide matches with the template, polymerase will be able to extendthe specific probe sequence primer or probe and the amplification signalis detected. The same principle can be used to detect DNA methylation.

Additional aspects of the compositions, reactions, methods and kitsdisclosed herein are based upon novel methods of detection that can beused with the foldback amplification reactions disclosed hereinincluding universal FQ probes and G-quadruplex probes.

As used herein, a template nucleic acid typically has a first strandthat has from 5′ to 3′: an optional F3 template sequence (F3T, FIG. 1),an F2 template sequence (F2T, FIG. 1), an F1 template sequence (F1T,FIG. 1), an R1 complementary template sequence (R1cT, FIG. 1), an R2complementary template sequence (R2cT, FIG. 1), and an optional R3complementary template sequence (R3cT, FIG. 1). A template nucleic acidtypically has a second strand that has from 5′ to 3′: an optional R3template sequence (R3T, FIG. 1), an R2 template sequence (R2T, FIG. 1),an R1 template sequence (R1T, FIG. 1), an F1 complementary templatesequence (F1cT, FIG. 1), an F2 complementary template sequence (F2cT,FIG. 1), and an optional F3 complementary template sequence (F3cT). Insome cases (e.g., GEAR amplification) the F1T and R1cT overlap or areone in the same region (with the corresponding being true for the F1cTand R1T, FIG. 1). While a template nucleic acid has a first and secondstrand, the amplification reactions herein can initiate when a sampleonly has the first strand or the second strand of the template.

The template nucleic acid to be used in the reactions disclosed hereininclude without limitation, cDNA, genome DNA, DNA-RNA hybrids, mRNA,miRNA, rRNA, tRNA, etc. In addition, the template nucleic acid can beinserted in a vector (and can include part of the vector and part of theinsert). The target nucleic acid used in the reactions disclosed hereinmay be purified or crude nucleic acid or chemically synthesized.Moreover, the reactions disclosed herein can be performed with targetnucleic acid in cells (in situ). In-situ genomic analysis can beperformed using as the template a double-stranded or single strandednucleic acid in cells.

When an mRNA (or other RNA) is a template nucleic acid, the mRNA mayfirst be converted to an RNA-DNA hybrid or cDNA through use of a reversetranscriptase. Preferably, the reverse transcriptase is active under thereaction conditions and can therefore be included in the amplificationreaction mixture. When the DNA polymerase used in the amplificationreactions disclosed herein has a reverse transcriptase activity, theRNA-DNA hybrid or cDNA synthesis can be performed using it as a singleenzyme under the same conditions as for the amplification reaction. Forexample, Bca DNA polymerase or BST DNA polymerase is a DNA polymerasehaving strand displacement activity as well as reverse transcriptaseactivity. As a matter of course, the amplification reactions disclosedherein can also be performed after the formation of the RNA-DNA hybridor even after complete double-stranded cDNA by the second strandsynthesis, which can be performed separately from the amplificationreaction.

The “amplicon nucleic acids” are any and all of the copies of thetemplate nucleic acid strand generated by the amplification reactionsdisclosed herein. The first primer dependent copy of the templatenucleic acid generated by the amplification reactions disclosed hereinis the “principal amplicon”. The first copy of the principal amplicongenerated by the amplification reactions disclosed herein is the “firstgeneration amplicon.” Further copies of the first generation amplicon(and copies of these copies, etc.) generated by the amplificationreactions disclosed herein are the “next generation amplicons”. Theamplicon nucleic acids therefore include all of the principal amplicons,the first generation amplicons, and the next generation amplicons.

As used herein nucleic acids can be DNA, RNA, and chimeras thereof.Nucleic acids can be naturally produced or artificially synthesized.Nucleic acids can include or be entirely comprised of non-naturallyoccurring nucleotides as long as the regions that need to anneal cananneal under the reaction conditions. By way of example, nucleic acidsmay have a backbone is formed partially or entirely by phosphorothioatebonds. The number of nucleotides making up a nucleic acid as disclosedherein is not limited unless expressly specified. For example, thenucleic acids of the template molecule can be intact eukaryoticchromosomes.

In some embodiments, the present invention relates to means for signalgeneration during nucleic acid strand-displacing amplification, such as,but not limited to, LAMP, SMAP, NEAR, NASBA, TMA, RCA, and EXPAR. In oneaspect, methods of monitoring isothermal amplification of a target DNAare provided. The methods generally comprise providing a reactionmixture comprising a target DNA and one or more target-specific primerscapable of amplifying the target DNA. A specific probe sequence islinked to the 5′ of a target-specific primer. The specific probesequence can be arbitrary sequences. Detection the interaction betweenthe specific probe sequences and other oligonucleotides or chemicalsmonitors the isothermal amplification for nucleic acid templateamplification and detection. For instance, a universal FQ probe is alsoprovided where the probe comprises two oligonucleotide strands, whereina first oligonucleotide strand comprises a quencher probe positioned ata 3′ end and wherein a second oligonucleotide strand of the universal FQprobe comprises a fluorophore conjugated at a 5′ end and iscomplementary to the first oligonucleotide stand at its 5′ portion. The3′ portion of the second oligonucleotide stand contains a full or partof the specific probe sequence. A ratio of the amount of the secondoligonucleotide strand to the amount of the first oligonucleotide strandthat is added to the reaction mixture may be less than 1:1. A DNApolymerase may also be added to the reaction mixture. Fluorescenceemitted by the reaction mixture including the specific probe and the FQprobe and the target DNA can be measured. The present inventioncontemplates use of novel detection methods for various uses, including,but not limited to clinical diagnostic purposes. In some embodiment, theuniversal detection probe may be single strand oligonucleotides, whereinthe quencher and fluorophore may be labeled at 3′ or 5′ end or at middleof the oligonucleotides. In another embodiment, the universal detectionprobes comprises more than one set of oligonucleotides, wherein thespecific detection probe initiates the sequential interaction amount thesets of the universal detection probe oligonucleotides to generateexponential amplification detection signal.

The interaction between the complementary sequence of the specific probesequence and the universal detection probe can be DNA polymeraseindependent, such as in the case of molecular beacon and Yin-yangprobes. In this case, the hybridization of the complementary sequence ofthe specific probe sequence to the universal FQ probe causes separationor structural change between the fluorescent and quench moieties in theFQ probe, giving the fluorescent signal. The interaction between thecomplementary sequence of the specific probe sequence and the universalFQ probe can alternatively be DNA polymerase dependent. In this case,the newly synthesized/displaced complementary sequence of the specificprobe sequence serves as a primer on the universal FQ probe and extendson the FQ probe as template, displacing the quench moiety away from thefluorescent moiety of the FQ probe and giving the fluorescent signal. Inanother case, the newly synthesized/displaced complementary sequence ofthe specific probe sequence serves as a template for the universal FQprobe and extends on the specific probe sequence to generate thefluorescent signal changes.

For an efficient LAMP reaction, six primers are used (two inner primers,two outer primer and two loop primers). A specific probe sequence can beattached upstream to the loop primer sequences. LAMP reaction willresult the synthesis of the complementary sequences of the specificprobe sequence. When the universal FQ probe is provided, the newlysynthesized complementary sequences of the specific probe sequence willhybridize onto the single-stranded region of the universal FQ probe andget extended along the FQ probe by strand-displacing polymerases,resulting in the separation of fluorescent and quenching oligos andhence the generation of fluorescence.

In another embodiment, the specific probe sequences are attachedupstream to the sequences of inner primers in the LAMP (FIP and BIP). Inanother embodiment, the specific probe sequences are attached upstreamto the sequences of gap primers (stem primers) in the LAMP. In anotherembodiment, the specific probe sequences are attached upstream to thesequence of loop primer in the SMAP reaction. In another embodiment, thespecific probe sequences are attached upstream to the sequences offoldback primer (FP) in the SMAP reaction. In another embodiment, thespecific probe sequences are attached upstream to the sequences of gapprimers (stem primers) in the SMAP reaction. In another embodiment, thespecific probe sequences are attached upstream to the sequences of innerprimers in the GEAR (FIP and BIP). In another embodiment, the specificprobe sequences are attached upstream to the sequences of loop primers(LF and LB) in the GEAR reaction. In another embodiment, the specificprobe sequences are attached upstream to any primers that do not containa nicking enzyme recognition site in the NEAR reaction.

In another embodiment, a second oligonucleotide that is complementary tothe specific probe sequence can be added and form a double-helix withthe specific probe sequence. Upon the reaction, the second oligo will bedisplaced off the specific probe sequence and can interact with theuniversal FQ probe to generate fluorescence.

In another embodiment, the second oligonucleotide contains a G-quadruplesequence. Once it is replaced from the specific probe sequences and thisoligonucleotides folds into a correct G-quadruplex conformation whichcan be detected by G-quadruplex detection methods known to those ofskill in the art.

In another embodiment, the second oligonucleotides contains an aptamersequences. Once it is replaced from the specific probe sequences andthis oligonucleotides folds into a correct aptamer conformation whichcan be detected by aptamer detection methods known to those of skill inthe art.

In another embodiment, the single stranded specific probe sequencecontains an RNA transcription promoter sequence. Upon the amplificationreaction, the complementary strand of this primer will be synthesizedwhich will generate a functional RNA transcription promoter. In thepresence of NTPs and the RNA polymerase that can initiate RNAtranscription from this promoter, large amount of RNA transcripts willbe generated. These RNA transcripts can be detected by methods known tothose of skill in the art.

In another embodiment, the single stranded specific probe sequencecontains a nicking endonuclease recognition sequence. Upon theamplification reaction, the complementary strand of this primer will besynthesized which will generate a functional nicking endonucleaserecognition site. In the presence of a corresponding nickingendonuclease, the double-stranded DNA will be nicked at a pre-definedposition. The strand-displacing polymerase will extend the nicked DNAstrand and displace a single-stranded DNA which can be used as templatefor further amplification. In one embodiment, the universal FQ probe isa molecular beacon. In another embodiment, the universal FQ probe is ayin-yang probe. In another embodiment, the universal probe is a circularDNA. In some embodiments, the newly synthesized complementary sequenceof specific probe sequence initiates rolling circle amplification (RCA)and the resulted RCA products are detected by methods known to those ofskill in the art.

In another embodiment, the universal probe is an EXPAR substrate. Insome embodiments, the newly synthesized complementary sequence ofspecific probe sequence initiates an EXPAR cascade and the resultingEXPAR products are detected by methods known to those of skill in theart.

In another embodiment, the universal probe is a FQ invader nucleic acid.In some embodiments, the FQ invader first anneals to the single strandedportion of the FQ probe and then displaces the second strand of the FQprobe where the FQ invader overlaps with the double stranded portion ofthe FQ probe. Displacing the second strand of the FQ probe from the FQprobe separates the fluorophore from the quencher, allowing thefluorophore to fluoresce.

Additional aspects of this disclosure and their various embodiments are[1] A method of detecting a template nucleic acid in a sample using astrand displacement isothermal amplification reaction comprising

-   -   (i) generating the reaction by combining the sample with (a) one        or more amplification primers configured to generate amplicon        nucleic acids from the template nucleic acids under suitable        amplification conditions, and (b) a strand displacement        amplification polymerase;    -   (ii) maintaining the reaction under the suitable amplification        conditions; and    -   (iii) detecting whether amplification occurs or has occurred in        step (ii) by monitoring during or after step (ii) interaction        between (c) a specific detection probe that, under the suitable        amplification conditions, hybridizes to the template nucleic        acid, its compliment, the amplicon nucleic acid or its        compliment, and (d) a universal detection probe.

[2] The method of [1], wherein the universal detection probe is auniversal FQ probe.

[3] The method of [1] or [2], wherein the universal detection probe doesnot anneal to the template nucleic acid or its complement under thesuitable amplification conditions.

[4] The method of any one of [1-3], wherein the interaction between thespecific detection probe and the universal detection probe is throughhybridization during the amplification.

[5] The method of any one of [1-3], wherein the interaction between thespecific detection probe and the universal detection probe is throughhybridization between the complement of the specific detection probe andthe universal detection probe.

[6] The method of any one of [1-3], wherein the interaction between thespecific detection probe and the universal detection probe is throughhybridization and polymerase extension during the amplification.

[7] The method of any one of [1-3], wherein the specific detection probecomprises an internal chemical moiety to stop polymerase extension.

[8] The method of any one of [1-7], wherein the universal detectionprobe comprises a first detection oligonucleotide strand and a seconddetection oligonucleotide strand.

[9] The method of [8], wherein (a) the first detection oligonucleotidestrand comprises a quencher moiety and the second detectionoligonucleotide strand comprises a fluorophore, or (b) the firstdetection oligonucleotide strand comprises a fluorophore and the seconddetection oligonucleotide strand comprises a quencher moiety, whereinthe quencher moiety and the fluorophore are configured so that thequencher moiety quenches the fluorescence of the fluorophore when firstdetection oligonucleotide strand and a second detection oligonucleotidestrand are annealed.

[10] The method of [9], wherein the ratio of the amount of the detectionoligonucleotide strand comprising the fluorophore to the amount of thedetection oligonucleotide strand comprising the quencher moiety is lessthan 1:1.

[11] The method of [9] or [10], wherein the detecting step (ii)comprises measuring fluorescence emitted during the isothermal stranddisplacement amplification.

[12] The method of any one of [8-11], wherein the second detectionoligonucleotide strand comprises an overhanging unmatched segment thatis not complementary to the first detection oligonucleotide strand.

[13] The method of any one of [8-12], wherein the specific detectionprobe or its complement includes an invader that hybridizes to a portionof the overhanging unmatched segment and to a portion of the seconddetection oligonucleotide strand that is complementary to the firstdetection oligonucleotide strand during or after the amplification.

[14] The method of [12], further comprising an invader kicker probeincludes mismatch near its 3′ end or at 3′ end when it hybridizes to thesecond detection oligonucleotide strand.

[15] The method of [14], further comprising an invader kickerreplacement probe to replace the invader kicker probe once the invaderkicker probe is extended along the second detection oligonucleotidestrand.

[16] A method of detecting a template nucleic acid in a sample using astrand displacement isothermal amplification reaction comprising

-   -   (i) generating the reaction by combining the sample with (a) one        or more amplification primers configured to generate amplicon        nucleic acids from the template nucleic acids under suitable        amplification conditions, and (b) a strand displacement        amplification polymerase;    -   (ii) maintaining the reaction under the suitable amplification        conditions; and    -   (iii) detecting whether amplification occurs or has occurred in        step (ii) by monitoring during or after step (ii) an aptamer        probe; wherein the aptamer probe is part of a specific detection        probe that, under suitable amplification conditions, hybridizes        to the template nucleic acid, its compliment, an amplicon        nucleic acid or its compliment.

[17] The method of [16], the aptamer probe is a G-quadruplex probe.

[18] The method of [16] or [17], wherein the G-quadruplex probegenerates a detectable signal selected from the group consisting ofchromogenesis, fluorescence, luminescence, and chemiluminescence.

[19] The method of any one of [1-18], wherein the strand displacementamplification polymerase is selected from the group consisting of BstDNA polymerase, Bca(exo-) DNA polymerase, Klenow fragment of DNApolymerase I, Vent DNA polymerase, Vent(Exo-) DNA polymerase(exonuclease activity-free Vent DNA polymerase), DeepVent DNApolymerase, DeepVent(Exo-) DNA polymerase (exonuclease activity-freeDeepVent DNA polymerase), Φ29 phage DNA polymerase, MS-2 phage DNApolymerase, Z-Taq DNA polymerase (Takara Shuzo), and KOD DNA polymerase(TOYOBO).

[20] The method of any one of [1-18], wherein the strand displacementamplification polymerase is Bst DNA polymerase or Bca(exo-) DNApolymerase.

[21] The method of any one of [1-20], wherein one of the amplificationprimers is foldback primer.

[22] The method of any one of [1-21], wherein the strand displacementisothermal amplification reaction is LAMP, SMAP, GEAR, NEAR, or CPA.

[23] The method of any one of [1-21], wherein the isothermalamplification reaction is omega amplification and the pair of primersare foldback primers and at least one of the foldback primers isextruding primer.

[24] The method of [23], wherein the extruding sequence in the extrudingprimer comprises the specific detection probe sequences.

[25] The method of [23] or [24], wherein the extruding sequencecomprises internal modification to stop polymerase extension.

[26] The method of any one of [1-25], wherein the strand displacementisothermal amplification reaction comprises one or more than one kickeraccelerator primers, or one or more than one stem accelerator primers,or one or more than one loop accelerator primers.

[27] The method of [26], wherein the kicker accelerator primer or loopaccelerator primer or stem accelerator primer comprises foldingsequences at its 5′ end to fold onto its 3′ end downstream sequencesafter 3′ end is extended by a polymerase.

[28] The method of any one of [1-20], wherein the strand displacementisothermal amplification reaction is RCA.

[29] The method of any one of [1-20], wherein the strand displacementamplification is nicking amplification and step (i) includes combining anicking enzyme included in the reaction.

[30] The method of any one of [1-29], wherein the specific detectionprobe is an oligonucleotide that participates in the isothermal stranddisplacement amplification.

[31] An omega amplification primer set comprising a first foldbackprimer and a second foldback primer that allow isothermal amplificationunder suitable omega amplification conditions of a portion of a targetnucleic acid sequence, wherein the first foldback primer comprises afirst extruding sequence at its 5′ terminus or the second foldbackprimer comprises a second extruding sequence at its 5′ terminus.

[32] The omega amplification primer set of [31], wherein:

-   -   (i) the target nucleic acid sequence has a first strand, wherein        the first strand is complimentary to a complementary strand;    -   (ii) the first foldback primer includes from 5′ to 3′:        -   (1-b) a sequence (F1c), wherein the sequence (F1c)            hybridizes to a sequence (F1T) in the complimentary strand            of the target nucleic acid sequence; and        -   (1-c) at the 3′ terminus, a sequence (F2), wherein the            sequence (F2) hybridizes to a sequence (F2cT) in the first            strand of the target nucleic acid sequence,        -   wherein the sequence (F1T) is 3′ of a sequence (F2T) in the            complimentary strand; and the sequence (F2T) is            complementary to the sequence (F2cT);    -   (iii) the second foldback primer includes from 5′ to 3′:        -   (2-b) a second sequence comprising: a sequence (R1c),            wherein the sequence (R1c) hybridizes to a sequence (R1T) in            the first strand of the target nucleic acid sequence,        -   (2-c) at the 3′ terminus, a sequence (R2), wherein the            sequence (R2) hybridizes to a sequence (R2cT) in the            complimentary strand of the target nucleic acid sequence,        -   wherein the sequence (R1T) is 3′ of a sequence (R2T) in the            first strand; and the sequence (R2T) is complementary to the            sequence (R2cT); and    -   (iv) the primer set further comprises:        -   (X) (1-a) a first extruding sequence at the 5′ terminus of            the first foldback primer, wherein the first extruding            sequence is at least 4 nucleotides and cannot hybridize to            the first strand or the complimentary strand, and wherein            the sequence (R1c) is at the 5′ terminus of the second            foldback primer;        -   (Y) (2-a) a second extruding sequence at the 5′ terminus of            the second foldback primer, wherein the second extruding            sequence is at least 4 nucleotides and cannot hybridize to            the first strand or the complimentary strand, and wherein            the sequence (F1c) is at the 5′ terminus of the first            foldback primer; or        -   (Z) (1-a) a first extruding sequence at the 5′ terminus of            the first foldback primers, wherein the first extruding            sequence is at least 4 nucleotides and cannot hybridize to            the first strand or the complimentary strand, and (2-a) a            second extruding sequence at the 5′ terminus of the second            primer, wherein the second extruding sequence is at least 4            nucleotides and cannot hybridize to the first strand or the            complimentary strand.

[33] The omega amplification primer set of [32], wherein a portion ofthe sequence (F1c) can hybridize to a portion of the sequence (R1c).

[34] The omega amplification primer set of [32], wherein the sequence(F1c) and the sequence (R1c) overlap by at least 1, 2, 3, 4, 5, 6, 7, 8,9, 10, 12, 14, 16, 18, 20, 25, or 30 nucleotides.

[35] The omega amplification primer set of any one of [31-34], whereinthe first extruding sequence or the second extruding sequence is atleast 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 25, 30, 35, 40, 45,50, 60, 70, 80, 90, 100, 150, or 200 nucleotides.

[36] The omega amplification primer set of any one of [31-35], whereinthe first extruding sequence or the second extruding sequence is lessthan 500, 450, 400, 350, 300, 250, 200, 150, 100, 90, 80, 70, 60, 50,45, 40, 35, 30, 25, or 20 nucleotides.

[37] The omega amplification primer set of any one of [31-36], whereinthe first extruding sequence or the second extruding sequence is 3 to100 nucleotides, 3 to 75 nucleotides, 3 to 50 nucleotides, or 4 to 30nucleotides in length.

[38] The omega amplification primer set of any one of [31-37], whereinthe first extruding sequence or the second extruding sequence comprisesa G-quadruplex, an aptamer sequence, an RNA promoter sequence, a nickingsequence, or an FQ detection sequence.

[39] The omega amplification primer set of any one of [31-38], whereinthe first extruding sequence or the second extruding sequence is G rich.

[40] The omega amplification primer set of any one of [31-39], whereinthe omega amplification reaction comprises one or more than one kickeraccelerator primers, or one or more than one stem accelerator primers,or one or more than one loop accelerator primers.

[41] The omega amplification primer set of any one of [31-40], whereinthe kicker accelerator primer or loop accelerator primer or stemaccelerator primer comprises folding sequences at its 5′ end to foldonto its 3′ end downstream sequences after 3′ end is extended by apolymerase.

[42] The omega amplification primer set of any one of [31-41], whereinthe first extruding primer or the second extruding primer has hairpinstructure at its 5′ terminus.

[43] The foldback primer amplification primer set of any one of [31-42],wherein foldback primer includes unnatural nucleotides.

[44] The foldback primer amplification primer set of any one of [31-43],wherein the folding hybridization sequence includes unnaturalnucleotides.

[45] A method for determining whether a sample includes a templatenucleic comprising

-   -   (i) combining the sample with the set of omega amplification        primers of any one of [31-44], a strand displacement        amplification polymerase, and a detection probe; and    -   (ii) maintaining the combination under the suitable omega        amplification conditions; and    -   (iii) determining whether the sample includes the template        nucleic acid by monitoring whether the detection probe is        involved in amplification during step (ii) or has been involved        in amplification after step (ii).

[46] A method for assessing the amount of a template nucleic acid in asample comprising

-   -   (i) combining the sample with the set of omega amplification        primers of any one of [31-44], a strand displacement        amplification polymerase, and a detection probe; and    -   (ii) maintaining the combination under the suitable omega        amplification conditions; and    -   (iii) quantifying the amount of the template nucleic acid by        monitoring the detection probe during or after step (ii).

[47] The method of [45] or [46], wherein the monitoring is performedduring step (ii).

[48] The method of any one of [45-47], wherein the monitoring is basedon a chromogenic reaction, a turbidity reaction, a chemiluminescentreaction, or a fluorescent reaction.

[49] The method of any one of [45-47], wherein the monitoring ismonitoring fluorescent signal change from the detection probe.

[50] The method of any one of [45-49], wherein the detection probe has auniversal FQ primer complement attached at its 5′ end.

[51] The method of any one of [44-49], wherein the detection probe is aspecific detection probe and the monitoring is based on interactionbetween the specific detection probe or its complement and a universalFQ probe during amplification or after amplification.

[52] The method of [51], wherein the universal FQ probe comprises afirst FQ oligonucleotide strand and a second FQ oligonucleotide strand.

[53] The method of [52], wherein the first FQ oligonucleotide strand andthe second FQ oligonucleotide strand do not hybridize to the templatestrand under the suitable omega amplification conditions.

[54] The method of [52] or [53], wherein (a) the first FQoligonucleotide strand comprises a quencher moiety and the second FQoligonucleotide strand comprises a fluorophore, or (b) the first FQoligonucleotide strand comprises a fluorophore and the second FQoligonucleotide strand comprises a quencher moiety, wherein the quenchermoiety and the fluorophore are configured so that the quencher moietyquenches the fluorescence of the fluorophore when first FQoligonucleotide strand and a second FQ oligonucleotide strand areannealed and the detecting comprises measuring fluorescence emittedduring the isothermal strand displacement amplification.

[55] The method of [54], wherein the ratio of the amount of the FQoligonucleotide strand comprising the fluorophore to the amount of theFQ oligonucleotide strand comprising the quencher moiety is less than1:1

[56] The method of any one of [52-55], wherein the second FQoligonucleotide strand comprises an overhanging unmatched segment thatis not complementary to the first FQ oligonucleotide strand.

[57] The method of [56], wherein the specific detection probe or itscomplement includes an invader that hybridizes to a portion of theoverhanging unmatched segment and to a portion of the second detectionoligonucleotide strand that is complementary to the first detectionoligonucleotide strand during or after the amplification.

[58] The method of [57], further comprising an invader kicker probeincludes mismatch near its 3′ end or at 3′ end when it hybridizes to thesecond detection oligonucleotide strand.

[59] The method of [58], further comprising an invader kickerreplacement probe to replace the invader kicker probe once the invaderkicker probe is extended along the second detection oligonucleotidestrand.

[60] The method of any one of [45-59], wherein the detection probe oruniversal detection probe includes a G-quadruplex probe or an aptamerprobe.

[61] The method of any one of [45-60], wherein the first extrudingsequence or the second extruding sequence comprises the detection probe.

[62] The method of any of [45-61], wherein the template nucleic acid isa human papilloma virus (HPV).

[63] The method of [62], wherein the HPV is HPV6, HPV11, HPV16, HPV18,HPV35, or HPV73.

[64] The method of [62], wherein the set of omega amplification primersare 18FIP (SEQ ID NO:1) and ex18BIP (SEQ ID NO:4), ex18FIP (SEQ ID NO:2)and 18BIP (SEQ ID NO:3), or ex18FIP (SEQ ID NO:2) and ex18BIP (SEQ IDNO:4), optionally including a kicker acceleration primer 18KF (SEQ IDNO:9) and/or 18 KB (SEQ ID NO:10), optionally including a loopacceleration primer 18LF (SEQ ID NO:5) and/or 18LB (SEQ ID NO:6), andoptionally including an FQ probe comprising FAM-18LB (SEQ ID NO:7) andQ-oligo (SEQ ID NO:8).

[65] The method of [62], wherein the set of omega amplification primersare 73ovlp-exFIP (SEQ ID NO: 15) and 73-BIP (SEQ ID NO:18),7350ovlp-exFIP (SEQ ID NO:16) and 73-BIP (SEQ ID NO:18), or 73-exFIP(SEQ ID NO:17) and 73-BIP (SEQ ID NO:18), optionally including a kickeracceleration primer 73-KF (SEQ ID NO:24) and/or 73-KB (SEQ ID NO:25),optionally including a loop acceleration primer 73ovlp-LF (SEQ IDNO:19), 7350ovlp-LF (SEQ ID NO:20), 73-LF (SEQ ID NO:21), and/or 73-LB(SEQ ID NO:22), and optionally including an FQ probe comprisingFam-73-LB (SEQ ID NO:23) and Q-oligo (SEQ ID NO:8).

[66] The method of [62], wherein the set of omega amplification primersare HPV6G-FIP (SEQ ID NO:27) and HPV6G BIP-22 nt (SEQ ID NO:29),optionally including a kicker acceleration primer HPV6G-KF (SEQ IDNO:33) and/or HPV6G-KB (SEQ ID NO:34), optionally including a loopacceleration primer 73ovlp-LF (SEQ ID NO:19), 7350ovlp-LF (SEQ IDNO:20), 73-LF (SEQ ID NO:21), and/or 73-LB (SEQ ID NO:22), andoptionally including an FQ probe comprising Fam-73-LB (SEQ ID NO:23) andQ-oligo (SEQ ID NO:8).

[67] The method of [62], wherein the set of omega amplification primersare 35-exFIP (SEQ ID NO: 45) and 35-BIP (SEQ ID NO: 37), optionallyincluding a kicker acceleration primer 35-KF (SEQ ID NO: 42) and/or35-KB (SEQ ID NO: 43), optionally including a loop acceleration primer35-LF (SEQ ID NO: 38), 35-FBLF (SEQ ID NO: 39), 35-LB (SEQ ID NO: 40),and/or 35-FBLB (SEQ ID NO: 41), and optionally including an FQ probecomprising 35-LF-FAM (SEQ ID NO: 44)) and Q-oligo (SEQ ID NO:8).

[68] A method of generating amplicon nucleic acids from a templatenucleic acid in a sample using an omega amplification reactioncomprising

-   -   (i) combining the sample with the set of omega amplification        primers of any one of [31-44], and a strand displacement        amplification polymerase; and    -   (ii) generating amplicon nucleic acids by maintaining the        combination under suitable omega amplification conditions.

[69] A method using the set of primers of any one of [32-44] to make anamplicon nucleic acid from the target nucleic acid molecule, wherein theamplicon nucleic acid is capable of forming a first stem and loop at afirst end, is capable of forming either a second stem and loop or afoldback loop at a second end, and has (i) the first extruding sequencelocated at the terminus of the first end, and/or (ii) the secondextruding sequence located at the terminus of the second end, the methodcomprising:

(a) combining a sample with the target nucleic acid molecule with theset of primers of any one of [32-44];

(b) annealing the sequence (F2) of the first primer to the sequence(F2cT) in the first strand of the target nucleic acid molecule;

(c) extending the first primer from its 3′ end, using a suitablepolymerase, to form a first single-stranded nucleic acid moleculecomprising the first primer at the 5′ end and the sequence (R2cT);

(d) displacing the first single-stranded nucleic acid molecule from thetarget nucleic acid sequence;

(e) annealing the sequence (R2) of the second primer to the sequence(R2cT) in the first single-stranded nucleic acid molecule; and

(f) making the replicated portion of the target nucleic acid molecule byextending the second primer from its 3′ end, using a suitablepolymerase, to form a second single-stranded nucleic acid moleculecomprising the second primer at the 5′ end and a sequence complimentaryto the first primer;

wherein the displacing step (d) is carried out by:

(i) annealing the sequence (F2) of an additional first primer to thesequence (F2cT) in the first strand of the target nucleic acid moleculeand extending the additional first primer from its 3′ end, using asuitable polymerase, to displace the first single-stranded nucleic acidmolecule;

(ii) steps (d) and (e); or

-   -   (iii) (1) providing a first kicker primer comprising, at its 3′        terminus, a sequence (F3), wherein the sequence (F3) hybridizes        to a sequence (F3cT) and the sequence (F3cT) is 5′ of the        sequence (F2cT) in the first strand of the target nucleic acid        sequence;        -   (2) annealing the sequence (F3) in the first kicker primer            to the sequence (F3cT) in the first strand of the target            nucleic acid molecule; and        -   (3) extending the first kicker primer from its 3′ end, using            a suitable polymerase, to displace the first single-stranded            nucleic acid molecule.

[70] The method of any one of [45-69], wherein the reaction is at least20% as fast, at least 30% as fast, at least 40% as fast, at least 50% asfast, at least 60% as fast, at least 70% as fast, at least 80% as fast,or even at least 100% as fast as the same reaction where the firstextruding primer does not comprises the first extruding sequence at its5′ terminus and/or the second extruding primer does not comprise asecond extruding sequence at its 5′ terminus.

[71] The method of any one of [45-70], wherein the first extrudingsequence or the second extruding sequence is at least 1, 2, 3, 4, 5, 6,7, 8, 9, 10, 12, 14, 16, 18, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90,100, 150, or 200 nucleotides.

[72] The method of any one of [45-71], wherein the first extrudingsequence or the second extruding sequence is 1 to 100 nucleotides, 2 to75 nucleotides, 3 to 50 nucleotides, or 4 to 30 nucleotides in length.

[73] The method of any one of [45-72], wherein the strand displacementamplification polymerase is selected from the group consisting of BstDNA polymerase, Bca(exo-) DNA polymerase, Klenow fragment of DNApolymerase I, Vent DNA polymerase, Vent(Exo-) DNA polymerase(exonuclease activity-free Vent DNA polymerase), DeepVent DNApolymerase, DeepVent(Exo-) DNA polymerase (exonuclease activity-freeDeepVent DNA polymerase), Φ29 phage DNA polymerase, MS-2 phage DNApolymerase, Z-Taq DNA polymerase (Takara Shuzo), and KOD DNA polymerase(TOYOBO).

[74] The method of any one of [45-72], wherein the strand displacementamplification polymerase is Bst DNA polymerase or Bca(exo-) DNApolymerase.

[75] The method of any one of [45-74], wherein the sample is selectedfrom a specimen, a culture, a patient sample, a subject sample, abiological sample, and an environmental sample.

[76] The method of [75], wherein the patient sample or the subjectsample is from blood, saliva, cerebral spinal fluid, pleural fluid,milk, lymph, sputum, semen, stool, swabs, Broncho Alveolar Lavage Fluid,tissue samples, or urine.

[77] The method of any one of [45-76], wherein the combining stepfurther comprises combining with a reaction accelerator selected fromthe group consisting of one or more acceleration primers, an RNApolymerase promoter, a nicking sequence, and combinations thereof.

[78] The method of [77], wherein the reaction accelerator comprises theone or more acceleration primers and the acceleration primers areselected from the group consisting of kicker acceleration primers, loopacceleration primers, and stem acceleration primers.

[79] The method of [77] or [78], wherein the reaction acceleratorcomprises the RNA polymerase promoter and the RNA polymerase promoter isincluded in the first extruding primer, the second extruding primer, thekicker acceleration primer, the loop acceleration primer, or the stemacceleration primer.

[80] The method of [77], wherein the RNA polymerase promoter is a T7 RNApolymerase promoter.

[81] The method of [77], wherein the reaction accelerator comprises thenicking sequence and the nicking sequence is included in the firstextruding primer, the second extruding primer, the kicker accelerationprimer, the loop acceleration primer, or the stem acceleration primer.

[82] A kit comprising the set of primers of any of [31-44].

[83] The kit of [82], further comprising a strand displacementamplification polymerase.

[84] The kit of [83], wherein the strand displacement amplificationpolymerase is selected from the group consisting of Bst DNA polymerase,Bca(exo-) DNA polymerase, Klenow fragment of DNA polymerase I, Vent DNApolymerase, Vent(Exo-) DNA polymerase (exonuclease activity-free VentDNA polymerase), DeepVent DNA polymerase, DeepVent(Exo-) DNA polymerase(exonuclease activity-free DeepVent DNA polymerase), Φ29 phage DNApolymerase, MS-2 phage DNA polymerase, Z-Taq DNA polymerase (TakaraShuzo), and KOD DNA polymerase (TOYOBO).

[85] The kit of [83], wherein the strand displacement amplificationpolymerase is Bst DNA polymerase or Bca(exo-) DNA polymerase.

[86] The kit of any one of [82-85], further comprising a kickeracceleration primer, a loop acceleration primer, and/or a stemacceleration primer.

[87] The kit of any one of [82-86], further comprising a detectionprobe.

[88] The kit of [87], further comprising a universal detection probethat interacts with the detection probe during isothermal amplification.

[89] The kit of any one of [82-88], further comprising a thermostableluciferase, luciferin and an enzyme that converts inorganicpyrophosphate to ATP.

[90] An amplicon nucleic acid derived from a target nucleic acidsequence comprising from 5′ to 3′:

(2) a second sequence comprising a sequence (R1c);

(3) a sequence (R2), wherein the sequence (R2) hybridizes to a sequence(R2cT) in a complimentary strand of the target nucleic acid sequence;

(4) a sequence (R1T), wherein the sequence (R1T) hybridizes to thesequence (R1c); (5) a sequence (F1cT);

(6) a sequence (F2c), wherein the sequence (F2c) hybridizes to asequence (F2T) in the complimentary strand of the target nucleic acidsequence; and

(7) a sequence (F1), wherein the sequence (F1) hybridizes to (F1cT)

wherein the nucleic acid further comprises:

-   -   (X) (8) a first extruding sequence at the 3′ terminus, wherein        the first extruding sequence is at least 4 nucleotides and        cannot hybridize to the template nucleic acid or its compliment,        and wherein the sequence (R1c) is at the 5′ terminus;    -   (Y) (1) a second extruding sequence at the 5′ terminus, wherein        the second extruding sequence is at least 4 nucleotides and        cannot hybridize to the template nucleic acid or its compliment,        and wherein the sequence (F1) is at the 3′ terminus; or

(Z) (8) a first extruding sequence at the 3′ terminus, wherein the firstextruding sequence is at least 4 nucleotides and cannot hybridize to thetemplate nucleic acid or its compliment, and (1) a second extrudingsequence at the 5′ terminus, wherein the second extruding sequence is atleast 4 nucleotides and cannot hybridize to the template nucleic acid orits compliment.

I. Foldback Primers

An aspect of the invention is the use of foldback primers in theamplification reactions described herein. An amplification reaction thatincludes at least one pair of foldback primers is foldbackamplification.

A. LAMP Primers

LAMP primers in the simplest form include two foldback primers designedto generate loops by folding back on the template (or the portion of thetemplate within the amplicon). The forward foldback primer for LAMPincludes a 5′ F1 complementary sequence (F1c, FIG. 1) that anneals tothe F1T sequence of the template nucleic acid sequence and a 3′ F2sequence (FIG. 1) that anneals to the F2cT sequence of the templatenucleic acid sequence. The reverse foldback primer for LAMP includes a5′ R1 complementary sequence (R1c, FIG. 1) that anneals to the R1Tsequence of the template nucleic acid sequence and a 3′ R2 sequence(FIG. 1) that anneals to the R2cT sequence of the template nucleic acidsequence. The forward and reverse primers may include one or morenucleotides between the F1c and F2 sequences and the R1c and R2sequences or they may overlap where they share a common sequence. TheF2T and F1T sequences and the R2T and R1T sequences of the templatenucleic acid sequence may have an intervening nucleic acid sequence.Preferably, the intervening sequence should not be so long that theeffective local concentration of the F1c sequence and the F1T sequenceor of the R1c sequence and the R1T sequence no longer results inself-annealing of the amplified nucleic acid being preferential overannealing of two separate molecules. Thus, a preferred length of theintervening sequence between the 2T and 1T sequences is typicallybetween 0 and 500 nucleotides, between 5 and 250 nucleotides, or between10 and 100 nucleotides. However, in some cases, too short of anintervening sequence may be disadvantageous for forming a self-annealingloop. Further, it is desirable that the formed loop has a structure thatenables annealing of a new forward loop primer (or a loop accelerationprimer where that form of acceleration is being used) and a smooth startto strand displacement complementary strand synthesis reaction. Thus,more preferably, the primers are designed such that the distance betweenthe 2T and 1T sequences is between 0 and 100 nucleotides or between 10and 70 nucleotides. The F1C sequences or R1C sequences can besubstantially complementary to the 3′ end downstream sequences after the3′ end is extended by a polymerase. For mutation detection, the 5′ endnucleotide of F1C or R1C can be designed to not complementary to themutation site to result in non-amplification or less degree ofamplification. The same approach can be applied for methylationdetection.

B. SMAP Primers

SMAP primers in the simplest form include a hairpin primer that foldsback on itself and a foldback primer designed to generate loops byfolding back on the template (or the portion of the template within theamplicon). The hairpin primer does not include sequences to fold ontodownstream of the 3′ end hairpin primer extension sequences. Forconvenience, the hairpin primer is referred to as the forward primer andthe foldback primer is referred to as the reverse primer, but this is anarbitrary designation. The hairpin primer can be the reverse primer andthe foldback primer can be the forward primer. The hairpin primer forSMAP includes a 5′ FB1 sequence (FIG. 2) that anneals to the FB1complementary sequence (FB1c, FIG. 2) of the forward primer and a 3′ F2sequence (FIG. 2) that anneals to the F2cT sequence of the templatenucleic acid sequence. The FB1c sequence is between the FB1 and the F2sequences. The reverse primer for SMAP includes a 5′ R1 complementarysequence (R1c, FIG. 2) that anneals to the R1T sequence of the templatenucleic acid sequence and a 3′ R2 sequence (FIG. 2) that anneals to theR2cT sequence of the template nucleic acid sequence. The foldback primercan include all of the features for foldback primers set out in SectionI(A) above. The hairpin primer may include one or more nucleotidesbetween the FB1c and FB1 sequences and between the FB1c and F2 sequencesor they may overlap where they share a common sequence. Preferably, theintervening sequence between the FB1c and FB1 sequences should not be solong that the effective local concentration of the FB1c and FB1sequences no longer results in self-annealing of the amplified nucleicacid being preferential over annealing of two separate molecules. Thus,a preferred length of the intervening sequence between the FB1c and FB1sequences is typically between 0 and 500 nucleotides, between 5 and 250nucleotides, or between 10 and 100 nucleotides. However, in some cases,too short of an intervening sequence may be disadvantageous for foldingand self-annealing. Further, in some instances it is desirable that theintervening sequence between the FB1c and FB1 sequences have a structurethat enables annealing of a loop acceleration primer and a smooth startto strand displacement complementary strand synthesis reaction. Thus,more preferably, the primers are designed such that the distance betweenthe FB1c and FB1 sequences is at least 10 nucleotides, at least 15nucleotides, at least 20 nucleotides or at least 30, at least 40nucleotides, at least 50 nucleotides or at least 60 nucleotides inlength or is between 30 and 100 nucleotides when foldback primeramplification is applied.

C. GEAR Primers

GEAR primers are subsets of SMAP primers or LAMP primers where the F1Tand R1cT overlap or are one in the same (with the corresponding beingtrue for the F1cT and R1T). The overlap between the F1T and the R1cT canbe at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 25, or 30nucleotides or the F1T and R1cT are one in the same. Otherwise, GEARprimers can have all of the features of LAMP primers and/or SMAP primersset out in Sections I(A) and I(B), above.

D. Common Features of Annealing Portions of Primers

The foldback primers and acceleration primers all include one or moresequences that anneals to the target nucleic acid, to the ampliconnucleic acids or to both under the reaction conditions. Annealingsequences therefore will be of sufficient length and composition ofnucleotides to enable such annealing with the required specificity underthe amplification reaction conditions. An annealing sequence is also apriming sequence if it provides at least one free 3′-OH group thatserves as the origin of strand synthesis for the strand displacementamplification polymerase. A primer will have at least one primingsequence. The minimal length of a primer recognized by known polymerasescatalyzing sequence-dependent nucleic acid synthesis is around 5nucleotides. In addition, to ensure a high probability ofnucleotide-sequence specificity, it is preferred to use an annealingsequence comprising ten nucleotides or more. Thus, the annealingsequence will preferably be at least 10 nucleotides, at least 20nucleotides, at least 30 nucleotides, at least 40 nucleotides, at least50 nucleotides, at least 60 nucleotides, or even at least 70 nucleotidesin length. On the other hand, longer nucleotide sequences are moreexpensive to chemically synthesize and therefore the upper limitsdisclosed herein are preferable. Preferably, the annealing sequences arefrom 5 to 200 nucleotides long, and more preferably are from 10 to 50nucleotides long.

Thus, annealing sequences will typically be substantially complementaryto the sequence to which it anneals. The term “substantiallycomplementary” means that the annealing sequence has sufficientcomplementarity to anneal to the sequence on the template nucleic acidand/or amplicon nucleic acid under the amplification reactionconditions. This typically requires that the annealing sequence has atleast 70%, 80%, 90%, 95%, 99% or 100% complementarity to the sequence onthe template nucleic acid and/or amplicon nucleic acid under theamplification reaction conditions.

E. Extruding Sequences

For omega amplification, at least one of the foldback primers willinclude an extruding sequence at its 5′ terminus. The extrudingsequences can be any kinds of oligonucleotides including natural orunnatural nucleotides. The foldback primers including extrudingsequences are called extruding primers. Omega amplification reactions asused herein are a subset of foldback primer amplification reactions. Insome embodiments, the extruding sequence is found at one (or both ends)of an amplicon nucleic acid. The extruding sequence therefore will notprovide a free ′3 OH from which a complementary strand can besynthesized during the omega amplification reaction. The extrudingsequence preferably will not anneal to the template nucleic acid at allor at least will not anneal to the template nucleic acid in proximity tothe amplified portion of the template nucleic acid.

The extruding sequence is at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12,14, 16, 18, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 150, or 200nucleotides. The extruding sequence can be less than 500, 450, 400, 350,300, 250, 200, 150, 100, 90, 80, 70, 60, 50, 45, 40, 35, 30, 25, or 20nucleotides. In certain aspects, the extruding sequence can be 1 to 100nucleotides, 2 to 75 nucleotides, 3 to 50 nucleotides, or 4 to 30nucleotides in length. The extruding sequence can be of any sequence aslong as the sequence will not provide a free ′3 OH from which acomplementary strand can be synthesized during the omega amplificationreaction. By way of example, the extruding sequence in a forwardfoldback primer will not anneal to the region immediately 3′ of the F1Tregion of the template second strand. In some embodiments, the extrudingsequence comprises a G-quadruplex, a T7 promoter sequence, a nickingsite, or an FQ sequence. In some embodiments, the extruding sequencewill be G rich because G-rich extruding sequences can accelerate theomega amplification reactions.

II. Reaction Accelerators

In addition to the foldback primers discussed above, the amplificationreactions may include one or more additional “acceleration primers” thatcan accelerate the rate of the amplification reaction such as kickeracceleration primers, loop acceleration primers, and stem accelerationprimers. In certain embodiments, the amplification reaction may alsoinclude other accelerators that can be incorporated into one or morefoldback primers and one or more acceleration primers. The accelerationprimers and the other accelerators are not mutually exclusive andtherefore can be used in any combination.

A. Kicker Acceleration Primers

Kicker acceleration primers are primers that have sequences that annealto a strand of the target nucleic acid 5′ of where the correspondingfoldback primer anneals (e.g., F3 and R3 of the target nucleic acid).For example, the forward kicker acceleration primer will comprise an F3sequence (FIG. 1 and FIG. 2) that anneals 5′ of the forward foldbackprimer which allows the strand displacement amplification polymerase todisplace the newly synthesized strand incorporating the forward foldbackprimer. The reverse kicker acceleration primer will comprise an R3sequence (FIG. 1 and FIG. 2) that anneals 5′ of the reverse foldbackprimer which allows the strand displacement amplification polymerase todisplace the newly synthesized strand incorporating the reverse foldbackprimer. Kicker acceleration primers may be simple primers that onlycomprise the annealing sequence F3 or R3, as applicable. In otherembodiments, the kicker acceleration primers may include additionalnucleotides on the 5′ end such as additional sequences for detection(e.g., an RNA polymerase promoter, an FQ primer complementary sequence,a second strand comprising an FQ primer or an FQ invader, etc.)),further acceleration (e.g., an RNA polymerase promoter or a nickingsequence), or even additional sequences so that the kicker accelerationprimer is an additional foldback primer to fold onto downstream of its3′ end extension sequences. In other embodiments, more than one forwardkicker acceleration primers or reverse kicker acceleration primers areused to increase the speed and sensitivity of the reaction.

B. Loop Acceleration Primers

Loop acceleration primers are primers that have sequences that anneal tothe loop formed when the strand of a foldback primer has been generatedor when the complementary strand of a foldback primer that include aloop has been generated. For example, a forward loop acceleration primerwill anneal to the template nucleic acid between F2(T) and F1T (FIG. 1).Extension and strand displacement from such a forward loop accelerationprimer will allow a new forward foldback primer to anneal to the F2cTsequence of the template nucleic acid. Similarly, a reverse loopacceleration primer will anneal to the template nucleic acid betweenR2(T) and R1T (FIG. 1). Extension and strand displacement from such aforward loop acceleration primer will allow a new forward foldbackprimer to anneal to the R2cT sequence of the template nucleic acid. Loopacceleration primers may be simple primers that only comprise theannealing sequence. In other embodiments, the loop acceleration primersmay include additional nucleotides on the 5′ end such as additionalsequences for detection (e.g., an RNA polymerase promoter, an FQ primercomplementary sequence, a second strand comprising an FQ primer or an FQinvader, etc.)), further acceleration (e.g., an RNA polymerase promoteror a nicking sequence), or even additional sequences so that the loopacceleration primer is an additional foldback primer or hairpin primer.

The disclosed invention discovered that the 5′ end sequence of loopprimer folding onto 3′ end of loop primer downstream sequences after the3′ end of loop primer is extended by polymerase can speed up thereaction and improve reaction sensitivity. The folding region can have alength of at least 5 nucleotides, at least 10 nucleotides, at least 15nucleotides, at least 20 nucleotides, at least 30 nucleotides, at least50 nucleotides, at least 100 nucleotides at least 200 nucleotides, atleast 300 nucleotides or at least 500 nucleotides. In anotherembodiment, the 5′end loop primer sequences can have chemical moiety tostop polymerase extension at a specific or intended location. In apreferred format, the 5′ end sequence of the loop primer is F1C sequencewhen the loop primer is a forward loop primer and the 5′ end sequence ofthe loop primer is R1C sequence when the loop primer is a reverse loopprimer. 5′ end loop primer can have different kind of sequence. Forinstance, part of the loop primer has the 5′ end folding sequence tospeed up the reaction and part of the loop primer can have 5′ endartificial sequence to carry FQ probe for detection and part of the loopprimer is fully complementary to the template hybridization sequences.In a specific amplification and detection reaction, the types of 5′ endsequences of loop primer used depends on specific applications andpurpose. An example of foldback primer amplification for mutationdetection, the 5′ end loop primer can have FQ probe and the 3′ end loopprimer can be positioned near or overlap with the mutation site. Amismatch at 3′ end loop primer will not be extended or less extended togenerate detectable amount signal. In order to increase specificity,additional mismatch can be designed near its 3′ end. Alternatively, near3′ end loop primer sequences can include ribonucleotides or O-methylnucleotides. The same approach can be used for methylation detection. Incurtain cases, a mixture of 5′ end of loop primer sequences can be used.Example of a specific amplification might include both partial of theforward loop accelerator primer fully hybridized to template and alsopartial of forward loop accelerator primer including 5′ end artificialsequences. 5′ end of the loop primer folds onto 3′ end of loop primerdownstream sequences after the loop primer is extended is a new type ofprimer for use in foldback primer amplification reactions generally(rather than being specific to omega amplification) and are therefore anindependent aspect of the disclosure.

C. Stem Acceleration Primers

U.S. Patent publication 2012/0157326 discloses stem acceleratedisothermal nucleic acid amplification technology that can be used toaccelerate the omega amplification and the foldback primer amplificationreactions disclosed herein through use of primers which bind to the stemregion, known as “stem primers” (referred to as “stem accelerationprimers” herein, and the application is incorporated by reference hereinfor its teachings regarding stem primers and their use in acceleratingisothermal amplification reactions, but not for any definitionstherein). The annealing region of the stem acceleration primerspreferably do not overlap with the annealing regions of the foldbackprimers. The region between the forward and reverse foldback primerannealing regions (e.g., F1CT and R1T or F1T and R1cT) represents aregion which is guaranteed to form part of the amplicon but does notitself conventionally provide for any primer binding sites in LAMP orSMAP. This region is referred to herein as the “stem region” of theamplicon nucleic acids. The stem region can have a length of at least 5nucleotides, at least 10 nucleotides, at least 15 nucleotides, at least20 nucleotides, at least 30 nucleotides, at least 50 nucleotides, atleast 100 nucleotides at least 200 nucleotides, at least 300 nucleotidesor at least 500 nucleotides.

Stem acceleration primers may be positioned anywhere between the forwardand reverse foldback primer annealing sites in the template nucleic acidprovided that the annealing site(s) of the stem acceleration primer(s)do(es) not significantly overlap with the forward or reverse foldbackprimer annealing sites in the template nucleic acid. When one or both ofthe foldback primers are loop primers, the foldback primer annealingsites in the template nucleic acid are the F1T and/or the R1cTsequences, as applicable, such that the stem acceleration primers arebetween the R1(c)T and F1(c)T sequences when two loop primers are used.

In some aspects, only one stem acceleration primer is used which bindseither the first or second strand of the template nucleic acid (oramplicon nucleic acid). In other aspects, two or more stem accelerationprimers may be used which can bind either to different strands of thetemplate nucleic acid (or amplicon nucleic acid) or to the same strand.The stem acceleration primer methods may be practiced with one, two,three, four or more stem acceleration primers which can be used in anyspatial combination and which may bind either the first or second strandprovided that the annealing sites for the stem acceleration primers donot significantly overlap with the forward or reverse foldback primerannealing regions or do not overlap at all. The stem accelerationprimers may further anneal to any part within the stem region of thetarget nucleic acid. Thus, the stem acceleration primer(s) may have anannealing site which is in close proximity to the forward or reversefoldback primer annealing regions. “Close proximity” means that theannealing region of the stem acceleration primer and the foldback primerannealing region are less than 10, 50, 100, 200, 300, 400, 500, 600,700, 800, 900 or 1000 nucleotides apart.

The stem acceleration primers may be at least 5 nucleotides, at least 10nucleotides, at least 20 nucleotides, at least 30 nucleotides, at least40 nucleotides, at least 50 nucleotides, at least 60 nucleotides, atleast 70 nucleotides, at least 80 nucleotides or at least 90 nucleotidesin length.

The stem acceleration primers may be simple primers. However, the stemacceleration primers that may include additional sequences for detection(e.g., an RNA polymerase promoter, an FQ primer complementary sequence,a second strand comprising an FQ primer or an FQ invader, etc.)),further acceleration (e.g., an RNA polymerase promoter or a nickingsequence), or even additional sequences so that the loop accelerationprimer is an additional folding primer or loop primer. Where more thanone stem acceleration primer is used, the stem acceleration primers maybe of the same kind or may be a combination of different kinds ofprimers (e.g., all simple primers, all detection primers, one simpleprimer and one acceleration primer, etc.).

D. RNA Polymerase Promoters

The amplification reactions herein can also be accelerated by combiningwith other isothermal amplification techniques that are dependent ontranscription as part of the amplification process, for example NucleicAcid Sequence Based Amplification (NASBA; U.S. Pat. No. 5,409,818, whichis incorporated herein for its disclosure on NASBA, but not fordefinitions that conflict with terms and their use herein) andTranscription Mediated Amplification (TMA; U.S. Pat. No. 5,399,491,which is incorporated herein for its disclosure on TMA, but not fordefinitions that conflict with terms and their use herein).

The RNA polymerase promoters can be included in any of the primersincluding: one or more of the extruding primers, one or more of thefoldback primers, one or more of the loop acceleration amplificationprimers, one or more of the kicker amplification primers, one or more ofthe stem amplification primers, or combinations thereof. In preferredembodiments, the RNA polymerase promoter is included in the extrudingsequence on one or more extruding primers. The functional RNA polymerasepromoter is generated when the strand complementary to the primer hasbeen synthesized. The RNA polymerase then binds to the double strandedpromoter and generates RNA that can be detected. In preferredembodiments, the RNA promoter is the T7 promoter and the RNA polymeraseis a thermostable T7 RNA polymerase. In order to carry out RNApolymerase acceleration with the amplification reactions disclosedherein, the reaction will include the strand displacement amplificationpolymerase and an RNA polymerase which catalyze the strand displacementcomplementary strand synthesis reaction. Alternatively, theamplification reaction can be configured to further copy the RNA strandto create more amplicons to amplify. To further accelerate theamplification reaction, a polymerase with reverse transcriptase activitycan be used to create RNA-DNA hybrids for further amplification. Inpreferred embodiments, the strand displacement amplification polymerasewill have reverse transcriptase activity.

E. Nicking Amplification

The amplification reactions herein can additionally be accelerated bycombining with other isothermal amplification techniques that aredependent on strand nicking as part of the amplification process, forexample Nicking and Extension Amplification Reaction for the exponentialamplification of nucleic acids (NEAR; U.S. Pat. Pub. 2009/0081670, whichis incorporated herein for its disclosure on NEAR, but not fordefinitions that conflict with terms and their use herein). The nickingsequence can be included in any of the primers including: one or more ofthe extruding primers, one or more of the foldback primers, one or moreof the loop acceleration primers, one or more of the kicker accelerationprimers, one or more of the stem acceleration primers, or combinationsthereof. Once the complementary strand of primer's strand has beengenerated, the nicking sequence will be created. The nicking enzyme canthen nick the double stranded nucleic acid to produce a 3′ OH from whichthe strand displacement amplification polymerase can extend. In someembodiments, the nicking enzyme will be able to continue to nick eachnew strand extended by the strand displacement amplification polymeraseto continue to accelerate the amplification reaction.

F. Chemicals

Certain chemicals when added to the omega amplification reaction canaccelerate the reaction significantly. The addition of the at least onebland magnesium chelator to the reaction mixture for nucleic acidamplification may, in some cases, speed up the amplification reactions.The bland magnesium chelator is preferably selected from among: sodiumcitrate, acetic acid, ADP, aspartic acid, ATP, n-butyric acid, citricacid, cysteine, 3,4-dihydroxybenzoic acid, 0,0-dimethylpurpurogallin,EDTA, EGTA, gluconic acid, glutamic acid, glutaric acid, glyceric acid,glycine, glycolic acid, glycylglycine, guanosine, B-hydroxybutyric acid,inosine triphosphate, lactic acid, malic acid, NTA, oxalic acid,polyphosphate, propionic acid, purine, salicylaldehyde, salicylic acid,succinic acid, tartaric acid, tetrametaphosphate, trimetaphosphate,triphosphate, uridine diphosphate. Preferably the bland magnesiumchelator is used in a concentration varying from 0.5 to 2 mM, morepreferably from 0.8 to 1.2 mM. The bland magnesium chelator particularlypreferred for the aims of the present invention is sodium citrate.

III. Methods of Amplification

The amplification reactions described herein are generally isothermalamplification methods, which means that the amplification reaction doesnot require a change in the reaction temperature as is required inconventional PCR amplification reactions.

The skilled person will be aware that, in addition to the primers neededfor amplification, the amplification reactions often will requirefurther reagents in order to generate the amplicon nucleic acids. One ofskill in the art will readily be able to determine the additionalreagents (which generally include a suitable buffer, dNTPs, a stranddisplacement amplification polymerase, etc.).

One of skill in the art will further appreciate that it is alsonecessary to provide suitable conditions for the generation of theamplicon nucleic acids. This can be achieved by providing a suitableincubation temperature, for example. It is preferred that amplificationoccurs under isothermal conditions. This means that during amplificationthe temperature is kept constant. “Constant” means that the temperaturevaries by no more than ±10° C., preferably no more than ±5° C. However,the amplification reactions also include methods that encompass a singletemperature change of greater than 10° C., two temperature changes ofgreater than 10° C., three temperature changes greater than 10° C., fourtemperature changes greater than 10° C. or five temperature changesgreater than 10° C. during the amplification process.

Preferably, the amplification reactions disclosed herein (including inpreferred embodiments of the detection methods) are performed in asealed vessel. This is of great utility since it reduces or eveneliminates the possibility of the sample becoming contaminated.Moreover, it reduces or even eliminates the possibility of thelaboratory becoming contaminated. This is particularly important as ifeven one copy of the template nucleic acid or amplicon nucleic acid wereto escape into the laboratory, this could potentially contaminate othersamples to be tested and give false-positive results. Thus, the abilityto prevent contamination is of particular importance where a method ofthe invention is used in a diagnostic application.

A. Strand Displacement Amplification Polymerases

The polymerases for use in the amplification reactions disclosed hereinare strand displacing polymerases. Many such polymerases are known inthe art. Exemplary DNA polymerases include: Bst DNA polymerase,Bca(exo-) DNA polymerase, Klenow fragment of DNA polymerase I, Vent DNApolymerase, Vent(Exo-) DNA polymerase (exonuclease activity-free VentDNA polymerase), DeepVent DNA polymerase, DeepVent(Exo-) DNA polymerase(exonuclease activity-free DeepVent DNA polymerase), 429 phage DNApolymerase, MS-2 phage DNA polymerase, Z-Taq DNA polymerase (TakaraShuzo), and KOD DNA polymerase (TOYOBO). In addition, various mutants ofthese enzymes can be used in the amplification reactions disclosedherein, so long as they have the activity of sequence-dependentcomplementary strand synthesis and the strand displacement activity.Such mutants include truncated enzymes having only the structures withthe catalytic activity or mutant enzymes whose catalytic activity,stability, or thermal stability has been modified by amino acidmutations, and such.

Among these enzymes, Bst DNA polymerase and Bca(exo-) DNA polymerase areparticularly preferred, because they have a high degree of thermalstability and high catalytic activity. Since the amplification reactionsoften require some heating, the use of thermostable enzymes ispreferred. The reaction can be achieved under a wide variety ofconditions using thermostable enzymes. For example, Vent(Exo-) DNApolymerase is a highly thermostable enzyme that has strand displacementactivity. It has been reported that the addition of a singlestrand-binding protein accelerates the reaction of strand displacementcomplementary strand synthesis by DNA polymerase (Paul M. Lizardi etal., Nature Genetics 19, 225-232, July, 1998). When used in theamplification reactions, acceleration of complementary strand synthesisis expected by the addition of single strand-binding protein. WhenVent(Exo-) DNA polymerase is used, T4 gene 32 is effective as the singlestrand-binding protein.

In certain embodiments, the strand displacement amplification polymeraseconcentration may be varied to influence the rate of the amplificationreaction and, thus decrease the time needed for detection of theproduction of the amplicon nucleic acid. For example, in one embodiment,the strand displacement amplification polymerase concentration may begreater than or equal to about 8 U, greater than or equal to about 16 U,greater than or equal to about 24 U, or greater than or equal to about32 U.

B. Reaction Conditions

The amplification reactions disclosed herein are typically carried outin the presence of buffer, providing a pH suitable for the polymerasereaction. In addition, amplification reactions disclosed herein can alsoinclude: salts required for annealing of the various primers and formaintaining the activity of the polymerase (and other optional enzymes),preservatives for the maintaining the polymerase (and other optionalenzymes), and, if desired, a melting temperature (T_(m)) regulator.Examples of salts that can be included to maintain the polymeraseactivity and to modulate the melting temperature (T_(m)) of nucleicacids include KCl, NaCl, (NH₄)₂SO₄, etc. The preservatives that may beused to maintain the polymerase activity include for example serumalbumins such as BSA and sugars such as sucrose, glycerol, etc.

Further, typical melting temperature (T_(m)) modulators include betaine,proline, dimethylsulfoxide (hereinafter abbreviated as DMSO), formamide,and trimethylamine-N-oxide (TMANO). When a melting temperature (T_(m))modulator is used, annealing of the primers described herein can beregulated within a limited temperature range. Moreover, betaine(N,N,N-trimethylglycine) and tetraalkylammonium salts effectivelycontribute to the improvement of the efficiency of strand displacementdue to its isostabilizing action by eliminating the melting temperaturedifference between GC rich and AT rich nucleic acids. The addition ofbetaine, at a concentration of about 0.2 to about 3.0 M, preferablyabout 0.5 to about 1.5 M, to the reaction can enhance the amplificationreactions disclosed herein. Since these melting temperature modulatorsdecrease the melting temperature, a condition giving desired stringencyand reactivity is empirically chosen by considering reaction conditions,such as salt concentration and reaction temperature.

Temperature conditions suitable for enzyme reactions can be readilychosen by utilizing a T_(m) regulator. T_(m) varies, depending on therelation of the primer and target nucleotide sequence. Thus, it ispreferable to adjust the amount of a T_(m) regulator so that theconditions that maintain the enzyme activity are consistent with theincubation conditions that meet the criterion of the present invention.Based on the disclosure of the present invention, those skilled in theart can readily choose proper amounts of a T_(m) regulator to be added,depending on the primer nucleotide sequence. For example, T_(m) can bedetermined based on the length of the annealing nucleotide sequence, theGC content, the salt concentration, and the concentration of the T_(m)regulator.

IV. Detection Methods

The generation of amplicon nucleic acids in the amplification reactionsdisclosed herein may be detected by methods known to those of skill inthe art. Suitable methods include but are not limited to the use offluorescent intercalating dyes, fluorescent primers or probes, measuringturbidity, electrochemical probes, bioluminescent signals andchemiluminescent probes.

The amplification of the target nucleic acid may be detected usingreal-time methods, i.e., methods that can detect the template nucleicacid and/or the amplicon nucleic acids as they are amplified. Examplesof such detection systems include, but are not limited to, fluorescence(e.g., fluorescent probes that are added during the amplificationreaction such as described more fully below), bioluminescent signals andelectrochemical probes. Other suitable reporter systems are readilyavailable to one of ordinary skill in the art. Alternatively, theamplification product may be detected using end-point measurements,i.e., measurements which take place after the amplification of thetemplate nucleic acid and/or amplicon nucleic acids has been completed.

The amplification of the template nucleic acid and/or amplicon nucleicacids can also be detected by other detection methods employed in othernucleic acid amplification systems. Suitable examples include, but arenot limited to, FISH, sequence, gene arrays, lateral flow strips,electrophoresis, mass spectroscopy and acoustic detection.

Further, the primers used in the present invention can be labeled withknown labeling substances. Such labeling substances include ligands withbinding capacity, such as digoxin and biotin; enzymes; fluorescentsubstances; luminescent substances; and radioisotopes. In addition,techniques are known for converting nucleotides in the primers tofluorescent analogues (WO 95/05391; Proc. Natl. Acad. Sci. USA, 91,6644-6648, 1994).

Further, any of the primers used in the amplification reactions can beimmobilized on a solid phase. Alternatively, an arbitrary portion of theprimers may be labeled with a ligand that has binding capacity, such asbiotin, and then can be indirectly immobilized via a binding partner,such as immobilized avidin. When an immobilized primer is used as thesynthesis origin, the synthesized nucleic acid product can beimmobilized on a solid phase, and thus can be readily separated. Theseparated product may be detected by nucleic acid-specific indicators orby further hybridizing a labeled probe. Alternatively, a nucleic acidfragment of interest can be recovered by digesting the nucleic acid withan arbitrary restriction enzyme.

A. FQ Probe

The detection method in current invention is based on interactionbetween the universal detection probe and specific detection probe. Theuniversal detection probe is actually an artificial sequence. The term“universal detection probes” as used herein refers to oligonucleotidesthat will interact with specific probe sequences directly or indirectly.The universal detection probes can be single stranded or double strandedoligonucleotides. These oligonucleotides can include natural orun-natural nucleotides. The universal detection probe can have secondarystructures such as stem loop hairpin structures. The universal detectionprobes can include one or more than one oligonucleotides. The specificdetection probe can initiate sequential interaction amount theseuniversal detection probes if more than one universal detection probesincluded in order to generate detectable amplification signal. Theinteraction between specific probe sequence and universal detectionprobes can be polymerase dependent or independent to polymeraseactivity. When polymerase involves the interaction between specificprobe sequences and universal detection probes, both specific probesequences and universal detection probe can be used either as a primeror a template. A typical universal detection probe may includes fourbasic components—a universal primer (FQ invader kicker), a trigger (FQinvader, a part of specific detection probe or complement of thespecific detection probe), a spine sequence (the second strand FQprobe), and a spine cover (the first strand of the FQ probe). A triggerrefers to an oligonucleotides that can interact with the spine andinitiate a cascade of signal amplification and detection reactions. Thetrigger can be part of the specific detection probe or reversecomplementary sequence of the specific detection probe, or it can be anysequence generated or released during amplification. The spine is anoligonucleotides containing complementary sequence of the FQ invaderkicker, the FQ invader, and the spine cover (the first strand of the FQprobe). A spine cover is hybridized with spine and prevents the FQinvader kicker from being extended when the trigger is not hybridizedwith spine. When the trigger is available, it hybridizes with the spine,separates the spine cover form the spine, and allows the FQ invaderkicker to hybridize with the spine and to get extended by a DNApolymerase with strand displacement activity. In turn, the trigger getsdisplaced and hybridizes with another un-reacted spine. Some formats maycombine two of the basic components in a single oligonucleotides via astem loop structure. For instance, the spine its self has hairpin loopstructure at its' 3′ end. But the 3′ end is flipped with a fewnucleotides to stop the 3′ end extension. In this case, a singlestranded hairpin oligonucleotides contains both spine and spine cover.Its 3′ end can be dye labeled and fluorescent intensity change can beused to monitor the amplification. In another embodiment, the 3′ end ofspine has a folding sequence, but cannot fold onto the spine due tospine cover. Upon FQ invader to hybridize to the spine to kick off thespine cover, the 3′ end spine will fold onto spine to extend to replacethe FQ invader probe. In another embodiment, spine cover is hybridizedat the 5′ end of spine. During amplification reaction, the 3′ end ofspine will use FQ invader as a template to extend. The extended spinewill fold onto itself to be further extended to replace 5′ end spinecover. Some formats of the universal detection probe may already haveone or more than one inactivated triggers hybridized with itscomplementary sequence as part of the spine or as a separateoligonucleotides in order to exponentially amplify fluorescent signal.In one embodiment, a spine may contain more than one spine covers. Someformats of the universal detection probe may carry the fluorophore andquencher on spine and spine cover, or vise versa, whereas other formatsmay carry fluorophore and quencher in the FQ invader kicker, or aseparate universal FQ probe is provided to generate fluorescent signal.Some formats may only carry fluorophore without a quencher in thesystem, and use intercalating dye as a fluorescence quencher (patentpub. NO.: US 2012/0282617 A1).

The invader kicker is artificial sequence that allows to incorporatefull or partial of aptamer sequence into spine. There are many kinds ofapatmer sequences available in literatures, such as thrombin aptamer,ATP aptamer, etc. One example of the partial aptamer is G-quadruplexsequences. For instance, the invader kicker may contain partial ofG-quadruplex sequences. A full G-quadruplex sequence is formed when theinvader kicker is extended with the spin as template. The extendedinvader kicker will form stable G-quadruplex structure to allow anotherinvader kicker to hybridize to spine to generate exponentialamplification. The invader kicker can include artificial sequence at its5′ end. The artificial sequence may include natural or unnaturalnucleotides as needed. In another embodiment, in order to preventinvader kicker to interact with the spine and spine cover before FQinvader to trigger the amplification, the 3′ end of the invader kickermay include mismatch when it is hybridized to the spine. The mismatchmay be at its 3′ end or near 3′ end. In another embodiment, the newlysynthesized double stranded spine from invader kicker can interact withanother FQ probe to generate exponential amplification. In anotherembodiment, the spine may contain chemical moiety to stop polymeraseextension.

In another embodiment, invader kicker has a hairpin structure with 5′end fluorescent dye labeled. The reaction system will includeintercalating dye to quench the invader kicker fluorescence before it ishybridized with spine. Upon it is hybridized with the spine due to FQinvade to trigger the reaction, 5′ end of invader kicker will be singlestranded and the 5′end fluorescent dye will not be quenched byintercalating dye. The changed fluorescent intensity can be used tomonitor the amplification.

A preferred detection method for the amplification reactions disclosedherein includes FQ probes. An “FQ probe” is a nucleic acid that includesa fluorophore and a quencher that become sufficiently separated duringthe amplification reaction and/or the detection method that thefluorophore will fluoresce. An exemplary form of FQ probes is disclosedin U.S. Patent Publ. 2013/0171643. The FQ probes are typically doublestranded nucleic acids where the fluorophore is on one strand and thequencher is on the other strand. The FQ probes will typically include asingle stranded region for annealing. During the amplification reaction,the strand displacing polymerase will separate the two strands of the FQprobes permitting the fluorophore to fluoresce. In preferred embodimentsany of the following may comprise FQ probes: one or both foldbackprimers, one or more stem acceleration primers, or one or more loopacceleration primers. In particularly preferred embodiments, one or moreof the extruding sequences will comprise an FQ probe.

In certain aspects, the FQ probe will be a universal probe. A “universalFQ probe” will not itself anneal to the template nucleic acid, butrather will anneal to an arbitrary sequence included in one or more ofthe primers involved in the foldback primer amplification reactionincluding: one or more foldback primers, one or more stem accelerationprimers, one or more loop acceleration primers, one or more kickeracceleration primers, or combinations thereof. The universal FQ probesare a new type of probe for use in foldback primer amplificationreactions generally (rather than being specific to omega amplification)and are therefore an independent aspect of the disclosure. Because theuniversal FQ probes do not anneal to the template nucleic acid, theuniversal FQ probes can be re-used in many different, unrelatedamplification reactions simply by including the arbitrary annealingsequence in one of the primers included in the reaction.

The universal FQ probes will generally be activated in one of two ways.First, an “FQ invader” behavior as a primer that will anneal to theuniversal FQ probe, preferably to a single stranded portion of theuniversal FQ probe. The strand displacement amplification polymerasewill then use FQ invader as a primer to extend and displace the doublestranded portion of the universal FQ probe so that the fluorophore isseparated from the quencher so that the fluorophore fluoresces. The FQinvader can be included as a second strand of any of the primers usedfor foldback amplification including, without limitation: one or morefoldback primers, one or more stem acceleration primers, or one or moreloop acceleration primers, or combinations thereof. Duringamplification, the FQ invader will then be displaced by the stranddisplacement amplification polymerase when the primer's complementarystrand is synthesized. Upon displacement, the FQ invader can then annealto the universal FQ probe to be used a primer to activate the universalFQ probe. Alternatively, the complementary sequence of the FQ invadercan be included in one or more of the primers so that the FQ invaderwill be generated by the strand displacement amplification polymerasewhen the primer's complementary strand is generated. Upon subsequentdisplacement the newly synthesized FQ invader will be able to anneal tothe universal FQ probe. In preferred embodiments, the FQ invader isannealed to one or more extruding sequences or the extruding sequence issingle stranded but includes the complementary sequence of the FQinvader. FIG. 3 provides an exemplary implementation of a universal FQprobe and an FQ invader that is annealed to a loop acceleration primer.In such case, FQ invader is a primer and the universal FQ probe is itstemplate for extension.

Second, an “FQ invader” behavior as a probe in toehold replacementreaction that will anneal to both a single stranded portion of theuniversal FQ probe and to a double stranded portion of the universal FQprobe. The FQ invader will first anneal to the single stranded portionof the universal FQ probe and then will displace the second strand ofthe universal FQ probe where the FQ invader overlaps with the doublestranded portion of the universal FQ probe. Displacing the second strandof the universal FQ probe from the universal FQ probe will separate thefluorophore from the quencher so that the fluorophore will fluoresce. Ina preferred embodiment, an “FQ invader kicker” will anneal to a doublestranded portion of the universal FQ probe on the same strand 5′ ofwhere the FQ invader anneals. Therefore, when the FQ invader anneals anddisplaces the second strand of the universal FQ probe, the invaderkicker will be able to anneal and provide a free 3′ OH group for thestrand displacement amplification polymerase to extend. Extension by thestrand displacement amplification polymerase will displace the FQinvader allowing it to anneal to another universal FQ probe that has notbeen activated. Thus, a single FQ invader will be able to activatemultiple universal FQ probes thereby further amplifying the signal. FIG.7 provides an exemplary implementation of a universal FQ probe and an FQinvader that is annealed to a loop acceleration primer. FIG. 7 furtherillustrates the use of an invader kicker to displace the FQ invader sothat it can continue to activate universal FQ probes in a signalamplification cycle.

Examples of the quencher may include, but are not limited to, DABCYL,TAMRA, and the Black Hole Quenchers (BHQ) (Biosearch Technologies,Novato, Calif.). Examples of the fluorophore may include, but are notlimited to, fluorescein, cy3, cy5, and any number of quantum dots asknown in the art. When the two strands of the FQ probe anneal, thefluorophore and the quencher are sufficiently close so that thefluorophore will not effectively fluoresce.

In certain embodiments, the ratio of the fluorophore containing strandto the quencher containing strand may be selected to be less than about1:1 (e.g., higher concentrations of the quencher containing strand thanfluorophore containing strand). Examples of such ratios may include, butare not limited to, less than about 1:1.1, less than about 1:1.2, lessthan about 1:1.3, less than about 1:1.4, less than about 1:1.5, lessthan about 1:1.6, less than about 1:1.7, less than about 1:1.8, lessthan about 1:1.9, and smaller. Examples of such ratios may furtherinclude, but are not limited to, less than about 1:2, less than about1:3, less than about 1:4, less than about 1:5 and smaller. Higher ratioshave been found to reduce the degree to which the presence of theuniversal FQ probe when incorporated into one of the primers inhibitsthe rate of the amplification reaction disclosed herein and reduce thedegree of background fluorescence confounding detection.

In further embodiments, the manner of mixing the two strands of the FQprobe when incorporated into one of the primers into the amplificationreaction mixture may be varied to increase the speed of theamplification reaction and, thus reducing the time needed to generate anamount of amplicon nucleic acid sufficient for detection. Thefluorophore containing strand and the quencher containing strand may bein an unannealed state with respect to each other when added to theamplification reactions disclosed herein. In certain embodiments, thefluorophore containing strand to the quencher containing strand may beadded to the amplification reactions disclosed herein concurrently withone another or at different times.

It was previously observed that adding the fluorophore containing strandand the quencher containing strand directly to a LAMP reaction mixtureindividually, as opposed to adding a double-stranded FQ probe to a LAMPreaction mixture, the LAMP reaction rate was relatively uninhibited,resulting in faster indication of a positive reaction (see, e.g.,Example 5 of US Patent Publ. 2013/0171643).

The total amount of the FQ probe within the amplification reaction mayalso be varied to influence the speed of the amplification reaction andthe onset of observable fluorescence. The detection time may besignificantly reduced by using less amounts of the fluorescent andquencher probe strands that are added to the amplification reaction. Forexample, the amount of fluorescence probe strand added to theamplification reaction may be greater than about 0.08 μM, greater thanor equal to about 0.4 μM, greater than or equal to about 1.6 μM, etc.and respective concentrations of the quencher probes may be greater thanor equal to about 0.16 μM, greater than or equal to about 1.6 μM, etc.

In further embodiments, the ratio of fluorescent probe strand to thequencher probe strand may be less than about 1:1. Examples of suchratios may include, but are not limited to, less than less than about1:1.5, less than about 1:2, less than about 1:2.5, less than about 1:3,less than about 1:3.5, less than about 1:1.4, less than about 1:1.4.5,less than about 1:5, less than about 1:5.5, less than about 1:1.60, lessthan about 1:1.65, less than about 1:1.70, less than about 1:1.75, lessthan about 1:1.80, less than about 1:8.5, less than about 1:9, less thanabout 1:9.5, and smaller. Examples of such ratios may further include,but are not limited to, about 1:2, about 1:3, about 1:4, about 1:5 andsmaller.

In certain embodiments, the amount of the fluorescent probe strand andthe quencher probe strand may be kept as low as possible while stillproviding detectable levels of fluorescence when positive amplificationof the template nucleic acid by the amplification reaction takes place.In this manner, detection may still be performed while substantiallyeliminating reduction in the amplification reaction rate due to thepresence of the universal FQ probe. In certain embodiments, the amountof the fluorescent probe strand may be within the range between about0.01 to about 0.4 μM. In further embodiments, the amount of the quencherprobe may selected be within the range between about 0.02 to about 0.8μM. In other embodiments, the total amount of the universal FQ probe maybe within the range between about 0.03 μM to about 1.2 μM.

B. Molecular Beacon

In certain aspects, molecular beacon sequences are used for detection ofamplification of the target nucleic acid and/or the amplicon nucleicacid. Nucleic acids in beacon configurations are extensively used asspecific DNA sensing matrices. The specific linkage of photoactivechromophores/quenchers to the hairpin termini results in chromophoreluminescence quenching. The subsequent lighting-up of the chromophoreluminescence by the hybridization of the analyzed DNA hairpins and thebeacons opening was used as a general motif for the photonic detectionof DNA (Tyagi, S.; Kramer, F. R. Nat. Biotechnol. 1996, 14, 303-308. (b)Tyagi, S.; Marras, S. A. E.; Kramer, F. R. Nat. Biotechnol. 1998, 18,1191-1196.). The quenching of dyes by molecular or nanoparticlequenchers (Dubertret, B.; Calame, M.; Libchaber, A. Nat. Biotechnol.2001, 19, 365-370.) or the fluorescence resonance energy transfer (FRET)between dyes was used for the optical detection of the hybridizationprocess of the DNA to the beacon.

C. G-Quadruplex Sequences

In certain aspects, G-quadruplex sequences are used for detection ofamplification of the target nucleic acid and/or the amplicon nucleicacid. In the presence of certain metal ions (e.g., K⁺), short guanine(G)-rich sequences fold into a structure known as a G-quartet orquadruplex. Quadruplexes are very stable and biophysical studies haveshown that they possess intrinsic optical properties (e.g., absorb lightat 300 nm) that distinguish them from other secondary structures.Previously, quadruplex-formation assays have been developed that exploitthis unique quadruplex signature to study enzymes that cleave DNA[Kankia, B. I. (2006) A real-time assay for monitoring nucleic acidcleavage by quadruplex formation, Nucleic acids research, 34, p. 141] orfacilitate strand-exchange reactions [Kankia, B. I. (2004) Opticalabsorption assay for strand-exchange reactions in unlabeled nucleicacids, Nucleic acids research, 32, p. 154]. Briefly, when G-richsequences with the potential to form a quadruplex are incorporated intoDNA substrates they are initially in the quenched state. Upon enzymaticactivity (e.g. strand cleavage or strand-exchange) the released sequencefolds into a quadruplex and becomes visible when monitored by absorptionand fluorescence spectroscopy. There are many publications in literatureto describe how to detect G-quadruplex formation by fluorescence (TopCurr Chem (2013) 330: 111-178, Chem. Commun., 2015, 51, 16033, CriticalReviews in Biochemistry and Molecular Biology, 2011; 46(6): 478-492).For instance, the porphyrinsmeso-5,10,15,20-Tetrakis-(N-methyl-4-pyridyl) porphine (TMPyP4) andN-methylmesoporphyrin IX (NMM), Thioflavin have been used as quadruplexdetection probes. Porphyrin interaction with DNA in the presence of lowcation concentrations showed that NMM can serve as an effectivefluorescent probe for quadruplex structures in presence of all cations,unlike TMPyP4. TMPyP4 was an effective probe in presence of potassiumonly. G-quadruplex can be detected by antibody (NATURE CHEMISTRY, VOL 5,MARCH 2013, 182). Moreover, biochemical studies show that G-quadruplexis a catalytic DNA that possesses peroxidase-like activities.G-quadruplex can form a supramolecular complex with hemin. This complexwas reported to catalyze the oxidation of2,2′-azinobis(3-ethylbenzothiozoline)-6-sulfonic acid, ABTS, by H₂O₂ (acommon reaction used for the assay of peroxidase activity). It wassuggested that the supramolecular docking of the guanine-quadruplexlayers facilitates the intercalation of hemin into the complex, and theformation of the biocatalytically active hemin center. In certainaspects, G-quadruplex sequences are used for detection of amplificationof the target nucleic acid and/or the amplicon nucleic acid. TheG-quadruplex sequences can be included in any of the primers in thefoldback primer amplifications reaction including: one or both foldbackprimers, one or more stem acceleration primers, one or more loopacceleration primers, one or more kicker acceleration primers, orcombinations thereof. The G quadruplex sequences are a new type of probefor use in foldback primer amplification reactions generally (ratherthan being specific to omega amplification) and are therefore anindependent aspect of the disclosure.

D. Intercalating Agents

Different types of detectable moieties have been described for thedetection of amplification products. One class of detectable moieties isintercalating agents, which bind non-specifically to double-strandednucleic acid. Intercalating agents have a relatively low fluorescencewhen unbound, and a relatively high fluorescence upon binding todouble-stranded nucleic acids. As such, intercalating agents can be usedto monitor the accumulation of double strained nucleic acids during anucleic acid amplification reaction. Examples of such non-specific dyesinclude intercalating agents such as SYBR Green I (Molecular Probes),propidium iodide, ethidium bromide, and the like. Other types ofdetectable moieties employ derivatives of sequence-specific nucleic acidprobes. For example, oligonucleotide probes are labeled with one or moredyes, such that upon hybridization to a template nucleic acid, adetectable change in fluorescence is generated.

E. Pyrophosphate

A large amount of inorganic pyrophosphate is produced as a result of theamplification reactions disclosed herein generating the amplicon nucleicacids. Pyrophosphate has been used in detection methods in the art.Exemplary detection methods are discussed below.

1. Turbidity

The robust nucleic acid amplification of the invention can generatelarge amounts of insoluble pyrophosphate as a reaction product.Detection using the insoluble substance as an indicator can be carriedout by measuring turbidity or by detecting precipitation. Measurement ofturbidity or detection of precipitation can be carried out by adding acoagulant (e.g., polyacrylic acid or carboxymethyldextran). The obtainedturbidity can be used as an indicator to detect nucleic acidamplification. When measuring the absorbance, commonly employedmeasuring apparatuses can be used. The wavelength for measuring theabsorbance can be suitably determined, and measurement is generallycarried out at 300 to 800 nm, preferably at the dominant wavelength of340 to 400 nm, and at the complementary wavelength of 600 to 800 nm.When measuring the scattered light intensity, commonly employedmeasuring apparatuses can be used. Specifically, measurement of changesin the absorbance over time enables the monitoring of the progress onnucleic acid amplification depending on the duration of the reactiontime. (U.S. Pat. No. 7,374,879). Addition of a coagulant such aspolyacrylic acid or carboxymethyldextran increases the precipitate yieldand can improve the detection sensitivity. Further, these insolublesubstances can be colored or labeled, thereby facilitating the detectionor improving the detection sensitivity. For example, addition of AcidOrange colorizes the insoluble substances and detection is facilitated.

2. HNB Dye

Hydroxynaphthol blue (HNB) is a metal ion indicator. As disclosed above,during the Omega amplification reaction, magnesium concentrationdecreases since magnesium forms complexes with pyrophosphate andprecipitates. The decrease in magnesium concentration accompanyingnucleic acid amplification causes a change in the color of a reactionmixture to which HNB has been added in a concentration varying from 0.05to 0.2 mM and, more preferably from 0.1 to 0.15 mM. In particular, thecolor of the mixture passes from a purple tone to a light blue tone. Thecolorimetric metal indicator particularly preferred for the aims of thepresent invention is hydroxynaphthol blue. Other colorimetric metalindicators can also be used, which are preferably selected from among:hydroxynaphthol blue, eriochrome black T, 8-hydroxyquinoline+butylamide,titanium yellow, xylidyl blue, calmagite, magon, thymol blue, eriochromecyanine R, alizarin S, o-cresolphthalein, 1,2,3-trihydroxyanthraquinone,leucoquinizarin, quinalizarin,p-nitrobenzene-azo-p-nitrobenzene-resorcinol, butylamide, chromotrope2B, ammonia+phenolphthalein, alkaline hypoiodites,pentamethinedibarbituric acid and diphenylcarbazide. Calcein, orfluorexon, is a chelating agent that fluoresces in the presence of boundCa′ and can be used as a colorimetric metal indicator.

3. Luminescence

In one embodiment, the Bioluminescent Assay in Real-Time (BART) reportersystem is used to detect the synthesis of the amplicon nucleic acids.This system has been explained in detail in WO2004/062338 andWO2006/010948 (which are hereby incorporated by reference). BART is anexample of a reporter system designed for isothermal amplificationreactions which produces a single type of signal from a sample: abioluminescent signal. BART uses the firefly luciferase-dependentdetection of inorganic pyrophosphate. As such, molecular diagnostics canbe achieved with BART simply by measuring the light emitted from closedtubes, in a homogeneous phase assay. BART has been used in a number ofisothermal amplification reactions, including those operating between50-63° C. The BART reporter is a particularly effective means to followthe rate of amplification in a reaction since the light outputrepresents a measure of the instantaneous rate of amplification. Incontrast, fluorescent detection methods typically show the accumulationof a signal and therefore the amplification rate has to be determinedbased upon the rate of change of fluorescent signal.

V. Applications of the Disclosed Methods

The amplification reactions disclosed herein may be used in variousapplications. One application includes methods for determining whether aparticular target nucleic acid sequence within a template nucleic acidis present in an organism's genetic code. For example, it could be usedfor determining whether the nucleic acid sequence of the templatenucleic acid has been genetically modified, for detection of DNAassociated with a particular non-genetically modified breed of plant ora genetically modified plant, for detection of DNA associated withpedigree breeds of animal or for medical or veterinary diagnosticapplications such as genetic testing or forensic. The methods of usingthe amplification reactions disclosed herein are also suitable for thedetection of single-nucleotide polymorphisms (SNPs).

The amplification reactions disclosed herein may be also used indiagnostic methods. In particular the reactions allow identification andquantification of organisms in a patient sample and other samples. Theorganism may be any microorganisms, such as viruses, bacteria,mycoplasma and fungi. The microorganism can be pathogenic but it mayalso be a non-pathogenic microorganism. The microorganism may also be agenetically modified organism (GMO). Furthermore, the amplificationreactions disclosed herein can be used to identify genetically modifiedcrops and animals, for the detection of a disease state, for theprediction of an adverse reaction from a therapy and also for theprediction of a disease state susceptibility.

“Patient samples” include any sample taken from a subject and caninclude blood, stool, swabs, sputum, Broncho Alveolar Lavage Fluid,tissue samples, urine or spinal fluids. Other suitable patient samplesand methods of extracting them are well known to those of skill in theart. A patient or subject from whom the sample is taken may be a humanor a non-human animal. When a sample is not specifically referred to asa patient sample, the term also comprises samples taken from othersources. Examples include swabs from surfaces, water samples (forexample waste water, marine water, lake water, drinking water), foodsamples, cosmetic products, pharmaceutical products, fermentationproducts, cell and microorganism cultures and other samples in which thedetection of a microorganism is desirable.

VI. Kits

In a further aspect, this disclosure includes kit for use in performingthe amplification reactions disclosed herein, which can be for aspecific application or detection method disclosed herein. The kitspreferably include all the components necessary to practice theamplification reaction or detection method disclosed herein, except thetarget nucleic acid which is to be amplified or tested (except where atarget nucleic acid may be included as a positive control).

The kit for use in the amplification reactions and methods disclosedherein preferably comprises a polymerase, the substrates for the nucleicacid polymerase and foldback primers suitable for isothermalamplification of the target nucleic acid as well as appropriateacceleration primers. More preferably, the kit further comprises bufferreagents, such as a source of magnesium ions, or additives known toimprove the shelf-life of kit reagents such as trehelose or additivesknown to help preserve reagents such as sodium azide. Alternatively, akit for use in a method according to the invention may comprise onlysome of these components and/or additional components. The sample andany other components that have been omitted from the kit may then beadded to the kit during use.

The kits may include additional components suitable for any detectionmethods to be performed during or after the amplification reaction ofthe kit. For example, the kit may include a thermostable luciferase,luciferin and an enzyme that converts inorganic pyrophosphate (PPi) toATP, such as ATP sulphurylase, and any other required substrates orcofactors of the enzyme that converts PPi to ATP, such as adenosine 5′phosphosulphate, may be included in the kit.

Preferably, at least one of the components of the kit is lyophilized oris in another form which is suitable for storage in the kit. Morepreferably, all of the components of the kit are lyophilized or in oneor more other forms suitable for storage. Such other forms includecomponents to which stabilizing factors have been added and/or arefrigerated or frozen master mix that contains the components of thekit.

EXAMPLES

The following are examples of methods and compositions of the presentdisclosure. It is understood that various other embodiments may bepracticed, given the general description provided above.

Example 1: Comparison of HPV18 Real Time Isothermal Amplification withOmega Primers and LAMP Primers

Omega primers containing extruding sequences on either the first primer(exFIP), second primer (exBIP), or both primers were utilized inreal-time isothermal amplification reactions. Amplification reactionwere carried out in a 25 ul reaction containing 20 mM Tris-HCl, 10 mM(NH4)2SO4, 10 mM KCl, 4 mM MgSO4, 0.1% Triton X-100, 0.4 mM each dNTP,0.2M Betaine, foldback primers 0.8 μM 18FIP (SEQ ID NO:1) or ex18FIP(SEQ ID NO:2) and 0.8 μM 18BIP (SEQ ID NO:3) or ex18BIP (SEQ ID NO:4),loop acceleration primers 0.4 μM 18LF (SEQ ID NO:5) and 0.3 μM 18LB (SEQID NO:6), FQ probe 0.1 μM FAM-18LB (SEQ ID NO:7) and 0.1 μM Q-oligo (SEQID NO:8), kicker acceleration primers 0.2 μM 18KF (SEQ ID NO:9) and 0.2μM 18 KB (SEQ ID NO:10), 8 Units of Bst DNA polymerase Large Fragment(New England Biolabs) and 20,000 copies of non-denatured recombinantplasmids containing HPV18 sequences (SEQ ID NO:11). The reaction wascarried out at 60° C. for 150 minutes with FAM fluorescence measured at30 second interval in a Biorad IQ-5 Real-time PCR Instrument. Thereal-time amplification profile was compared to that of LAMP primers(FIG. 9). Both LAMP primers and extruding omega primers were able toamplify target DNA and gave comparable real-time fluorescent signalintensity. Amplification with a single-side omega primer showed aslightly slower rate comparing to a standard LAMP reaction using thisprimer set. Amplification with omega primers on both sides showed adramatic delay comparing to a standard LAMP reaction.

(SEQ ID NO: 1) 5′-ACGTCTGGCCGTAGGTCTTTGCAGCTACAGCACACCCCCTCA(SEQ ID NO: 2) 5′-TTTTTTTTTT- ACGTCTGGCCGTAGGTCTTTGCAGCTACAGCACACCCCCTCA(SEQ ID NO: 3) 5′-TGCTACACGACCTGGACACTGTGGA- TGTAGGTGTAGCTGCACCGAGA(SEQ ID NO: 4) 5′-TTTTTTTTTT-TGCTACACGACCTGGACACTGTGGA-TGTAGGTGTAGCTGCACCGAGA (SEQ ID NO: 5) 5′-CGGACACGGTGCTGGAATAC(SEQ ID NO: 6) 5′-CATTGTGGACCTGTCAACCCA (SEQ ID NO: 7)5′-Fam-CACAGCCACTCCGCAGGGTCCACGCACGATCGCACCTG- CATTGTGGACCTGTCAACCCA(SEQ ID NO: 8) 5′-CAGGTGCGATCGTGCGTGGACCCTGCGGAGTGGCTGTG-BHQ(SEQ ID NO: 9) 5′-CGGTATCCGCTACTCAGCTTGT (SEQ ID NO: 10)5′-TGTTACCACTACAGAGTTTCCGTCTT (SEQ ID NO: 11)5′-AATATGGGAACACAGGTACGTGGGAAGTACATTTTGGGAATAATGTAATTGATTGTAATGACTCTATGTGCAGTACCAGTGACGACACGGTATCCGCTACTCAGCTTGTTAAACAGCTACAGCACACCCCCTCACCGTATTCCAGCACCGTGTCCGTGGGCACCGCAAAGACCTACGGCCAGACGTCGGCTGCTACACGACCTGGACACTGTGGACTCGCGGAGAAGCAGCATTGTGGACCTGTCAACCCACTTCTCGGTGCAGCTACACCTACAGGCAACAACAAAAGACGGAAACTCTGTAGTGGTAACACTACGCCTATAATACATTTAAAAGGTGACAGAAACAGTTTAAAATGTTTACGGTACAGATTGCGAAAACATAGCGAC CACTATAGAGA

Example 2: Comparison of Omega and LAMP Amplification Product Size

Amplification products were run on a 1.5% agarose gel with 0.5 μg/mlEthidium Bromide in TBE buffer. The amplified DNA products werevisualized under UV light. Both Omega and LAMP primers generated largeamplification products with a similar size pattern (FIG. 10).

Example 3: Comparison of Omega and LAMP Products by Restriction EnzymeDigestion Analysis

Experiments were performed as described in Example 1 except withfollowing fold-back primer pairs for each reaction: Lane 1&5,EcoRI-ex18FIP (SEQ ID NO:12) and 18BIP (SEQ ID NO:3); Lane 2&6, 18FIP(SEQ ID NO:1) and EcoRI-ex18BIP (SEQ ID NO:13); Lane 3,4,7,8 EcoRI-18FIP(SEQ ID NO:14) and 18BIP (SEQ ID NO:3). Amplification products wereseparated on a 1.5% agarose gel in TBE buffer. The gel was stained withEthidium Bromide and the amplified DNA products were visualized under UVlight.

Amplification products produced using Omega and LAMP primers weretreated with restriction enzymes EcoRI, and subsequently run on a gel todetermine the size patterns of the digested products (FIG. 11). Lanes1-4 display amplification products cut by the restriction enzymes. Lanes5-8 display amplification products not cut by the restriction enzymes.These results demonstrate that, unlike in the LAMP amplification wherethe FIP and BIP sequences are duplicated repeatedly in the finalamplification products, the Omega extruding sequence is not repeatedlyduplicated in the amplification product. Therefore, the Omegaamplification products were not cut by the restriction enzyme EcoRIrepeatedly to produce short and distinguishable fragments, while theLAMP amplification products were cut into short and distinguishablefragments by restriction enzymes.

(SEQ ID NO: 12) 5′-TTTTGAATTC-ACGTCTGGCCGTAGGTCTTTGCAGCTACAGCACACCCCCTCA (SEQ ID NO: 13)5′-TTTTTTTTTTTTTTTTGAATTC- TGCTACACGACCTGGACACTGTGGA-TGTAGGTGTAGCTGCACCGAGA (SEQ ID NO: 14) 5′-ACGTCTGGCCGTAGGTCTTTGC-GAATTC-AGCTACAGCACACCCCCTCA

Example 4: Omega Amplification with Both Folding Primer Fold to the SameRegion in the Template

Experiments were performed as described in Example 1 except withfollowing primers: omega amplification primers 0.8 μM 73ovlp-exFIP (SEQID NO:15) (or 7350ovlp-exFIP (SEQ ID NO:16) or 73-exFIP (SEQ ID NO:17)),0.8 μM 73-BIP (SEQ ID NO:18), loop acceleration primers 0.4 μM 73ovlp-LF(SEQ ID NO:19) (or 7350ovlp-LF (SEQ ID NO:20) or 73-LF (SEQ ID NO:21),correspondingly), and 0.3 μM 73-LB (SEQ ID NO:22), FQ probe 0.1 μMFam-73-LB (SEQ ID NO:23), 0.1 μM Q-oligo (SEQ ID NO:8), and kickeracceleration primers 0.2 μM 73-KF (SEQ ID NO:24) and 0.2 μM 73-KB (SEQID NO:25), with 20,000 copies of recombinant plasmids containing HPV73sequences as template DNA (SEQ ID NO:26). The reaction was carried outat 60° C. for 100 minutes with fluorescence measured at 30 secondinterval in a Biorad IQ-5 Real-time PCR Instrument. Both standard Omegaamplification and overlapping folding Omega amplification were able toamplify target DNA and gave comparable real-time fluorescent signalcurves.

(SEQ ID NO: 15) 5′-TTTTTTTTTT-ACTCTCGTTCAGCTTGTCTGTCTAGAT-CTTACATGTTACGAGTCATTGGACA (SEQ ID NO: 16)5′-TTTTTTTTTT-TTGTCTGTCTAGATGGCTGTCTGTTTC- CCGAAATTGACCTTACATGTTACGAGT(SEQ ID NO: 17) 5′-TTTTTTTTTT-GCTGTCTGTTTCATCCTCATCCTCTG-GAAACCAACAACCGAAATTGACCTT (SEQ ID NO: 18)5′-ATCTAGACAGACAAGCTGAACGAGAGT- TGTTGCTTTCAATGGCAAGGC (SEQ ID NO: 19)5′-GTCTGTTTCATCCTCATCCTCT (SEQ ID NO: 20) 5′-CTCATCCTCTGAGTTGTCCA(SEQ ID NO: 21) 5′-AGTTGTCCAATGACTCGTAACATG (SEQ ID NO: 22)5′-AGAATAGTTACTGACTGCACGAAGT (SEQ ID NO: 23)5′-Fam-CACAGCCACTCCGCAGGGTCCACGCACGATCGCACCTG- AGAATAGTTACTGACTGCACGAAGT(SEQ ID NO: 24) 5′-CCTTGCAGGACATTACTTTAGACCT (SEQ ID NO: 25)5′-ACCCATAAGCAACTCTTCTATCACTC (SEQ ID NO: 26)5′-AAGATGCATGGAAAAAAAACAACCTTGCAGGACATTACTTTAGACCTGAAACCAACAACCGAAATTGACCTTACATGTTACGAGTCATTGGACAACTCAGAGGATGAGGATGAAACAGACAGCCATCTAGACAGACAAGCTGAACGAGAGTGTTACAGAATAGTTACTGACTGCACGAAGTGTCAGTGCACAGTATGCCTTGCCATTGAAAGCAACAAAGCTGATTTAAGAGTGATAGAAGAGTTGCTTATGGGTACACTAGGTATTGTGTGCCCCAACTGTTCCAGA

Example 5: STEM Primer Accelerates Omega Amplification

Experiments were performed as described in Example 1 except withfollowing primers: 0.8 μM HPV6G-FIP (SEQ ID NO:27), 0.8 μM HPV6G-BIP(SEQ ID NO:28) or 0.8 μM HPV6G BIP-22 nt (SEQ ID NO:29), forward loopaccelerator primer 0.4 μM HPV6G-LF (SEQ ID NO:30), FQ Probe 0.1 μMHPV6G-LB-Fam (SEQ ID NO:31) and 0.1 μM Q-oligo (SEQ ID NO:8), reverseloop accelerator primer 0.3 μM HPV6G-LB (SEQ ID NO:32), and kickeraccelerator primers 0.2 μM HPV6G-KF (SEQ ID NO:33) and 0.2 μM HPV6G-KB(SEQ ID NO:34), with or without 0.4 μM HPV6GP (SEQ ID NO:47) in thepresence of 20,000 copies of recombinant plasmids containing HPV6sequences as template DNA (SEQ ID NO:35). The reaction was carried outat 60° C. for 90 minutes with fluorescence measured at 30 secondinterval in a Biorad IQ-5 Real-time PCR Instrument. Real-timeamplification curves showed that the stem primer significantlyaccelerated Omega amplification.

(SEQ ID NO: 27) 5′-CGAACGTTGCTGTCACATCCACAG- TGGACGGACAAGATTCACAACCTT(SEQ ID NO: 28) 5′-GAGAAGTGCAACAGCTTCTGTTGGG-CTGAATCGTCCGCCATCGTT(SEQ ID NO: 29) 5′-TTTTTTTTTTTTTTTTTTTTTT- GAGAAGTGCAACAGCTTCTGTTGGG-CTGAATCGTCCGCCATCGTT (SEQ ID NO: 30) 5′-CAACAGGTCACTATTTGGTAATGTTGTT(SEQ ID NO: 31) 5′-FAM-CACAGCCACTCCGCAGGGTCCACGCACGATCGCACCTG-CATCTGCGCACCGAAGACA (SEQ ID NO: 32) 5′-CATCTGCGCACCGAAGACA(SEQ ID NO: 33) 5′-GCAATTAGTAGACAGCTCAGAAGATGA (SEQ ID NO: 34)5′-TGTACACCCAGACCCCTCAT (SEQ ID NO: 47)5′-TGGTTGTGCAGTGTACAGAAACAGACATCA (SEQ ID NO: 35)5′-CCCTGTAGGGTTACATTGCTATGAGCAATTAGTAGACAGCTCAGAAGATGAGGTGGACGAAGTGGACGGACAAGATTCACAACCTTTAAAACAACATTACCAAATAGTGACCTGTTGCTGTGGATGTGACAGCAACGTTCGACTGGTTGTGCAGTGTACAGAAACAGACATCAGAGAAGTGCAACAGCTTCTGTTGGGAACACTAAACATAGTGTGTCCCATCTGCGCACCGAAGACATAACAACGATGGCGGACGATTCAGGTACAGAAAATGAGGGGTCTGGGTGTACA GGATGGTTTATGGTAGAAGCTA

Example 6: Fold-Back Loop Primers Accelerate LAMP and OmegaAmplification

Experiments were performed as described in Example 1 except withfollowing primers for LAMP amplification reactions: 35-FIP (SEQ ID NO:36), 35-BIP (SEQ ID NO: 37), 35-LF (SEQ ID NO: 38) or 35-FBLF (SEQ IDNO: 39), 35-LB (SEQ ID NO: 40) or 35-FBLB (SEQ ID NO: 41), 35-KF (SEQ IDNO: 42), 35-KB (SEQ ID NO: 43) and 0.1 μM 35-LF-FAM (SEQ ID NO: 44); andfor Omega amplification reactions: 35-exFIP (SEQ ID NO: 45), 35-BIP,35-LF or 35-FBLF, 35-LB or 35-FBLB, 35-KF, 35-KB and 0.1 μM 35-LF-FAM,in the presence of 2,0000 copies of recombinant plasmids containingHPV35 sequences as template DNA (SEQ ID NO: 46). The reaction wascarried out at 60° C. for 40 minutes with fluorescence measured at 60second interval in a Biorad CFX-96 Real-time PCR Instrument. Compared toregular loop primers, fold-back loop primers accelerated isothermalamplification reactions both in the LAMP and Omega amplifications.

(SEQ ID NO: 36) 5′-AGGCTTTGGTATGGGTCTCGGTGGT- GCACAGAACTATCCACTGCTGA(SEQ ID NO: 37) 5′-GGCACCACAGAAACGCAGAAGACA-CTGAGTCGCACTCGCTTGG(SEQ ID NO: 38) 5′-GGCGTGTAGCTGTGTAGCAAT (SEQ ID NO: 39)5′-AGGCTTTGGTATGGGTCTCGGTGGT- GGCGTGTAGCTGTGTAGCAAT (SEQ ID NO: 40)5′-AATCACAAACGACTTCGAGGGG (SEQ ID NO: 41) 5′-GGCACCACAGAAACGCAGAAGACA-AATCACAAACGACTTCGAGGGG (SEQ ID NO: 42) 5′-GTAATTGTTTGTCCTGAATCTGTATTTAGC(SEQ ID NO: 43) 5′-GTCAACACTGTCCACGGCA (SEQ ID NO: 44)5′-FAM-CACAGCCACTCCGCAGGGTCCACGCACGATCGCACCTG GGCGTGTAGCTGTGTAGCAAT(SEQ ID NO: 45) 5′-TTTTTTTTTT-AGGCTTTGGTATGGGTCTCGGTGGT-GCACAGAACTATCCACTGCTGA (SEQ ID NO: 46)5′-TATGGGAAGTGCATGTGGGTGGTCAGGTAATTGTTTGTCCTGAATCTGTATTTAGCAGCACAGAACTATCCACTGCTGAAATTGCTACACAGCTACACGCCTACAACACCACCGAGACCCATACCAAAGCCTGCTCCGTGGGCACCACAGAAACCCAGAAGACAAATCACAAACGACTTCGAGGGGGTACCGAGCTCCCCTACAACCCCACCAAGCGAGTGCGACTCAGTGCCGTGGACAGTGTTGACAGAGGGGTCTACTCTACATCTGA

Example 7: Universal Detection Probes can be Used as a SignalAmplification and Detection Method for an Target Sequence Detection orfor an Isothermal Amplification Reaction

Universal detection probes were utilized to detect an invader trigger ina real-time isothermal reaction using the format as shown in FIG. 14.Reaction were carried out in a 25 ul reaction containing 20 mM Tris-HCl,10 mM (NH4)2SO4, 10 mM KCl, 4 mM MgSO4, 0.1% Triton X-100, 0.4 mM eachdNTP, 0.2M Betaine, 0.1 μM spine sequence (SEQ ID NO: 74), 0.1 μM spinecover (SEQ ID NO: 48), 0.8 μM universal primer (SEQ ID NO: 49), 8 Unitsof Bst DNA polymerase Large Fragment (New England Biolabs) and variousconcentration of invader trigger (SEQ ID NO: 50) as the target. Spinesequence and spine cover were mix together before universal primer andpolymerase were added. The reaction was carried out at 60° C. for 60minutes with FAM fluorescence measured at 60 second interval in an ABIStepOne Real-time PCR Instrument. This universal detection system wasable to amplify and detect signal generated from less than 8 nM invadertrigger (FIG. 23A).

Moreover, these universal detection probes were utilized in a LAMPreaction in replacement of a specific FQ probe using a design shown inFIG. 9. Experiments were performed as described above except withfollowing primers for LAMP amplification reactions and signal detection:33-FIP (SEQ ID NO: 51), 33-BIP (SEQ ID NO: 52), 33-LF (SEQ ID NO: 53),33-LB (SEQ ID NO: 54), 33-KF (SEQ ID NO: 55), 33-KB (SEQ ID NO: 56), and0.1 μM 33-FQ-LB (SEQ ID NO: 57) with quencher probe (SEQ ID NO:8) or 0.1μM 33-TRIGGER′-LB (SEQ ID NO: 58) with universal detection probes (SEQID NO: 48-50 and 74). 10000 copies of plasmid containing HPV33 targetsequence (SEQ ID NO: 59) were used as template. 33-FQ-LB and quencherprobe, or 33-TRIGGER′-LB and trigger sequence were pre-mixed beforebeing added to the reaction. Signal detection using universal detectionprobe showed comparable speed as that using specific probe detection(FIG. 23B)

(SEQ ID NO: 74) 5′-AGCCTGAGTGCGTCCAACCGTGCGACAGGTGCGATCGTGCGTGGACCCTGCGGAGTGGCTGTG-BHQ (SEQ ID NO: 48)5′-Fam-CACAGCCACTCCGCAGGGTCCACGC-TT (SEQ ID NO: 49) 5′-CACAGCCACTCCGC(SEQ ID NO: 50) 5′-AGGGTCCACGC-ACGATCGCACCTGTCGCACGGTTGGACGCACTC(SEQ ID NO: 51) 5′-CACAGGTAGGGCACACAATATTCACTG-CAACAGTACAGCAAGTCACCTACGA (SEQ ID NO: 52)5′-AACATCATCTACAATGGCCGATCCTGA- GACTGCTTCTACCTCAAACCAACC (SEQ ID NO: 53)5′-TGCCCATAAGTAGTTGCTGTATGGT (SEQ ID NO: 54) 5′-GTACAAATGGGGCTGGGATG(SEQ ID NO: 55) 5′-CACTTGTAACACCACAGTTCGTT (SEQ ID NO: 56)5′-TCTGAAATATTATCTCCTGTTCTTCTCTCT (SEQ ID NO: 57)5′-Fam-CACAGCCACTCCGCAGGGTCCACGCACGATCGCACCTG- GTACAAATGGGGCTGGGATG(SEQ ID NO: 58) 5′-GAGTGCGTCCAACCGTGCGACAGGTGCGATCGTGCGTGGACCCT-GTACAAATGGGGCTGGGATG (SEQ ID NO: 59)5′-CACTTGTAACACCACAGTTCGTTTATGTGTCAACAGTACAGCAAGTGACCTACGAACCATACAGCAACTACTTATGGGCACAGTGAATATTGTGTGCCCTACCTGTGCACAACAATAAACATCATCTACAATGGCCGATCCTGAAGGTACAAATGGGGCTGGGATGGGGTGTACTGGTTGGTTTGAGGTAGAAGCAGTCATAGAGAGAAGAACAGGAGATAATATTTCAGA

Example 8: Universal Detection Probes with Additional Trigger in Spinecan be Used as a Signal Amplification and Detection Method

Universal detection probes with additional trigger in spine wereutilized to detect an invader trigger in a real-time isothermal reactionusing the format as shown in FIG. 15. Reaction were carried out in a 25ul reaction containing 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 4 mMMgSO4, 0.1% Triton X-100, 0.4 mM each dNTP, 0.2M Betaine, 0.1 μM spinesequence (SEQ ID NO: 75-C3spacer-SEQ ID NO: 76), 0.1 μM spine cover (SEQID NO: 77), 0.2 μM invader kicker (SEQ ID NO: 49), 8 Units of Bst DNApolymerase Large Fragment (New England Biolabs) and variousconcentration of invader trigger (SEQ ID NO: 50) as the target. Spinesequence and spine cover were mix together before universal primer andpolymerase were added. The reaction was carried out at 60° C. for 60minutes with FAM fluorescence measured at 60 second interval in an ABIStepOne Real-time PCR Instrument.

(SEQ ID NO: 75-C3 spacer-SEQ ID NO: 76) 5′-CGAGA-AGGGTCC-ACGCACGATCGCACCTGTCGCACGGTTGGACGCACTC-GA-C3spacer-GA-GAGTGCGTCCAACCGTGCGACAGGTGCGATCGTGCGT-GGACCCT-TCTCG-TTTTTGAGTGCGTCCAACCGTGCGACAGGTGCGATCGTGCGTGGACCCTGCGGAGTGGCTGTC-Fam (SEQ ID NO: 77)5′-BHQ-GACAGCCACTCCGCAGGGTCCACGCACG-TTT

Example 9: Universal Detection Probes with an Additional Spine Cover anda Second Invader Kicker can be Used as a Signal Amplification andDetection Method

Universal detection probes with an additional spine cover and a seconduniversal primer were utilized to detect an invader trigger in areal-time isothermal reaction using the format as shown in FIG. 16.Reaction were carried out in a 25 ul reaction containing 20 mM Tris-HCl,10 mM (NH4)2SO4, 10 mM KCl, 4 mM MgSO4, 0.1% Triton X-100, 0.4 mM eachdNTP, 0.2M Betaine, 0.1 μM spine sequence (SEQ ID NO: 47), 0.1 μM spinecover 1 (SEQ ID NO: 48), 0.1 μM spine cover 2 (SEQ ID NO: 53), 0.1 μMuniversal primer 1 (SEQ ID NO: 79), 0.1 μM universal primer 2 (SEQ IDNO: 80), 8 Units of Bst DNA polymerase Large Fragment (New EnglandBiolabs) and various concentration of invader trigger (SEQ ID NO: 81) asthe target. Spine sequence and spine covers were mix together beforeinvader kicker and polymerase were added. The reaction was carried outat 60° C. for 60 minutes with FAM fluorescence measured at 60 secondinterval in an ABI StepOne Real-time PCR Instrument.

(SEQ ID NO: 78) 5′-ACGATCGCACCTGTCGCACG-TTTT (SEQ ID NO: 79)5′-CAGCCACTCCGC (SEQ ID NO: 80) 5′-GTCCACGC-ACGA (SEQ ID NO: 81)5′-GCACCTGTCGCACGGTTGGACGCACTCAGGCT

Example 10: Universal Detection Probes can be Applied Together with aG-Quadruplex Motif Mediated Exponential Signal Detection Method

Universal detection probes with G-quadruplex motif mediated exponentialsignal detection mechanism were utilized to detect an invader trigger ina real-time isothermal reaction using the format as shown in FIG. 17.Reaction were carried out in a 25 ul reaction containing 20 mM Tris-HCl,10 mM (NH₄)₂SO₄, 10 mM KCl, 4 mM MgSO₄, 0.1% Triton X-100, 0.4 mM eachdNTP, 0.2M Betaine, 0.1 μM spine sequence (SEQ ID NO: 82), 0.1 μM spinecover (SEQ ID NO: 83), 0.1 μM invader kicker (SEQ ID NO: 84), 8 Units ofBst DNA polymerase Large Fragment (New England Biolabs) and variousconcentration of invader trigger (SEQ ID NO: 50) as the target. Spinesequence and spine cover were mix together before invader kicker andpolymerase were added. The reaction was carried out at 60° C. for 60minutes with FAM fluorescence measured at 60 second interval in an ABIStepOne Real-time PCR Instrument.

(SEQ ID NO: 82) 5′-GAGTGCGTCCAACCGTGCGACAGGTGCGAT-CGTGCGTGGACCCT-CCCACCCACCCTC-BHQ (SEQ ID NO: 83)5′-Fam-GAGGGTGGGTGGG-AGGGTCCACGCACG-TAA (SEQ ID NO: 84)5′-GG-GAGGGTGGGTG

Example 11: Universal Detection Probes with a Fam-Labeled, MolecularBeacon-Formed Invader Kicker can be Used as a Signal Amplification andDetection Method

Universal detection probes with a Fam-labeled, molecular beacon(MB)-formed universal primer were utilized to detect an invader triggerin a real-time isothermal reaction using the format as shown in FIG. 18.Reaction were carried out in a 25 ul reaction containing 20 mM Tris-HCl,10 mM (NH₄)₂SO₄, 10 mM KCl, 4 mM MgSO₄, 0.1% Triton X-100, 0.4 mM eachdNTP, 0.2M Betaine, 6.25 μg/ml methylene blue as liquid quencher, 0.1 μMspine sequence (SEQ ID NO: 60), 0.12 μM spine cover (SEQ ID NO: 61), 0.1μM MB-formed invader kicker (SEQ ID NO: 62-C3 spacer-SEQ ID NO: 85), 8Units of Bst DNA polymerase Large Fragment (New England Biolabs) andvarious concentration of invader trigger (SEQ ID NO: 50) as the target.Spine sequence and spine cover were mix together before invader kickerand polymerase were added. The reaction was carried out at 60° C. for 60minutes with FAM fluorescence measured at 60 second interval in an ABIStepOne Real-time PCR Instrument.

(SEQ ID NO: 60) 5′-AGCCTGAGTGCGTCCAACCGTGCGACAGGTGCGATCGTGCGTGGACCCTGCGGAGTGGCTGTG (SEQ ID NO: 61) 5′-CACAGCCACTCCGCAGGGTCCACGC-TT(SEQ ID NO: 62-C3 spacer-SEQ ID NO: 85)5′-Fam-GCGGA-C3 spacer-CACAGCCACTCCGC

Example 12: Universal Detection Probes with Spine and Cover Sequence inOne Oligo can be Used as a Signal Amplification and Detection Method

Universal detection probes with spine and cover sequence in one oligowere utilized to detect an invader trigger in a real-time isothermalreaction using the format as shown in FIG. 19. Reaction were carried outin a 25 ul reaction containing 20 mM Tris-HCl, 10 mM (NH₄)₂SO₄, 10 mMKCl, 4 mM MgSO₄, 0.1% Triton X-100, 0.4 mM each dNTP, 0.2M Betaine, 6.25μg/ml methylene blue as liquid quencher, 0.1 μM spine-cover sequence(SEQ ID NO: 63), 0.2 μM invader kicker (SEQ ID NO: 64), 8 Units of BstDNA polymerase Large Fragment (New England Biolabs) and variousconcentration of invader trigger (SEQ ID NO: 65) as the target. Thereaction was carried out at 60° C. for 60 minutes with FAM fluorescencemeasured at 60 second interval in an ABI StepOne Real-time PCRInstrument.

(SEQ ID NO: 63) 5′-CCACGAGTGCCAGTGCGTC-CAACGCGTCGACAGGTGCGATCGT-GATCTCTCGTTAT-GCG GAG TGG C TG TG-ATCCGC- ATAACGAGAGA/T-FAM/CTT(SEQ ID NO: 64) 5′-CAGCCAC-TCCGC (SEQ ID NO: 65)5′-ATAACGAGAGATC-ACGATCGCACCTGTCGACGCGTTG

Example 13: Universal Detection Probes with a Self-Priming Spine can beUsed as a Signal Amplification and Detection Method

Universal detection probes with a self-priming spine were utilized todetect an invader trigger in a real-time isothermal reaction using theformat as shown in FIG. 20. Reaction were carried out in a 25 ulreaction containing 20 mM Tris-HCl, 10 mM (NH₄)₂SO₄, 10 mM KCl, 4 mMMgSO₄, 0.1% Triton X-100, 0.4 mM each dNTP, 0.2M Betaine, 0.1 μM spinesequence (SEQ ID NO: 66), 0.11 μM quencher probe (SEQ ID NO: 67), 0.12μM spine cover (SEQ ID NO: 68), 8 Units of Bst DNA polymerase LargeFragment (New England Biolabs) and various concentration of invadertrigger (SEQ ID NO: 69) as the target. Spine sequence, spine cover andquencher probe were mix together before polymerase were added. Thereaction was carried out at 60° C. for 60 minutes with FAM fluorescencemeasured at 60 second interval in an ABI StepOne Real-time PCRInstrument.

(SEQ ID NO: 66) 5′-Fam-GCGTGGACCCTGCGGAGTGGCTGTG-AT-CACTCCCTCCAACCCTCCCACACCTCCCATCCT-CCCTCCACCCT- GAGCTA-CACATC-TAGCTC(SEQ ID NO: 67) 5′-CACAGCCACTCCGCAGGGTCCACGC-BHQ (SEQ ID NO: 68)5′-GAGCTAGATGTGTAGCTCAGGGTGGAGGGAGGATGGGAG-TTT (SEQ ID NO: 69)5′-AGGGTGGAGGGAGGATGGGAGGTGTGGGAGGGTTGGAGGGA-TTT

Example 14: Universal Detection Probes Featuring a Spine that is Capableof Self-Priming after Extension Along the Invader Trigger can be Used asa Signal Amplification and Detection Method

Universal detection probes with a spine that is capable of self-primingafter extension along the invader trigger were utilized to detect aninvader trigger in a real-time isothermal reaction using the format asshown in FIG. 21. Reaction were carried out in a 25 ul reactioncontaining 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 4 mM MgSO4, 0.1%Triton X-100, 0.4 mM each dNTP, 0.2M Betaine, 0.1 μM spine sequence (SEQID NO: 70), 0.12 μM quencher probe (SEQ ID NO: 67), 8 Units of Bst DNApolymerase Large Fragment (New England Biolabs) and variousconcentration of invader trigger (SEQ ID NO: 71) as the target. Spinesequence and quencher probe were mix together before polymerase wasadded. The reaction was carried out at 60° C. for 60 minutes with FAMfluorescence measured at 60 second interval in an ABI StepOne Real-timePCR Instrument.

(SEQ ID NO: 70) 5′-Fam-GCGTGGACCCTGCGGAGTGGCTGTG-AT-GCATGCACGATCGCACCTGTCGCAC-GAGTCCTCCCAACC (SEQ ID NO: 71)5′-GCATGCACGATCGCACCTGTCGCACGGTTGGGAGGACTC-TAT

Example 15: Universal Detection Probes Featuring a Hairpin-StructuredSpine that is Capable of Self-Priming after Extension Along the InvaderTrigger can be Used as a Signal Amplification and Detection Method

Universal detection probes featuring an alternative design of a spinethat is capable of self-priming after extension along the invadertrigger were utilized to detect an invader trigger in a real-timeisothermal reaction using the format as shown in FIG. 22. Reaction werecarried out in a 25 ul reaction containing 20 mM Tris-HCl, 10 mM(NH4)2SO4, 10 mM KCl, 4 mM MgSO4, 0.1% Triton X-100, 0.4 mM each dNTP,0.2M Betaine, 0.1 μM spine sequence (SEQ ID NO: 72), 0.12 μM quencherprobe (SEQ ID NO: 67), 8 Units of Bst DNA polymerase Large Fragment (NewEngland Biolabs) and various concentration of invader trigger (SEQ IDNO: 73) as the target. Spine sequence and quencher probe were mixtogether before polymerase was added. The reaction was carried out at60° C. for 60 minutes with FAM fluorescence measured at 60 secondinterval in an ABI StepOne Real-time PCR Instrument.

(SEQ ID NO: 72)  5′-Fam-GCGTGGACCCTGCGGAGTGGCTGTG-AT-GCCGAGAGTCCTCCCAACCGTCTGT-AGCGAGAC-ATAT-GTCGCAC- GTCTCGCA-TCCCAC(SEQ ID NO: 73) 5′-GTCGCACGTGGGA- ACAGACGGTTGGGAGGACTCTCGGC-/3phos/

Example 16

Example 16 shows an exemplary experiment result using universaldetection probes in a real-time isothermal reaction based on the formatas shown in FIG. 14. 0 nM (green), 0.8 nM (black), 8 nM (red), 80 nM(light blue) and 800 nM (dark blue) invader trigger was detected in a 25ul reaction containing 0.1 μM spine sequence, 0.1 μM spine cover, 0.8 μMinvader kicker. The reaction was carried out at 60° C. for 48 minuteswith FAM fluorescence measured at 60 second interval in an ABI StepOneReal-time PCR Instrument. FIGS. 23A and 23B shows comparison result of aLAMP reaction using universal detection probe as shown in FIG. 9 ascompared to a LAMP reaction using universal FQ probe detection.

All of the compositions and/or methods disclosed and claimed herein canbe made and executed without undue experimentation in light of thepresent disclosure. While the compositions and methods of this inventionhave been described in terms of preferred embodiments, it will beapparent to those of skill in the art that variations may be applied tothe compositions and/or methods and in the steps or in the sequence ofsteps of the method described herein without departing from the concept,spirit and scope of the invention. More specifically, it will beapparent that certain agents which are both chemically andphysiologically related may be substituted for the agents describedherein while the same or similar results would be achieved. All suchsimilar substitutes and modifications apparent to those skilled in theart are deemed to be within the spirit, scope and concept of theinvention as defined by the appended claims.

1. A method of detecting a template nucleic acid in a sample using astrand displacement isothermal amplification reaction comprising (i)generating the reaction by combining the sample with (a) one or moreamplification primers configured to generate amplicon nucleic acids fromthe template nucleic acids under suitable amplification conditions, and(b) a strand displacement amplification polymerase; (ii) maintaining thereaction under the suitable amplification conditions; and (iii)detecting whether amplification occurs or has occurred in step (ii) bymonitoring during or after step (ii) interaction between (c) a specificdetection probe that, under the suitable amplification conditions,hybridizes to the template nucleic acid, its compliment, the ampliconnucleic acid or its compliment, and (d) a universal detection probe. 2.The method of claim 1, wherein the universal detection probe is auniversal FQ probe.
 3. The method of claim 1 or claim 2, wherein theuniversal detection probe does not anneal to the template nucleic acidor its complement under the suitable amplification conditions.
 4. Themethod of any one of claims 1-3, wherein the interaction between thespecific detection probe and the universal detection probe is throughhybridization during the amplification.
 5. The method of any one ofclaims 1-3, wherein the interaction between the specific detection probeand the universal detection probe is through hybridization between thecomplement of the specific detection probe and the universal detectionprobe.
 6. The method of any one of claims 1-3, wherein the interactionbetween the specific detection probe and the universal detection probeis through hybridization and polymerase extension during theamplification.
 7. The method of any one of claims 1-3, wherein thespecific detection probe comprises an internal chemical moiety to stoppolymerase extension.
 8. The method of any one of claims 1-7, whereinthe universal detection probe comprises a first detectionoligonucleotide strand and a second detection oligonucleotide strand. 9.The method of claim 8, wherein (a) the first detection oligonucleotidestrand comprises a quencher moiety and the second detectionoligonucleotide strand comprises a fluorophore, or (b) the firstdetection oligonucleotide strand comprises a fluorophore and the seconddetection oligonucleotide strand comprises a quencher moiety, whereinthe quencher moiety and the fluorophore are configured so that thequencher moiety quenches the fluorescence of the fluorophore when firstdetection oligonucleotide strand and a second detection oligonucleotidestrand are annealed.
 10. The method of claim 9, wherein the ratio of theamount of the detection oligonucleotide strand comprising thefluorophore to the amount of the detection oligonucleotide strandcomprising the quencher moiety is less than 1:1.
 11. The method of claim9 or claim 10, wherein the detecting step (ii) comprises measuringfluorescence emitted during the isothermal strand displacementamplification.
 12. The method of any one of claims 8-11, wherein thesecond detection oligonucleotide strand comprises an overhangingunmatched segment that is not complementary to the first detectionoligonucleotide strand.
 13. The method of any one of claims 8-12,wherein the specific detection probe or its complement includes aninvader that hybridizes to a portion of the overhanging unmatchedsegment and to a portion of the second detection oligonucleotide strandthat is complementary to the first detection oligonucleotide strandduring or after the amplification.
 14. The method of claim 12, furthercomprising an invader kicker probe includes mismatch near its 3′ end orat 3′ end when it hybridizes to the second detection oligonucleotidestrand.
 15. The method of claim 14, further comprising an invader kickerreplacement probe to replace the invader kicker probe once the invaderkicker probe is extended along the second detection oligonucleotidestrand.
 16. A method of detecting a template nucleic acid in a sampleusing a strand displacement isothermal amplification reaction comprising(i) generating the reaction by combining the sample with (a) one or moreamplification primers configured to generate amplicon nucleic acids fromthe template nucleic acids under suitable amplification conditions, and(b) a strand displacement amplification polymerase; (ii) maintaining thereaction under the suitable amplification conditions; and (iii)detecting whether amplification occurs or has occurred in step (ii) bymonitoring during or after step (ii) an aptamer probe; wherein theaptamer probe is part of a specific detection probe that, under suitableamplification conditions, hybridizes to the template nucleic acid, itscompliment, an amplicon nucleic acid or its compliment.
 17. The methodof claim 16, the aptamer probe is a G-quadruplex probe.
 18. The methodof claim 16 or claim 17, wherein the G-quadruplex probe generates adetectable signal selected from the group consisting of chromogenesis,fluorescence, luminescence, and chemiluminescence.
 19. The method of anyone of claims 1-18, wherein the strand displacement amplificationpolymerase is selected from the group consisting of Bst DNA polymerase,Bca(exo-) DNA polymerase, Klenow fragment of DNA polymerase I, Vent DNApolymerase, Vent(Exo-) DNA polymerase (exonuclease activity-free VentDNA polymerase), DeepVent DNA polymerase, DeepVent(Exo-) DNA polymerase(exonuclease activity-free DeepVent DNA polymerase), Φ29 phage DNApolymerase, MS-2 phage DNA polymerase, Z-Taq DNA polymerase (TakaraShuzo), and KOD DNA polymerase (TOYOBO).
 20. The method of any one ofclaims 1-18, wherein the strand displacement amplification polymerase isBst DNA polymerase or Bca(exo-) DNA polymerase.
 21. The method of anyone of claims 1-20, wherein one of the amplification primers is foldbackprimer.
 22. The method of any one of claims 1-21, wherein the stranddisplacement isothermal amplification reaction is LAMP, SMAP, GEAR,NEAR, or CPA.
 23. The method of any one of claims 1-21, wherein theisothermal amplification reaction is omega amplification and the pair ofprimers are foldback primers and at least one of the foldback primers isextruding primer.
 24. The method of claim 23, wherein the extrudingsequence in the extruding primer comprises the specific detection probesequences.
 25. The method of claim 23 or claim 24, wherein the extrudingsequence comprises internal modification to stop polymerase extension.26. The method of any one of claims 1-25, wherein the stranddisplacement isothermal amplification reaction comprises one or morethan one kicker accelerator primers, or one or more than one stemaccelerator primers, or one or more than one loop accelerator primers.27. The method of claim 26, wherein the kicker accelerator primer orloop accelerator primer or stem accelerator primer comprises foldingsequences at its 5′ end to fold onto its 3′ end downstream sequencesafter 3′ end is extended by a polymerase.
 28. The method of any one ofclaims 1-20, wherein the strand displacement isothermal amplificationreaction is RCA.
 29. The method of any one of claims 1-20, wherein thestrand displacement amplification is nicking amplification and step (i)includes combining a nicking enzyme included in the reaction.
 30. Themethod of any one of claims 1-29, wherein the specific detection probeis an oligonucleotide that participates in the isothermal stranddisplacement amplification.
 31. An omega amplification primer setcomprising a first foldback primer and a second foldback primer thatallow isothermal amplification under suitable omega amplificationconditions of a portion of a target nucleic acid sequence, wherein thefirst foldback primer comprises a first extruding sequence at its 5′terminus or the second foldback primer comprises a second extrudingsequence at its 5′ terminus.
 32. The omega amplification primer set ofclaim 31, wherein: (i) the target nucleic acid sequence has a firststrand, wherein the first strand is complimentary to a complementarystrand; (ii) the first foldback primer includes from 5′ to 3′: (1-b) asequence (F1c), wherein the sequence (F1c) hybridizes to a sequence(F1T) in the complimentary strand of the target nucleic acid sequence;and (1-c) at the 3′ terminus, a sequence (F2), wherein the sequence (F2)hybridizes to a sequence (F2cT) in the first strand of the targetnucleic acid sequence, wherein the sequence (F1T) is 3′ of a sequence(F2T) in the complimentary strand; and the sequence (F2T) iscomplementary to the sequence (F2cT); (iii) the second foldback primerincludes from 5′ to 3′: (2-b) a second sequence comprising: a sequence(R1c), wherein the sequence (R1c) hybridizes to a sequence (R1T) in thefirst strand of the target nucleic acid sequence, (2-c) at the 3′terminus, a sequence (R2), wherein the sequence (R2) hybridizes to asequence (R2cT) in the complimentary strand of the target nucleic acidsequence, wherein the sequence (R1T) is 3′ of a sequence (R2T) in thefirst strand; and the sequence (R2T) is complementary to the sequence(R2cT); and (iv) the primer set further comprises: (X) (1-a) a firstextruding sequence at the 5′ terminus of the first foldback primer,wherein the first extruding sequence is at least 4 nucleotides andcannot hybridize to the first strand or the complimentary strand, andwherein the sequence (R1c) is at the 5′ terminus of the second foldbackprimer; (Y) (2-a) a second extruding sequence at the 5′ terminus of thesecond foldback primer, wherein the second extruding sequence is atleast 4 nucleotides and cannot hybridize to the first strand or thecomplimentary strand, and wherein the sequence (F1c) is at the 5′terminus of the first foldback primer; or (Z) (1-a) a first extrudingsequence at the 5′ terminus of the first foldback primers, wherein thefirst extruding sequence is at least 4 nucleotides and cannot hybridizeto the first strand or the complimentary strand, and (2-a) a secondextruding sequence at the 5′ terminus of the second primer, wherein thesecond extruding sequence is at least 4 nucleotides and cannot hybridizeto the first strand or the complimentary strand.
 33. The omegaamplification primer set of claim 32, wherein a portion of the sequence(F1c) can hybridize to a portion of the sequence (R1c).
 34. The omegaamplification primer set of claim 32, wherein the sequence (F1c) and thesequence (R1c) overlap by at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12,14, 16, 18, 20, 25, or 30 nucleotides.
 35. The omega amplificationprimer set of any one of claims 31-34, wherein the first extrudingsequence or the second extruding sequence is at least 3, 4, 5, 6, 7, 8,9, 10, 12, 14, 16, 18, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100,150, or 200 nucleotides.
 36. The omega amplification primer set of anyone of claims 31-35, wherein the first extruding sequence or the secondextruding sequence is less than 500, 450, 400, 350, 300, 250, 200, 150,100, 90, 80, 70, 60, 50, 45, 40, 35, 30, 25, or 20 nucleotides.
 37. Theomega amplification primer set of any one of claims 31-36, wherein thefirst extruding sequence or the second extruding sequence is 3 to 100nucleotides, 3 to 75 nucleotides, 3 to 50 nucleotides, or 4 to 30nucleotides in length.
 38. The omega amplification primer set of any oneof claims 31-37, wherein the first extruding sequence or the secondextruding sequence comprises a G-quadruplex, an aptamer sequence, an RNApromoter sequence, a nicking sequence, or an FQ detection sequence. 39.The omega amplification primer set of any one of claims 31-38, whereinthe first extruding sequence or the second extruding sequence is G rich.40. The omega amplification primer set of any one of claims 31-39,wherein the omega amplification reaction comprises one or more than onekicker accelerator primers, or one or more than one stem acceleratorprimers, or one or more than one loop accelerator primers.
 41. The omegaamplification primer set of any one of claims 31-40, wherein the kickeraccelerator primer or loop accelerator primer or stem accelerator primercomprises folding sequences at its 5′ end to fold onto its 3′ enddownstream sequences after 3′ end is extended by a polymerase.
 42. Theomega amplification primer set of any one of claims 31-41, wherein thefirst extruding primer or the second extruding primer has hairpinstructure at its 5′ terminus.
 43. The foldback primer amplificationprimer set of any one of claims 31-42, wherein foldback primer includesunnatural nucleotides.
 44. The foldback primer amplification primer setof any one of claims 31-43, wherein the folding hybridization sequenceincludes unnatural nucleotides.
 45. A method for determining whether asample includes a template nucleic comprising (i) combining the samplewith the set of omega amplification primers of any one of claims 31-44,a strand displacement amplification polymerase, and a detection probe;and (ii) maintaining the combination under the suitable omegaamplification conditions; and (iii) determining whether the sampleincludes the template nucleic acid by monitoring whether the detectionprobe is involved in amplification during step (ii) or has been involvedin amplification after step (ii).
 46. A method for assessing the amountof a template nucleic acid in a sample comprising (i) combining thesample with the set of omega amplification primers of any one of claims31-44, a strand displacement amplification polymerase, and a detectionprobe; and (ii) maintaining the combination under the suitable omegaamplification conditions; and (iii) quantifying the amount of thetemplate nucleic acid by monitoring the detection probe during or afterstep (ii).
 47. The method of claim 45 or claim 46, wherein themonitoring is performed during step (ii).
 48. The method of any one ofclaims 45-47, wherein the monitoring is based on a chromogenic reaction,a turbidity reaction, a chemiluminescent reaction, or a fluorescentreaction.
 49. The method of any one of claims 45-47, wherein themonitoring is monitoring fluorescent signal change from the detectionprobe.
 50. The method of any one of claims 45-49, wherein the detectionprobe has a universal FQ primer complement attached at its 5′ end. 51.The method of any one of claims 44-49, wherein the detection probe is aspecific detection probe and the monitoring is based on interactionbetween the specific detection probe or its complement and a universalFQ probe during amplification or after amplification.
 52. The method ofclaim 51, wherein the universal FQ probe comprises a first FQoligonucleotide strand and a second FQ oligonucleotide strand.
 53. Themethod of claim 52, wherein the first FQ oligonucleotide strand and thesecond FQ oligonucleotide strand do not hybridize to the template strandunder the suitable omega amplification conditions.
 54. The method ofclaim 52 or claim 53, wherein (a) the first FQ oligonucleotide strandcomprises a quencher moiety and the second FQ oligonucleotide strandcomprises a fluorophore, or (b) the first FQ oligonucleotide strandcomprises a fluorophore and the second FQ oligonucleotide strandcomprises a quencher moiety, wherein the quencher moiety and thefluorophore are configured so that the quencher moiety quenches thefluorescence of the fluorophore when first FQ oligonucleotide strand anda second FQ oligonucleotide strand are annealed and the detectingcomprises measuring fluorescence emitted during the isothermal stranddisplacement amplification.
 55. The method of claim 54, wherein theratio of the amount of the FQ oligonucleotide strand comprising thefluorophore to the amount of the FQ oligonucleotide strand comprisingthe quencher moiety is less than 1:1
 56. The method of any one of claims52-55, wherein the second FQ oligonucleotide strand comprises anoverhanging unmatched segment that is not complementary to the first FQoligonucleotide strand.
 57. The method of claim 56, wherein the specificdetection probe or its complement includes an invader that hybridizes toa portion of the overhanging unmatched segment and to a portion of thesecond detection oligonucleotide strand that is complementary to thefirst detection oligonucleotide strand during or after theamplification.
 58. The method of claim 57, further comprising an invaderkicker probe includes mismatch near its 3′ end or at 3′ end when ithybridizes to the second detection oligonucleotide strand.
 59. Themethod of claim 58, further comprising an invader kicker replacementprobe to replace the invader kicker probe once the invader kicker probeis extended along the second detection oligonucleotide strand.
 60. Themethod of any one of claims 45-59, wherein the detection probe oruniversal detection probe includes a G-quadruplex probe or an aptamerprobe.
 61. The method of any one of claim 45-60, wherein the firstextruding sequence or the second extruding sequence comprises thedetection probe.
 62. The method of any of claims 45-61, wherein thetemplate nucleic acid is a human papilloma virus (HPV).
 63. The methodof claim 62, wherein the HPV is HPV6, HPV11, HPV16, HPV18, HPV35, orHPV73.
 64. The method of claim 62, wherein the set of omegaamplification primers are 18FIP (SEQ ID NO:1) and ex18BIP (SEQ ID NO:4),ex18FIP (SEQ ID NO:2) and 18BIP (SEQ ID NO:3), or ex18FIP (SEQ ID NO:2)and ex18BIP (SEQ ID NO:4), optionally including a kicker accelerationprimer 18KF (SEQ ID NO:9) and/or 18 KB (SEQ ID NO:10), optionallyincluding a loop acceleration primer 18LF (SEQ ID NO:5) and/or 18LB (SEQID NO:6), and optionally including an FQ probe comprising FAM-18LB (SEQID NO:7) and Q-oligo (SEQ ID NO:8).
 65. The method of claim 62, whereinthe set of omega amplification primers are 73ovlp-exFIP (SEQ ID NO: 15)and 73-BIP (SEQ ID NO:18), 7350ovlp-exFIP (SEQ ID NO:16) and 73-BIP (SEQID NO:18), or 73-exFIP (SEQ ID NO:17) and 73-BIP (SEQ ID NO:18),optionally including a kicker acceleration primer 73-KF (SEQ ID NO:24)and/or 73-KB (SEQ ID NO:25), optionally including a loop accelerationprimer 73ovlp-LF (SEQ ID NO:19), 7350ovlp-LF (SEQ ID NO:20), 73-LF (SEQID NO:21), and/or 73-LB (SEQ ID NO:22), and optionally including an FQprobe comprising Fam-73-LB (SEQ ID NO:23) and Q-oligo (SEQ ID NO:8). 66.The method of claim 62, wherein the set of omega amplification primersare HPV6G-FIP (SEQ ID NO:27) and HPV6G BIP-22 nt (SEQ ID NO:29),optionally including a kicker acceleration primer HPV6G-KF (SEQ IDNO:33) and/or HPV6G-KB (SEQ ID NO:34), optionally including a loopacceleration primer 73ovlp-LF (SEQ ID NO:19), 7350ovlp-LF (SEQ IDNO:20), 73-LF (SEQ ID NO:21), and/or 73-LB (SEQ ID NO:22), andoptionally including an FQ probe comprising Fam-73-LB (SEQ ID NO:23) andQ-oligo (SEQ ID NO:8).
 67. The method of claim 62, wherein the set ofomega amplification primers are 35-exFIP (SEQ ID NO: 45) and 35-BIP (SEQID NO: 37), optionally including a kicker acceleration primer 35-KF (SEQID NO: 42) and/or 35-KB (SEQ ID NO: 43), optionally including a loopacceleration primer 35-LF (SEQ ID NO: 38), 35-FBLF (SEQ ID NO: 39),35-LB (SEQ ID NO: 40), and/or 35-FBLB (SEQ ID NO: 41), and optionallyincluding an FQ probe comprising 35-LF-FAM (SEQ ID NO: 44)) and Q-oligo(SEQ ID NO:8).
 68. A method of generating amplicon nucleic acids from atemplate nucleic acid in a sample using an omega amplification reactioncomprising (i) combining the sample with the set of omega amplificationprimers of any one of claims 31-44, and a strand displacementamplification polymerase; and (ii) generating amplicon nucleic acids bymaintaining the combination under suitable omega amplificationconditions.
 69. A method using the set of primers of any one of claims32-44 to make an amplicon nucleic acid from the target nucleic acidmolecule, wherein the amplicon nucleic acid is capable of forming afirst stem and loop at a first end, is capable of forming either asecond stem and loop or a foldback loop at a second end, and has (i) thefirst extruding sequence located at the terminus of the first end,and/or (ii) the second extruding sequence located at the terminus of thesecond end, the method comprising: (a) combining a sample with thetarget nucleic acid molecule with the set of primers of any one ofclaims 32-44; (b) annealing the sequence (F2) of the first primer to thesequence (F2cT) in the first strand of the target nucleic acid molecule;(c) extending the first primer from its 3′ end, using a suitablepolymerase, to form a first single-stranded nucleic acid moleculecomprising the first primer at the 5′ end and the sequence (R2cT); (d)displacing the first single-stranded nucleic acid molecule from thetarget nucleic acid sequence; (e) annealing the sequence (R2) of thesecond primer to the sequence (R2cT) in the first single-strandednucleic acid molecule; and (f) making the replicated portion of thetarget nucleic acid molecule by extending the second primer from its 3′end, using a suitable polymerase, to form a second single-strandednucleic acid molecule comprising the second primer at the 5′ end and asequence complimentary to the first primer; wherein the displacing step(d) is carried out by: (i) annealing the sequence (F2) of an additionalfirst primer to the sequence (F2cT) in the first strand of the targetnucleic acid molecule and extending the additional first primer from its3′ end, using a suitable polymerase, to displace the firstsingle-stranded nucleic acid molecule; (ii) steps (d) and (e); or (iii)(1) providing a first kicker primer comprising, at its 3′ terminus, asequence (F3), wherein the sequence (F3) hybridizes to a sequence (F3cT)and the sequence (F3cT) is 5′ of the sequence (F2cT) in the first strandof the target nucleic acid sequence; (2) annealing the sequence (F3) inthe first kicker primer to the sequence (F3cT) in the first strand ofthe target nucleic acid molecule; and (3) extending the first kickerprimer from its 3′ end, using a suitable polymerase, to displace thefirst single-stranded nucleic acid molecule.
 70. The method of any oneof claims 45-69, wherein the reaction is at least 20% as fast, at least30% as fast, at least 40% as fast, at least 50% as fast, at least 60% asfast, at least 70% as fast, at least 80% as fast, or even at least 100%as fast as the same reaction where the first extruding primer does notcomprises the first extruding sequence at its 5′ terminus and/or thesecond extruding primer does not comprise a second extruding sequence atits 5′ terminus.
 71. The method of any one of claims 45-70, wherein thefirst extruding sequence or the second extruding sequence is at least 1,2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 25, 30, 35, 40, 45, 50,60, 70, 80, 90, 100, 150, or 200 nucleotides.
 72. The method of any oneof claims 45-71, wherein the first extruding sequence or the secondextruding sequence is 1 to 100 nucleotides, 2 to 75 nucleotides, 3 to 50nucleotides, or 4 to 30 nucleotides in length.
 73. The method of any oneof claims 45-72, wherein the strand displacement amplificationpolymerase is selected from the group consisting of Bst DNA polymerase,Bca(exo-) DNA polymerase, Klenow fragment of DNA polymerase I, Vent DNApolymerase, Vent(Exo-) DNA polymerase (exonuclease activity-free VentDNA polymerase), DeepVent DNA polymerase, DeepVent(Exo-) DNA polymerase(exonuclease activity-free DeepVent DNA polymerase), Φ29 phage DNApolymerase, MS-2 phage DNA polymerase, Z-Taq DNA polymerase (TakaraShuzo), and KOD DNA polymerase (TOYOBO).
 74. The method of any one ofclaims 45-72, wherein the strand displacement amplification polymeraseis Bst DNA polymerase or Bca(exo-) DNA polymerase.
 75. The method of anyone of claims 45-74, wherein the sample is selected from a specimen, aculture, a patient sample, a subject sample, a biological sample, and anenvironmental sample.
 76. The method of claim 75, wherein the patientsample or the subject sample is from blood, saliva, cerebral spinalfluid, pleural fluid, milk, lymph, sputum, semen, stool, swabs, BronchoAlveolar Lavage Fluid, tissue samples, or urine.
 77. The method of anyone of claims 45-76, wherein the combining step further comprisescombining with a reaction accelerator selected from the group consistingof one or more acceleration primers, an RNA polymerase promoter, anicking sequence, and combinations thereof.
 78. The method of claim 77,wherein the reaction accelerator comprises the one or more accelerationprimers and the acceleration primers are selected from the groupconsisting of kicker acceleration primers, loop acceleration primers,and stem acceleration primers.
 79. The method of claim 77 or claim 78,wherein the reaction accelerator comprises the RNA polymerase promoterand the RNA polymerase promoter is included in the first extrudingprimer, the second extruding primer, the kicker acceleration primer, theloop acceleration primer, or the stem acceleration primer.
 80. Themethod of claim 77, wherein the RNA polymerase promoter is a T7 RNApolymerase promoter.
 81. The method of claim 77, wherein the reactionaccelerator comprises the nicking sequence and the nicking sequence isincluded in the first extruding primer, the second extruding primer, thekicker acceleration primer, the loop acceleration primer, or the stemacceleration primer.
 82. A kit comprising the set of primers of any ofclaim 31-44.
 83. The kit of claim 82, further comprising a stranddisplacement amplification polymerase.
 84. The kit of claim 83, whereinthe strand displacement amplification polymerase is selected from thegroup consisting of Bst DNA polymerase, Bca(exo-) DNA polymerase, Klenowfragment of DNA polymerase I, Vent DNA polymerase, Vent(Exo-) DNApolymerase (exonuclease activity-free Vent DNA polymerase), DeepVent DNApolymerase, DeepVent(Exo-) DNA polymerase (exonuclease activity-freeDeepVent DNA polymerase), Φ29 phage DNA polymerase, MS-2 phage DNApolymerase, Z-Taq DNA polymerase (Takara Shuzo), and KOD DNA polymerase(TOYOBO).
 85. The kit of claim 83, wherein the strand displacementamplification polymerase is Bst DNA polymerase or Bca(exo-) DNApolymerase.
 86. The kit of any one of claims 82-85, further comprising akicker acceleration primer, a loop acceleration primer, and/or a stemacceleration primer.
 87. The kit of any one of claims 82-86, furthercomprising a detection probe.
 88. The kit of claim 87, furthercomprising a universal detection probe that interacts with the detectionprobe during isothermal amplification.
 89. The kit of any one of claims82-88, further comprising a thermostable luciferase, luciferin and anenzyme that converts inorganic pyrophosphate to ATP.
 90. An ampliconnucleic acid derived from a target nucleic acid sequence comprising from5′ to 3′: (2) a second sequence comprising a sequence (R1c); (3) asequence (R2), wherein the sequence (R2) hybridizes to a sequence (R2cT)in a complimentary strand of the target nucleic acid sequence; (4) asequence (R1T), wherein the sequence (R1T) hybridizes to the sequence(R1c); (5) a sequence (F1cT); (6) a sequence (F2c), wherein the sequence(F2c) hybridizes to a sequence (F2T) in the complimentary strand of thetarget nucleic acid sequence; and (7) a sequence (F1), wherein thesequence (F1) hybridizes to (F1cT) wherein the nucleic acid furthercomprises: (X) (8) a first extruding sequence at the 3′ terminus,wherein the first extruding sequence is at least 4 nucleotides andcannot hybridize to the template nucleic acid or its compliment, andwherein the sequence (R1c) is at the 5′ terminus; (Y) (1) a secondextruding sequence at the 5′ terminus, wherein the second extrudingsequence is at least 4 nucleotides and cannot hybridize to the templatenucleic acid or its compliment, and wherein the sequence (F1) is at the3′ terminus; or (Z) (8) a first extruding sequence at the 3′ terminus,wherein the first extruding sequence is at least 4 nucleotides andcannot hybridize to the template nucleic acid or its compliment, and (1)a second extruding sequence at the 5′ terminus, wherein the secondextruding sequence is at least 4 nucleotides and cannot hybridize to thetemplate nucleic acid or its compliment.